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Chapter 1 
Epo and SCF cooperate to induce expansion of 
erythroid progenitors: An introduction 
Chapter 1 
1.1 Growth factors, receptors and signal transduction, a general introduction 
Both in higher eukaryotes as well as in bacteria, cells have to find a way to sense their sur-
roundings to be able to respond to different circumstances. Sensing light, nutrition gradients, 
osmotic differences or chemical concentrations are examples of environmental input crucial 
for bacteria or a lower single cell eukaryotes to survive. A multi-cellular organism consists of 
various different cell types with different functions and at different locations. Some cell types 
can only find a niche in a specific organ with tight boundaries like the liver, spleen etc. Other 
cell types are found all over the body like macrophages or dendritic, antigen presenting, cells. 
Also for these cells it is of crucial importance to scan the environment to make proper adjust-
ments and adaptations to function within the organism. Erythroid progenitors (the precursors 
of red blood cells), for instance, can sense a multitude of chemicals and peptides of which 
two are of crucial importance, Stem cell factor (SCF) and Erythropoietin (Epo). Interestingly, 
these factors elicit a different response when sensed in combination or when sensed on their 
own. In general the factors, ligands, bind to their specific protein counterpart, receptors, pres-
ent on or in the recipient cell. Binding of a ligand to the receptor induces a signal transduc-
tion cascade in which a multitude of proteins is involved resulting in a cellular response. In 
the case of the erythroid progenitor the combination of SCF and Epo plus glucocorticoids 
induces expansion or "renewal" of progenitor cells, while Epo alone causes maturation into 
an erythrocyte. One important factor determining the strength of signal transduction is the 
concentration of the ligand present in the environment. For instance, at steady state condi-
tions, the concentration of Epo is sub-optimal and more than 20% of the erythroid progeni-
tors in the bone marrow fail to undergo maturation and die via apoptosis. A slight increase of 
Epo leads to enhanced survival of erythroid progenitors and hence to an increase in red 
blood cells. The concentration of Epa is dependent on the oxygen pressure in blood as 
sensed by the kidney and thus directly related to the environment the organism is living in. In 
general there are ligand concentration gradients present in the body as a result of dilution: i) 
a high concentration at the source of ligand production that decreases with increasing dis-
tance from the source in the case of local production and ii) a systemic production of hor-
mones present with overall similar concentrations in the serum but resulting in concentration 
gradients in tissues. In addition to soluble factors, cell-cell contact can induce signalling 
events and, importantly, membrane bound ligands, like SCF, or ligand-presenting molecules 
like proteoglycans, can initiate signal transduction with different dynamics compared to the 
soluble counterpart. This way highly complex microenvironments are created in which a mul-
titude of ligands is present at various concentrations or in membrane bound states that affect 
the strength and duration of signal transduction and cellular responses, probably at a slight-
ly different level for each cell. To understand the cues that determine the fate of erythroid pro-
genitors it is important to know which proteins are involved in the signal transduction path-
ways and how these pathways of various receptors and combinations of receptors can have 
a profoundly different outcome with respect to proliferation, differentiation and survival. 
1.2 The hematopoietic system 
A typical example of a complex microenvironment is the hematopoietic birth chamber: the 
bone marrow. All hematopoietic cells derive from one cell type; the stem cells. Stem cells are 
able to undergo constant self-renewal, while they also develop into the different hematopoi-
etic progenitors that finally differentiate into the different functional blood cells (figure 1 ). 
Because of the limited life span of functional blood cells, constant replenishing of cells need-
ed. 
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Chapter 1 
To cope with the dynamic requirements of the organism for certain blood cell types, progen-
itors are constantly sensing varying concentrations of a set of growth factors. According to 
the "instructive model", these different growth factor gradients influence the decision to which 
lineage the progenitor becomes committed and hence controls the number of cells entering 
the various lineages. In contrast, in the "permissive" model hematopoiesis is defined as a sto-
chastic process in which the different growth factors play a role in the permission of lineages 
and in control of the total number of cells created within a lineage but not the actual lineage 
commitment decision itself. Nevertheless, both models dictate an enormous plasticity within 
hematopoietic system. Ultimate prove for one or the other model has not yet been obtained. 
As expected, a large number of growth factors, cytokines and hormones act on the 
hematopoietic system to control survival and a proper balance between expansion and mat-
uration of cells at various stages in the distinct lineages of the hematopoietic system. Partly, 
these factors target different progenitors but in various combinations they also act synergis-
tically on the same target cell. Some receptors may be lineage specific antennae for survival, 
proliferation or differentiation, like the receptor for erythropoietin (Epa) on the erythroid pro-
genitors or granulocyte-colony stimulating factor (G-CSF) receptor on neutrophilic progeni-
tors. In addition, the signalling molecules present in a specific cell type may determine their 
signalling capacities. Other receptors are expressed more widely in the hematopoietic sys-
tem like the receptor for stem cell factor (SCF), or interleukin 3 (IL-3). Their signalling prop-
erties may be determined by the cellular context and the activation of cooperating receptors. 
Our knowledge on general signalling pathways used by distinct receptors has increased 
largely over the recent years. However, we still understand little of the specificity in signalling, 
nor of the integration mechanism of signals induced by cooperating receptors. 
1.3 Erythropoiesis 
1.3.1 The erythrocyte 
45% of the blood volume consists of erythrocytes (red blood cells). Human mature erythro-
cytes have an average life span of 120 days (compared to 55 days in mice). Non-functional 
red blood cells are removed through phagocytosis by macrophages in the spleen and liver 1 • 
Since 1 011 senescent erythrocytes are removed each day, the same number has to be pro-
duced to maintain proper red blood cell numbers. Epa levels in the serum mainly control this 
balance. Tight control is crucial as tiny fluctuations in red blood cell levels in the blood cause 
the blood to thicken in case of over production, which could lead to blood clotting, thrombo-
sis, stroke etc. while a decreased production results in low oxygen pressure in tissues. 
1.3.2 Developmental stages in erythropoiesis 
Erythroid colony formation from total bone marrow has been studied extensively and has 
given insight into the cytokines and other growth factors necessary throughout erythropoiesis 
but has also into morphological changes and progenitor expansion kinetics at various stages 
of the erythroid development. . 
This way a crude separation has been made between early and late committed progenitors. 
The burst forming units-erythroid or BFU-E, is a committed early progenitor able to generate 
a colony of up to 5000 erythrocytes (12 cell divisions) when grown in semi-solid media in 
presence of Epa and SCF 23 • The colony forming units-erythroid, the CFU-E, is a late progen-
itor able to generate up to 60 erythrocytes when grown in semisolid medium in presence of 
Epa (6 cell divisions). The BFU-E is mainly dependent on SCF and subsequently matures 
into a CFU-E, which is dependent on Epa for its expansion and survival during differentiation. 
12 
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In addition to this classification by colony formation, erythroid progenitors can be classified 
from CFU-E to the maturated erythrocyte by morphology and the expression of stage-specif-
ic antigens. A CFU-E is morphologically defined as a pro-erythroblast, that develops into the 
basophilic erythroblast, the polychromatic erythroblast, the orthochromatic erythroblast and 
then to the erythrocyte. This process is accompanied by i) cell size reduction due to cell divi-
sions with loss of size control ii) condensation of chromatin in the nucleus followed by enu-
cleation and iii) increasing hemoglobin production. The enucleated reticulocyte still contains 
mitochondria, ribosomes and a golgi apparatus, which is lost within 24h during of further mat-
uration into the erythrocyte. 
Further characterization of erythroid differentiation is facilitated by suspension cultures in 
which pro-erythroblasts can be induced to undergo up to 20 'renewal divisions' in expansion 
medium (serum free medium supplemented with Epa, SCF and glucocorticoids), while they 
will synchronously differentiate to enucleated erythrocytes when expansion medium is 
replaced by differentiation medium (medium supplemented with Epa, Insulin and transfer-
ring). Differentiation entails 3 cell divisions without size control 4'5 • The large amounts of pure 
erythroid progenitors in a synchronous stage allows for extensive biochemical studies. An 
advantage of these suspension cultures of erythroid progenitors is the ease with which the 
erythroid progenitor is immortalized in absence of p53 without disrupting the differentiation 
capacity. This allows the establishment of cell lines from genetically modified mice p53 (128 , 
Schmidt in press) 
1.3.3 Stress and fetal liver erythropoiesis 
Upon blood loss, hemolysis, oxygen deprivation (high altitudes) or impaired erythrocyte func-
tion more red blood cells have to be made to sustain a proper oxygen tension in the body. 
This stress-induced erythropoiesis takes place in the spleen of mice and in the bone marrow 
in man. The necessary increase in red blood cells is accomplished by increasing the number 
of cell divisions an erythroid progenitor makes without entering terminal differentiation. This 
is further referred to as the "renewal" capability of erythroid progenitors. While basal condi-
tions only require to replace the senescent loss (2.5% of total red blood cell population per 
day), stress induces a 1 0-fold increase in erythropoiesis. Several lines of evidence indicate 
that cooperation between the Epa-receptor, c-Kit and glucocorticoids is essential for stress-
induced expansion of erythroid progenitors. Interestingly, it has been proposed that fetal ery-
thropoiesis resembles stress erythropoiesis in its mission to sustain an adequate increase of 
erythrocytes through enhanced self-renewal. In fact, in the early embryo adult hematocrit lev-
els have to be reached within only a few days, imposing huge demands on the erythropoiet-
ic system. This requires the erythroid progenitors to expand rigorously resembling the stress-
erythropoiesis situation. The liquid cultures described in 1.3.2. exploit this self-renewal capa-
bility of the erythroid progenitor to obtain large amounts of erythroid progenitor. These cul-
tures hence resemble a stress erythropoiesis model. 
1.4 Cytokines and growth factors in erythropoiesis 
Although Epa plays an important role in erythropoiesis it is not the only factor involved. A vari-
ety of other factors play a role in erythropoiesis. The major other factor is SCF, while in addi-
tion, ligands of nuclear hormone receptors (glucocorticoids, retinoic acid), transforming 
growth factor beta family members (TGFb, activin), insulin and insulin-like growth Ffactor-1 
(IGF-1), apoptosis inducers like the tumor necrosis factors (TNF), the interferon family and 
also ligands of G-protein coupled receptors (thrombin, nucleosides) have a role in mainte-
13 
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nance and control of erythroid cell numbers. Below the growth factors relevant to this thesis 
namely are outlined, followed by a short description of factors negatively influencing erythro-
poiesis. 
1.4.1 Erythropoietin 
The importance of Epo in erythropoiesis has been shown in knockout studies. Mice deficient 
in Epo or the EpoR die at day 12,5 of gestation with a lack of fetal liver erythrocytes 6• It has 
long remained unclear whether Epo is required for every aspect of erythropoiesis including 
lineage determination, expansion, survival and differentiation. Epo is not required for lineage 
commitment since Epo-/- fetal livers do contain CFU-E progenitors that can be rescued in 
vitro by exogenous Epo 6•7• In addition, over-expression of the EpoR does not result in 
increased commitment to the erythroid lineage 8 • In contrast, Epo is a limiting factor for expan-
sion and survival of erythroid progenitors during onset of differentiation. 
Epo is mainly produced in the kidney in response to the oxygen-pressure. However very low 
levels of Epo are produced independently of oxygen-levels by early erythroid progenitors 
(BFU-E) 9·10 . Due to the limiting concentrations of Epo in plasma, it is estimated that 20% of 
erythroblasts in the bone marrow undergo apoptosis 11.12. However, this number could be an 
underestimation, due to rapid phagocytosis of apoptotic erythroid cells by macrophages in 
vivo. Elevation of Epo results in survival of progenitors during the differentiation process and 
therefore in increased red blood cell production 13-15 • 
In discussions on the permissive versus instructive role of lineage specific growth factors and 
cytokines, it is often claimed that permitting cell survival is the only function of Epo signalling. 
This hypothesis is supported by the finding that the prolactin receptor, GM-CSF, GCSF or the 
GH-receptor expression in erythroid progenitors can rescue erythroid colony formation of 
fetal liver cells from Epa-receptor (EpoR) -/- mice 16 or in absence of Epo during culturing 17'18 • 
In addition, BFU-E are committed to erythropoiesis but do not respond to Epo. These data 
indicate that the Epo/EpoR is not involved in the lineage decision. Notably, the receptors 
used to replace the EpoR are of the same class and recruit largely similar signalling path-
ways (e.g. Jak2, STAT5, PI3K). The apparent "lineage incompatible receptor switch rescue" 
phenotype may indicate that receptors of the same class, largely similar in signal transduc-
tion, but having a different activating ligand are evolutionary developed only to ensure line-
age specificity. However, in most of these experiments the colony-forming ability of erythroid 
progenitors was scored without reporting proper differentiation parameters like hemoglo-
binization and enucleation. It is also not clear from these experiments whether the receptors 
for GM-CSF, GH and prolactin can synergize with the SCF receptor c-Kit. Nevertheless, the 
experiments show that induction of survival is vital during differentiation. Along the same 
lines, over-expression of the anti-apoptotic protein BciXL, a STAT5 target induced late in ery-
throid differentiation, is sufficient for proper, Epa-independent differentiation of erythroid cells 
underscoring the necessity to prevent apoptosis 19 • It is possible that specific features of the 
EpoR are required to interact and cooperate with additional receptors under conditions that 
require expansion and its feedback control like stress, while steady state erythropoiesis in 
healthy mice mainly requires the survival function of the EpoR. 
1.4.2 Stem cell factor is required for expansion of erythroid cells 
While Epo acts exclusively on erythroid cells in the hematopoietic system, its effects are mod-
ulated by the more generally expressed growth factor SCF. SCF is required for the develop-
ment of multiple cellular lineages. It is crucial for the migration of stem cells from the neural 
14 
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crest to the reproductive system (giving rise to germ cells), the skin (giving rise to 
melanocytes) and the bone marrow 20 • Absence of SCF or c-Kit protein results in death in 
utero or in the perinatal period with severe macrocytic anemia. SCF is produced in various 
cell types including endothelial cells, fibroblasts, hematopoietic progenitors, and marrow stro-
mal cells both as a soluble factor and as a membrane bound factor 21 • Steel Dicky (Sid) is a 
mutation in SCF that disrupts membrane association but allows synthesis of soluble SCF 22• 
Mice carrying this mutation are viable, but lack skin pigmentation, are sterile and have severe 
anemia. The marrow of SI/Sid mice contains strongly reduced numbers of CFU-granulocyte-
macrophage (CFU-GM), CFU-spleen (CFU-S), BFU-E and CFU-E, indicating that membrane 
bound SCF has a crucial role in the proliferation of early hematopoietic progenitors 23 . It must 
be emphasized that the hematopoietic system of these mice is severely perturbed in all line-
ages underscoring a defect in early stem cells rather than in the specific lineages. 
Interestingly, injection of wt mice with antibodies directed against c-Kit, preventing ligand-
induced c-Kit activation, had no effect on steady state erythropoiesis. However, upon induc-
tion of anemia no stress erythropoiesis was observed in the spleen of c-kit antibody treated 
mice 24 • This indicates i) that SCF is crucial for stress erythropoiesis but appears to be non-
essential during steady state erythropoiesis and ii) that the anemia in observed in the SI/Sld 
mice is probably caused by stem cell aberrations. 
Analysis of transgenic mice expressing various forms of SCF showed that some cells (e.g. 
the hematopoietic precursor) can only benefit from membrane bound SCF, while other cells 
(e.g. myeloid progenitors) require soluble SCF 25 • In in vitro assays, soluble SCF is biologi-
cally active in erythropoiesis when used at relatively high concentrations (1 00 ng/ml; 4). 
Addition of SCF in conjunction with Epa yields large size erythroid colonies in colony assays. 
In liquid cultures, expansion of erythroid progenitors also requires the combined action of Epa 
and SCF 4• Although SCF delays differentiation and promotes renewal divisions of cells 
grown in culture, it does not completely block differentiation. As a result it yields enhanced 
numbers of mature erythrocytes. It has been suggested that the maturation of erythroid cells 
in presence of high levels of SCF may be due to SCF-induced down-modulation of its recep-
tor c-Kit 26·27 . However, constitutive expression of wt c-Kit did not block renewal divisions of 
erythroid cells either and also yielded increased numbers mature erythrocytes 28 • 
Epa-induced differentiation of erythroid progenitors involves loss of c-Kit and relocalization of 
erythroid cells from stromal cells to macrophages, where enucleation takes place 29 • 
Macrophages are not required for enucleation, but they do phagocyte the nuclei. 
Interestingly, the effect of SCF on erythroid progenitors is exclusively measured in combina-
tion with Epa (note: although there has been one report of partial rescue of EpoR-/- progen-
itors by the combination of SCF/TPO and IL-6 30). When added in absence of Epa the ery-
throid progenitors undergo apoptosis 4 •31 ·32• From these in vivo and in vitro experiments it is 
clear that Epa and SCF cooperate to induce expansion of erythroblasts. 
1.4.3 Glucocorticoids and stress erythropoiesis 
One other factor found to be important in this cooperation are glucocorticoids (GC). Indeed, 
insufficient glucocorticoid levels are associated with anemia in Morbus Addison disease while 
overproduction, in patients with Cushing's syndrome, results in increased red blood cell, 
hemoglobin and hematocrit levels. GC-receptor (GR)-deficient mice die at birth due to respi-
ratory failure. In addition the mice present with development failures (E15.5 onward) in mul-
tiple organs like liver and adrenal glands 33 • Isolated fetal liver erythroid progenitors from 
these GR-/- mice at E14.5 fail to proliferate in expansion medium (Epa, SCF and the artificial 
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glucocorticoid ligand Dexamethasone or Dex), indicating that Epa and SCF signalling 
requires functional GR to induce expansion. Replacing the normal GR with one deficient in 
DNA-binding in mice (GRdim/dim) results in viable mice that show impaired regulation of GR-
dependent genes (which indicates that GR function in development does not rest on the 
DNA-binding capacity but rather on its association with other (transcription) protein complex-
es that can either be inducing or suppressing, though precise description exceeds the topic 
of this thesis 34•35 • These mice have normal adult erythropoiesis but do not show stress ery-
thropoiesis when hypoxia is induced. While the number of splenic CFU-E in normal mice 
showed a 6-fold increase upon hypoxia induction, spleen CFU-E numbers did not change fol-
lowing hypoxia induction of GRdim/dim mice 5• Wt fetal liver cells transplantated in sublethal-
ly irradiated GRdim/dim mice responded to hypoxic conditions with a normal stress response 
i.e. increase of spleen CFU-E. Thus the requirement for an intact GR in stress erythropoiesis 
is intrinsic to the erythroid progenitors. Importantly, the data show that the GR is not crucial 
for normal erythropoiesis but only in the specific cases of fetal liver and stress erythropoiesis. 
Moreover, the data suggest that erythroid progenitor expansion during fetal and stress ery-
thropoiesis relies on similar mechanisms. The molecular mechanism of the cooperation 
between the GR and the Epor/cKit -in expansion of erythroid progenitors remains to be elu-
cidated. It is been suggested that GR modulates the balance between differentiation and pro-
liferation through regulation of the expression of transcription factors such as c-Myb 36•37 and 
its binding to GATA-1 38·39 • Moreover, the GR has been found to associate with STATS and AP-
1 40,41. 
A growing number of (transcription) factors downstream of Epa and SCF signalling, like E2f4, 
Stat5a/b (phosphorylated after Epa stmulation), ATF4 (upregulated by SCF) and Sfxn1 
(flexed tail a protein involved in iron metabolism), seem to be essential for fetal liver and 
stress erythropoiesis rather than for steady state 42-45; personal observations). This opens the 
possibility that Epa and SCF signalling cooperates with the GR in activating or suppressing 
specific Epa-, SCF-, GC-controlled genes. Studies have been done and are on the way to 
identify these and GC specific genes in erythroid progenitors 35 ; unpublished results). In vivo 
GCs are also described to regulate Epa production in the kidney 46 via an unknown mecha-
nism. This could also play an additional role in the observed absence of stress erythropoiesis. 
However, the combination of in vitro and in vivo experiments indicate a direct requirement of 
GCs in expansion of erythroid progenitors in response to hypoxia. 
In conclusion, the cooperation of SCF and GCs with Epa appears to be to be redundant in 
normal erythropoiesis. The necessity for progenitor expansion and the observed synergy or 
cooperation probably is fetal liver and stress erythropoiesis specific to enable the maximum 
capacity of red cell production required at that particular stage. Taken together, expansion of 
the erythroid compartment involves renewal divisions of the erythroid progenitor (late BFU-E 
and CFU-E) for which SCF and glucocorticoids need to cooperate with Epa, while Epa is suf-
ficient to allow differentiation. 
1.4.4. Death receptors and erythropoiesis 
Negative regulators of erythropoiesis include interferon gamma (IFN-y), members of the 
tumor necrosis factor-alta (TNF-cx, TRAIL-R), Fas-ligand and transforming growth factor beta 
(TGF-p). The first three act mainly by inducing apoptosis, although they also may accelerate 
differentiation due to the activation of caspases. Cleavage of the capsases 1, 3 and 9 has 
been shown to be accelerating differentiation 150 • TGF-P inhibits progenitor proliferation and 
promotes differentiation via unknown mechanisms 47-51. Due to limiting Epa levels, apoptosis 
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of erythroblasts in the bone marrow during erythropoiesis is quite significant (20%). Control 
of apoptosis may be very important to maintain proper red blood cells levels. Loss of control 
could cause enhanced erythroblasts survival resulting in erythrocytosis or anemia. 
1.5 Signal transduction in erythroid progenitors. 
To begin to understand why cells undergo renewal divisions in presence of Epa, SCF and 
GC, while they mature to erythrocytes in presence of Epa only, we need to get insight into 
how these growth factors elicit their effect on cells. Cooperation between Epa and SCF 
begins at the level of receptor activation and leads to activation of a myriad of signaling inter-
mediates that control cellular processes such as gene expression, mRNA translation and pro-
tein trafficking. Although much is already known about the downstream signals of cytokine 
receptors, the specificity of each pathway with respect to differentiation, proliferation and sur-
vival is not clear. A main aim of this work was to analyse signal transduction by Epa and/or 
SCF to map the proteins responsible for erythroid progenitor expansion (cooperation 
between Epa and SCF) or differentiation (Epa only). 
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Figure 2. The SCF/Epo receptor complex. SCF and Epo induce tyrosine phosphorylation of c-Kit and the EpoR 
respectively. The phosphorylated c-terminal tails recruit and activate various signalling intermediates resulting in sig-
nal transduction and biological responses (see text for details) 
1.5.1 Epo downstream signaling; the Epa-receptor. 
The functional EpoR is a homodimer without tyrosine kinase activity, which is constitutively 
associated with the cytoplasmic tyrosine kinase Jak2 through the domain containing amino 
acid residue W282 (52; EvdA chapter 5, figure 2). Both the EpoR knockout and the Jak2 
knockout are embryonic lethal due to absence of functional erythrocytes 6•7·53. The EpoR 
belongs to the hematopoietic type 1 receptor superfamily, also including c-MPL, GM-CSFR, 
GCSFR, IL-2R, IL-7R, IL-9R, IL 11 R, IL 12R, GHR and LIFR 54•55 • This family is characterized 
by a 20 amino acids stretch called the cytokine receptor homology region (CRH). This motif 
is located in the extracellular part near the transmembrane domain and contains four con-
served cysteine residues and the so-called WSXWS motif. In addition, most family members 
share two intracellular motifs near the transmembrane: box1 (1 Oaa) and box2 (1 Oaa) 56-63 . 
17 
Upon ligand binding, the conformation of the EpoR changes bringing the Jak2 kinases 
together 64•65• This induces phosphorylation and activation of Jak2 and subsequent phospho-
rylation of 8 tyrosines in the intracellular part of the EpoR. These serve as docking sites for 
a large number of signalling intermediates that are activated in turn 66·67 . Below some exam-
ples of recruited protein to the EpoR are given, ordered from the transmembrane region of 
the Epa-receptor intracellular part to the c-terminus. The transcription factor STAT5 is recruit-
ed to Y343 and Y403 68.70 • Doppler et al. 71 showed that STAT5 is able to bind to the GRand 
that this interaction leads to enhanced and synergistic transcription of the STAT5 target beta-
casein but could also lead to transcription of specific GR-Stat5 responsive genes of which 
transcription is not induced by GCs or Stat5 alone. STAT5 knockout mice are not deficient in 
expansion but show significant increase in apoptosis during differentiation 43·72 • The role of 
STAT5 has thus been linked to survival during erythropoiesis and the interaction with GR 
could relate to this function. The tyrosine phosphatase SHP2 Is recruited to Y 403, the same 
site as STAT5 73. SHP2 is thought to remove inhibitory signals, thereby activating signalling 
e.g. by Jak2 and Grb2 74 • In contrast, the tyrosine phosphatase SHP1, docking to Y431/429 
75
.
77
, decreases signalling by dephosphorylation of the EpoR and Jak2. Interestingly, in rare 
cases of familial erythrocytosis a truncated Epa-receptor that lacks the recruitment site for 
SHP1 is expressed. These people are hyper-responsive to Epo and show prolonged Jak2 
activation 151 • The Src kinase Lyn docks with its SH2 domain to Y464 and Y479 78 • The p85 
subunit of phosphoinositide 3-kinase (PI3K) binds to Y 481 75•79·80 and the bridging molecule 
Grb2 docks to Y464 66 and may subsequently recruit several other molecules such as Gab1, 
Gab2 and She 81. 84 , all phosphorylated upon EpoR activation 85·86• 
Confusingly, C-terminal truncations do not hamper the mitogenic properties of the EpoR. 
Notably, even an EpoR with a C-terminal deletion that lacks all 8 tyrosines but still binds Jak2, 
can mediate cell survival and proliferation in factor dependent cell lines 87 • Expression of this 
truncated EpoR or a truncated EpoR lacking 7 of the 8 tyrosines can restore erythroid colony 
formation in fetal liver cells that lack the EpoR 16•87 • In summary, the fact that truncation 
mutants are not deficient in mitogenic signalling suggests i) that the c-terminal part and its 
signalling properties are not important for steady state erythropoiesis and fetal liver erythro-
poiesis and/or ii) the presence of compensating mechanism activated by Epo but independ-
ent of the C-terminal part of the EpoR, for instance through the actions of large docking mol-
ecules. 
Several docking proteins are tyrosine phosphorylated after Epo stimulation among 
which are IRS2, Gab1 and Gab2 85•88•89 • These docking proteins are not recruited by the Epa-
receptor but the presence of a PH-domain recruits them to phosphatidylinositol-3,4,5-triphos-
phate (PI3K activity)in the vicinity of a receptor 90•91 • These docking proteins recruit PI3K them 
selves leading to increased PI3K activity, functioning as a positive feedback loop 92•93 • Indeed, 
over-expression of Gab1 potentates the activation of PKB (a protein downstream of PI3K), 
while expressing a Gab1 mutant lacking the PI3K recruitment site results in decreased PKB 
activation 94 • Besides PI3K, these docking molecules recruit a growing list of other signaling 
mediators, like phospholipase C (PLCs), She, Grb2, Crkl, Shp2, Shp1 and SHIP, plugging 
into several important signalling events (for review see 95·96). For instance, Shp2 recruitment 
has been shown to be important for the activation of the Erk-MAPK route via stimulation with 
different stimuli resulting in mitotic responses 82·95·97 , while the activation of the PLC-gamma 
family may be a way to control calcium release and diacylglycerol production (and PKC acti-
vation, 98). Potential kinases responsible for the phosphorylation of Gab proteins have been 
found and include members of the Src-kinase family but also the tyrosine kinase receptor c-
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Met 99•100 • Interestingly, Gab1 comprises a unique domain with which it docks to c-Met called 
the Met-binding-sequence (MBS). Absence of this domain results in abrogation of Gab1 tyro-
sine phosphorylation, while including the MBS sequence in Gab2 (normally not a c-Met sub-
strate) results in Gab2 tyrosine phosphorylation by c-Met 101 • In erythroid progenitors a homo-
logue of c-Met is expressed. This tyrosine kinase receptor named RON (or Stk in mice) is the 
susceptibility gene for spleen-focus-forming-virus-induced erythroleukemia. Comparable to 
its binding to c-Met, Gab1 is also a substrate of RON/Stk and Gab1 binding is mediated via 
the same MBS sequence (chapter 5). Gab1 deficiency leads to embryonic death due to liver 
defects and resembles the phenotype of HGF and c-Met knockout mice 99•102·103 • In contrast, 
the Gab2 and Gab3 deficient mice are viable and have only mild phenotypes 104•105 • Gab1 is 
more ubiquitously expressed, while Gab2 and Gab3 are tissue specific. The absence of phe-
notype in the Gab2 and Gab3 knockout mice may be due to compensation via Gab1. 
In conclusion, these docking proteins, when activated, become signalling platforms with over-
lapping downstream signalling events and recruited proteins when compared to the proteins 
recruited by the EpoR or c-Kit themselves. 
1.5.2 The RON/Stk tyrosine kinase 
The tyrosine kinase receptor RON/STK was identified as the Fv2 Friend virus resistance 
locus 106·107 • Friends disease, existing only in mice, was first characterized by Charlotte Friend 
152 and represents a multi-step carcinogenesis disease inflicted by spleen focus forming virus 
(SFFV; reviewed by 107 • There are two forms of SFFV, namely a polycythemic (SFFV-P) and 
an anemic (SFFV-A) strain, reflecting the effects of virus infection. Upon infection of erythroid 
progenitors with SFFV-P the viral gp55 protein interacts with the transmembrane domain of 
the Epa-receptor 108 • This interaction depends on residue S238 of the murine Epa-receptor 
(absent in the human EpoR) and M390 of gp55 108 • Interestingly, susceptibility to SFFV 
depends on the presence of a short form of the tyrosine kinase receptor RON, suggesting a 
link between the EpoR!gp55 complex to RON. Indeed, RONsf and the EpoR interact when 
over-expressed in COS cells 107 (chapter 5) and gp55 has been shown to bind to RONsf 
resulting in constitutive activation of RONsf 109 • The EpoR-gp55 interaction induces constitu-
tive phosphorylation of several Epa-downstream targets like the MAPK route, Gab1/2 and 
PI3K resulting in erythroid polycythemia. Subsequent genetic events (inactivation of p53 and 
upregulation of PU-1), result in a differentiation block and the final disease state: erythroid 
leukemia. Notably, over-expression of a family member of RON, v-Sea, in chicken erythrob-
lasts results in PI3K and MAPK dependent transformation 110 • Moreover, signal transduction 
by c-Met, another family member of RON, depends on the activation of the Gab docking pro-
teins and the subsequent activation of the MAPK route and PI3K. The constitutive activation 
of RONsf in SFFV transformed erythroblasts may lead to the constitutive activation of the 
Gab proteins, PI3K and the MAPK route though direct evidence for this as not been found. 
In both humans and mice, RON is expressed in erythroblasts as a long and a short form, orig-
inating from the same gene. An additional promoter containing a GATA-1 site in intron 10 cre-
ates a transcription initiation site for the short form of RON (RONsf), which lacks the extra-
cellular part but retains the trans-membrane and intracellular domains 111 • C57/B6 mice har-
bour a mutation in the GATA 1 site and consequently lack the short form of RON and are 
resistant to SFFV infections. Apart from its ability to phosphorylate Gab1, the expression of 
RON in erythroid progenitors and the implication of RONsf in constitutive activation of EpoR 
by SFFV-gp55 prompted us to study the role of RONfl in erythroid proliferation and differen-
tiation and in Epa-induced signal transduction in particular (chapter 5). We found that RON 
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is a downstream effector of EpoR signalling responsible for recruitment and Epa-induced 
phosphorylation of Gab1. 
1.5.3 The SCF-receptor: c-Kit 
c-Kit is a receptor tyrosine kinase that belongs to the family of so called split kinase recep-
tors 112 • This subfamily includes FLT3 and the receptors for CSF-1/M-CSF and PDGF, and is 
characterized by the separation of the ATP-binding region and the catalytic region of the 
kinase domain by an interkinase domain 113• Ligand binding induces receptor oligomerization 
and subsequent auto/transphosphorylation, followed by activation of cytoplasmic target pro-
teins. Members of the Src-family of tyrosine kinases, Lyn in particular, associate with phos-
photyrosines 567 and 569 in the juxtamembrane region of murine c-Kit (corresponding to 
Y568 and Y570 in human c-Kit, respectively; 114• This interaction is important for the phospho-
rylation of adapter molecule She and activation of Ras and Erk1 /2, and correlated with SCF-
induced mitogenicity in aortic endothelial cells 115 • Binding and activation of PI3K is mediated 
via phosphotyrosine 719 (Y721 in human c-Kit) in the inter kinase domain 116 • Bone marrow 
derived mast cells expressing KitY719F have a reduced mitogenic and suNival response, 
while SCF-induced secretion, adhesion and ruffling are completely absent 116•117 • In addition, 
tyrosine residues 703 and 936 in human c-Kit bind the adapter proteins Grb2 and Grb7 118• 
Grb2 may link c-Kit to Sos, SHP2, or Cbl, while no binding partners of Grb7 are currently 
identified. The tyrosine kinase Jak2 and its targets STAT1 and STAT5 were reported to be 
activated by c-Kit 119•120, although this is likely to be cell dependent, as we have never found 
any evidence for SCF mediated JAK-STAT activation in erythroid progenitors (unpublished 
results). 
Although c-Kit contains multiple tyrosine residues that could seNe as SH2-domain docking 
sites, only few have been implicated in signal transduction. Instead, the activation of Lyn and 
PI3K appears to orchestrate multiple pathways in concert (figure 2; 117 • Therefore, we 
focussed on proteins downstream of SCF-induced PI3K and Lyn. In chapter 2 we describe 
that after SCF stimulation the tyrosine kinase Tee is activated downstream of PI3K and Lyn 
and that this activation of Tee leads to the phosphorylation of the docking protein Dok-1. Dok-
1 can recruit multiple different proteins, and over-expression of Dok-1 is reported to lead to 
prolonged signalling 121 • 
1.6 Epo and SCF cooperation; intracellular mechanisms 
On the level of progenitor expansion or 'renewal' the cooperation between Epo, and SCF is 
evident. However, our current knowledge of the actual intracellular fundaments of this coop-
eration is surprisingly poor. FRET-analysis showed that the EpoR and c-Kit are in close prox-
imity 24 • Indeed, the EpoR and c-Kit interact irrespective of stimulation and cross-phosphory-
lation has been reported 122-124 (personal obseNations ). Stimulation with SCF and remarkably 
also Epo results in clustering of c-Kit in the membrane again proving that c-Kit and the EpoR 
can be situated in the same membrane fraction/complex 122 • Nevertheless, it is not known if 
all c-Kit or EpoR is associated in the larger complexes or whether single c-Kit!EpoR combi-
nations are present in the membrane. Neither is it known if there is a qualitative or quantita-
tive difference between the c-Kit!EpoR complex or c-Kit, EpoR single receptor signalling at 
the same stage. So, the actual significance of this interaction with respect to the obseNed 
cooperation remains elusive. 
During signal transduction induced by Epo and SCF co-stimulation, protein complexes can 
be formed or activated which, compared to the stimulation of the single receptors are i) 
20 
introduction 
unique to co-stimulation and signaling (the activation of a protein not activated by either 
receptor when stimulated on its own); ii) more sustained or robust in strength due to activa-
tion of similar pathways giving additive effects or iii) inhibited upon co-stimulation and signal-
ing. Evidence for the first and the third explanation has not been found until now, which jus-
tifies the search for new signal transduction pathways induced by Epa and SCF. We and oth-
ers have found evidence for the second explanation. Upon co-stimulation of erythroid pro-
genitors with Epa and SCF an additive effect can be seen with respect to duration and level 
of PKB and ERK phosphorylation 4 • We have found that inhibition of PI3K but not the MAPK 
route results in differentiation of erythroid progenitors under expansion conditions (Epa and 
SCF) 125•126• In agreement with this, p85a deficient mice have transient fetal anemia and 
decreased numbers of erythroid progenitors as assessed by counting the number of CFU-Es 
and BFU-Es 127• These data justify a thorough investigation of PI3K downstream pathways as 
these are potentially involved in the decision between self-renewal and differentiation of ery-
throid progenitors. 
1.6.1 PI3K downstream events 
Activation of PI3K yields PIP3 in the cell membrane, which subsequently recruits molecules 
with a Pleckstrin Homology (PH) domain like threonine/serine kinase (e.g. PDK and PKB; 128), 
docking proteins (e.g. Dok, Gab or IRS family members) and tyrosine kinases (e.g. the Tee 
family). These proteins, when recruited and activated, control major cellular processes like 
mRNA translation and transcription, for instance through the de-activation of the PI3K 
dependent forkheads that play a role in cell cycle control and growth arrest during differenti-
ation 126 • However, we focussed on signalling intermediates that could play a role in the imme-
diate control or initiation of receptor signalling strength and duration. 
Among these proteins are the Tee-family kinases of which Btk has been shown to be highly 
expressed in avian erythroblasts 129• Tee family kinases have been shown to be implicated in 
signal amplification in response to different receptors 130·131 • The high expression of Btk in ery-
throblasts suggests a function for this kinase or a related family member in erythropoiesis. 
However, the downstream substrates of this family of kinases in erythroid progenitors are 
unknown. We were interested to see whether the Tee-kinase family plays a role in SCF or 
Epa signal transduction and whether these proteins could be important in the decision 
between expansion and differentiation. The function and downstream effectors of Btk and its 
family member Tee have been addressed in chapters 2, 3 and 4. 
PH-domain containing docking proteins are also potentially interesting PI3K dependent tar-
gets. Similar like the Tee-family kinases, the phosphorylation of docking proteins has also 
been shown to result in signal enhancement. This is due to their ability to recruit similar sig-
nalling intermediates as the studied receptors (for review see 132 ). The level of docking-mole-
cule-phosphorylation may thus directly correlate with increased downstream signalling (as is 
observed after co-stimulation with Epa and SCF) and this could be a crucial mechanism for 
receptor cooperation. We observed a clear additive effect on the activation of PI3K and the 
MAPK route during Epa and SCF co-stimulation. Both PI3K and the MAPK route are down-
stream events of the docking proteins Gab1 and Gab2 (for review see 95 ). Indeed, expression 
of only the PH domain of Gab1, thereby preventing normal Gab1 recruitment, results in atten-
uation of MAPK and PI3K activation after EGF stimulation 133 • In chapter 5 we addressed the 
function of these docking proteins in erythroid progenitors. In this light, we were also interest-
ed in the kinases responsible for Gab family phosphorylation and activation. In chapter five 
we found that the Epa-induced phosphorylation of Gab1 can accomplished by two kinases, 
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the Src kinase Lyn and the tyrosine kinase receptor RON/STK, while Gab2 is exclusively 
phosphorylated by Lyn. Its function in Gab1 phosphorylation/activation could make RON an 
important player in signal amplification. This has been addressed in chapter 5. 
1.7. Erythropoiesis and disease: Fanconi anemia 
A disbalance of red blood cell levels resulting in anemia or erythrocytosis is a major cause of 
disease related morbidity and mortality worldwide. In many cases anemia is secondary to dis-
eases of other systems and hence may be indirect of nature, like low Epo levels in diabetes 
related renal failure or malaria. Major erythroid diseases in which anemia is caused by pri-
mary defects in the maturation of erythrocytes are sickle cell disease and thalassemias. 
Other diseases in which anemia is a prominent feature are myelodysplastic syndrome (MDS) 
and Fanconi disease. It is suggested that the anemia in these diseases is caused by aber-
rant events at the multi-potent progenitor level rather than an effect on the erythroid progen-
itor itself. Administration of Epa to Fanconi or MDS patients is not beneficial and in addition, 
cytokine signalling has been reported to be aberrant in both diseases while BFU-E and CFU-
E numbers are severely decreased. Therefore, an aberrant erythroid progenitor phenotype 
leading to anemia may not be excluded. 
Fanconi anemia (FA) is an autosomal recessive disease present in all races and ethnics 
groups (incidence 3 in 1 million). Patients with FA present in the clinic at early age (median 
7 years) and have various symptoms among which decreased platelet counts and aplastic 
anemia. Before the age of 40, 81% of cases progresses to total bone marrow failure or other 
hematological abnormalities, which is also the major cause of death (for a review see 134. 
The actual cause of bone marrow failure and the observed anaemia are not fully understood. 
FA, at present, has eleven complementation groups: A, B, C, D1, D2, E, F, G, I, J and L most 
of them defined by cell fusion analysis 135.139• The core proteins FANCA, B, C, E, F, G and L 
form a complex in the nucleus upon activation by certain cytokines (TNF-a treatment; 140 or 
by DNA-crosslinkers, and have a function in DNA (miss-match) repair and chromosomal sta-
bility 141 ·142 ; for review see 143 • FANCL, the only Fane protein with recognizable intramolecular 
structures (WD40-repeats and a ring finger), is responsible for the mono-ubiquitination of 
FancD2. Conform the role of the fanconi complex in DNA miss-match repair, the mono-ubiq-
uitinated FANCD2 preferentially associates with chromatin and nuclear matrix, whereas non-
ubiquitinated FANCD2 largely resides in the soluble nuclear fraction 144• Malfunction of this 
complex is believed to result in chromosomal instability due to accumulation of DNA-damage. 
From the recently identified FANCI and FANCJ the functions are relatively unknown, though 
it was reported that FANCI acts upstream and FANCJ downstream of FANCD2 ubiquitination 
145 
Apart from its role in DNA-repair and chromosomal stability, a positive role for FANCC has 
been suggested in activation and recruitment of Stat proteins to the IFN-y receptor and relat-
ed to this Fancc knockout mice have increased responses to IFN-y, due to aberrant feedback 
contro1 146·147• Interestingly, Fanconi deficient cells are highly sensitive to oxidative stress 148·149 • 
The production of ROS has been shown to influence the activity of phosphatases and may 
be another way to regulate cytokine receptor signalling. A higher sensitivity to IFN-y-induced 
apoptosis due to ROS levels or due to aberrant Stat recruitment may give an alternative 
explanation to the observed bone marrow failure in fanconi patients. The absence of Fanconi 
proteins may thus affect cytokine or growth factor receptor signalling. We have examined the 
erythroid progenitors of Fanconi deficient mice for cytokine signal transduction potential and 
for their ability to expand and differentiate (chapter 6). This issue has been addressed in 
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chapter 6. 
1.8 Main aim of the thesis 
In this thesis we set out to unravel the components of the EpoR/c-Kit signalling complex to 
gain insight into the intracellular proteins involved in Epo and SCF regulated differentiation, 
survival and expansion. At present the proteins responsible for these processes are poorly 
described though recent data indicates that PI3K dependent signal transduction drives the 
expansion of erythroid progenitors. Absence of these signals results in accelerated differen-
tiation. The signal transducing mediators downstream of PI3K may thus be part of an impor-
tant switch, responsible for the regulation of the amounts of erythrocytes produced. Due to 
their described role in signal amplification and mitogenic signalling we focussed on PI3K reg-
ulated Tee-family kinases and docking molecules activated by SCF and/or Epo. 
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Chapter 2 
Abstract 
Stem cell factor (SCF) has an important role in the proliferation, differentiation, survival, and 
migration of hematopoietic cells. SCF exerts its effects by binding to c-Kit, a receptor with 
intrinsic tyrosine kinase activity. Activation of phosphatidylinositol 3'-kinase (PI3-K) by c-Kit 
was previously shown to contribute to many SCF-induced cellular responses. Therefore we 
investigated P13-K-dependent signaling pathways activated by SCF. Here we report the P13-
K-dependent activation and phosphorylation of the tyrosine kinase Tee and the adapter mol-
ecule p62Dok-1. We show that Tee and Dok-1 form a stable complex with Lyn and two 
unidentified phosphoproteins of 56 and 140 kD. Both the Tee homology- and SH2-domain of 
Tee were identified as being required for the interaction with Dok-1, while two domains in Dok-
1 appeared to mediate the association with Tee. In addition, Tee and Lyn were shown to phos-
phorylate Dok-1, while phosphorylated Dok-1 was demonstrated to bind to the SH2 domains 
of several signaling molecules activated by SCF, including Abl, Crkl, SHIP, and PLCg-1, but 
not those of Vav and She. These findings suggest that p62Dok-1 may function as an impor-
tant scaffold molecule in c-Kit-mediated signaling. 
Introduction 
Stem cell factor (SCF; also called steel factor, mast cell growth factor, or Kit ligand) is an 
important growth factor for multiple cell types, including hematopoietic progenitor cells. SCF 
exerts its effects by binding to the product of the c-Kit proto-oncogene 1 • c-Kit is a receptor with 
intrinsic tyrosine kinase activity, structurally-related to Flt3 and the receptors for colony-stim-
ulating factor-1 (CSF-1) and platelet-derived growth factor (PDGF)Z. Loss-of-function muta-
tions in the loci for murine c-Kit, White Spotting (W), or SCF, Steel3-6, lead to macrocytic ane-
mia and to mast cell deficiency, as well as a series of non hematological defects1·7•8 • 
Conversely, mutations that render c-Kit constitutively active have been found in mastocytoma 
and myeloproliferative disease9•10 • 
Within the hematopoietic compartment, SCF can support the survival and renewal of 
the earliest multilineage progenitors and regulates proliferation and differentiation of mast cell 
precursors. In combination with lineage-restricted cytokines, SCF delays differentiation and 
enhances the expansion of already committed progenitors of all lineages\ This phenomenon 
is particularly apparent in erythropoiesis, where the co-operation of c-Kit with the erythropoi-
etin receptor (EpoR) is crucial for the proliferation of erythroblasts11.12. It has been shown that 
c-Kit and the EpoR are closely associated in erythroid cells13 , but the molecular basis for the 
synergy between c-Kit and the EpoR or other cytokine receptors has not been resolved. 
The profound effects of SCF on proliferation and survival of different progenitor cell 
types has raised considerable interest in the identification of critical signal transduction path-
ways activated by c-Kit. SCF binding to c-Kit results in dimerization/oligomerization and sub-
sequent transient tyrosine phosphorylation of the receptor14 . As a result, proteins of the 
p21 Ras-MAPK pathway, the phosphatidylinositol 3'-kinase (P13-K), the tyrosine kinases 
Src/Fyn/Lyn and Tee, phospholipase Cg-1 (PLCg-1 ), Vav, Cbl, and p62Dok-1 are recruited to 
the c-Kit signaling complex and subsequently activated/phosphorylated15.22 • However, the 
mechanism by which these molecules are recruited and activated has remained largely unre-
solved. Although human and murine c-Kit contain 20 intracellular tyrosine residues, only a few 
were described as docking sites for signaling molecules, when phosphorylated. Tyrosine's 
703 and 936 in human c-Kit bind the adapter molecules Grb2 and Grb7, while Src-kinases 
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bind to tyrosine's 567 and 569 in the membrane proximal region, and p85 binds to tyrosine 
719 in the kinase-insert domain of murine c-Kit16·23·24. A concerted action of Src kinases and 
PI3-K appears to be required for the (indirect) activation of the small G-protein Rae and the 
protein kinase JNK, which is an important step in mast cell proliferation24. 
In vitro studies have shown that activation of PI3-K contributes to survival, mitogen-
esis, chemokinesis, and differentiation induced by SCP6·24-26. Introduction of c-Kit mutants 
unable to activate PI3-K into c-Kit deficient mast cells does not restore SCF-induced cell 
adhesion, and only partially restores SCF-induced proliferation16. Furthermore, we recently 
observed that the PI3-K inhibitor LY294002 suppressed the biological effect of SCF on ery-
throid progenitors (manuscript in preparation). PI3-K yields PIP3 in the cell membrane, there-
by creating binding sites for pleckstrin homology (PH)-domain containing signaling mole-
cules27. The tyrosine kinase Tee is one such PH-domain containing protein activated by c-Kit18. 
Tee is also the founding member of a family of tyrosine kinases that includes Brutons' tyro-
sine kinase (Btk), Bmx, ltk/Tsk!Emt, and Rlk!Txk28·29. These kinases are characterized by a 
PH- and a Tee homology (TH)-domain in their amino-terminus, followed by SH3-, SH2-, and 
kinase domains30. In contrast to Src-kinases, they are devoid of a membrane-targeting 
myristylation site, and yet are rapidly recruited to the plasma membrane after stimulation of 
various cytokine receptors, the T and B cell receptors, and CD2831-35. The interaction between 
PIP3 and the PH-domain of Btk is critical for this translocation36. In the plasma membrane, 
Tee members are thought to be activated by Lyn or other members of the Src family37·38. Other 
studies have shown that the TH-domain of Tee is essential for the (in)direct interaction with 
c-Kit, but also for its association with Lyn and Vav33·39. 
In this study we show that Tee is activated by SCF in erythroid and megakaryocytic 
cell lines and that, when activated, it forms a stable complex with various proteins, including 
the recently cloned docking protein p62Dok-1. We found that both the activation of Tee and 
the phosphorylation of Dok-1 require PI3-K activity. We show that the TH- and SH2-domains 
of Tee mediate the interaction with Dok-1, while two separate domains in Dok-1 are involved 
in the interaction with Tee. We further show that Tee, and also Lyn, can phosphorylate Dok-
1. Dok-1 contains 15 tyrosine residues, suggesting an important role for Dok-1 in recruiting 
SH2-domain containing proteins to the c-Kit signaling complex. In support of this hypothesis, 
we provide evidence that phosphorylated Dok-1 binds the SH2-domains of multiple signaling 
molecules. 
Materials and methods 
Cells, plasmids, and oligonucleotides 
The human erythroleukemia cell lines F36P and TF-1, and the megakaryocytic cell line Mo7e, 
were maintained in RPMI1640 medium (Life Technologies; Breda, The Netherlands) supple-
mented with 10% fetal calf serum (FCS; Life Technologies) and recombinant human GM-CSF 
(5 ng/ml; lmmunex; Seattle, WA). COS, 293, and amphotropic Phoenix cells were cultured in 
Dulbecco's modified Eagle's medium (DMEM; Life Technologies) supplemented with 10% 
FCS. 
The complete cDNAs of murine Tee, human c-Kit, and human Dok-1 (a kind gift of Nick 
Carpino, St. Jude Children's Hospital, Memphis, Tennessee) were cloned in the expression 
vector pSG5 (Stratagene, La Jolla, CA) and the retroviral vector pBabe40. The expression vec-
tors encoding Tee mutants and Llp85 have been described previously41 '42. Constructs DokLl Y1 
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and DolffiY5 were generated by PCR using the oligonucleotides Dok-F (5'-CGG AAT TCC 
CGG GGG CCA TGG ACG GA-3'), Dok-L1 Y1 (5'-AAA ACT GCA GGT TAA CGG CTC TAC 
AAG GAG TTC TCC AGC-3'), and Dok-L1Y5 (5'-AAA ACT GCA GGT TAA CCA GCC TAC 
AGG GCT GGG GGA CTG-3') and the Expand High Fidelity PCR System (Roche; Basel, 
Switzerland). Fragments were cloned in the EcoRI/Pstl sites of a modified pSG5. Constructs 
tagged with the hemagglutinin (HA) epitope, HA-Dok, HA-Dolffi Y5, and HA-Dolffi Y1 respec-
tively, were generated by subcloning PCR products into pMT2SM-HA vector. The Pstl frag-
ments of pMT2HA-Dok and pMTHA-Dolffi Y5 were subcloned into pBABE to generate pBHA-
Dok and pBHA-Dolffi Y1, respectively. 
Transient transfection and viral transduction 
For transfection experiments, COS cells were cultured in six-well dishes (Costar; Corning, 
NY), and 293 cells were cultured in 20 cm2 dishes (Becton Dickinson, Franklin Lakes, NJ). 
After 24 hours, the cells were transfected with 6-12 mg of supercoiled plasmid DNA as 
described previousl}f3• 16-20 hours after transfection, medium was refreshed and cells were 
harvested 24 hours later. 
For viral transduction experiments, amphotropic Phoenix cells were cultured in six-well dish-
es and, 3 hours later, the cells were transfected using calcium phosphate. After 48 hours, 
cells were treated with mitomycin C (1 0 mg/ml) for 1 hour, washed three times and washed 
three more times 4 hours later. F36P cells (2x1 05/ml) were added and co-cultured for 20-24 
hours in RPMI/DMEM medium (50/50%). F36P cells were removed carefully from the 
Phoenix cells and cultured in RPMI 1640 medium. To select for stable transfected cells, 
puromycin (2 mg/ml) was added 48 hours later. 
lmmunoprecipitations, western blotting, and antibodies 
After serum starvation for 16 hours, F36P, Mo7e, and TF-1 cells (30x 1 06/ml) were stimulat-
ed with SCF (100 ng/ml; a generous gift of Amgen; Thousend Oakes, CA), EPO (5 U/ml; a 
generous gift of Janssen-Cilag; Tilburg, The Netherlands), or GM-CSF (50 ng/ml), or left 
unstimulated for 5 (SCF) or 10 (EPO and GM-CSF) minutes at 3rc. Reactions were stopped 
by adding ice-cold phosphate-buffered saline (PBS). Cells were lyzed in lysisbuffer (1% NP-
40, 20 mM Tris-HCI, pH 8.0, 137 mM NaCI, 10 mM EDTA, and 10% glycerol, supplemented 
with Complete protease inhibitor mix (Roche), Pefablock (Merck; Darmstadt, Germany), and 
1 mM orthovanadate) on ice for 15 minutes and centrifuged at 4 oc for 10 minutes at 15000 
rpm. Lysates of 15 x 106 cells were pre-cleared with protein G beads (Sigma; St. Louis, MO), 
incubated with the appropriate antibody (1 mg) for 90 minutes at 4oC and protein G beads 
were added for an additional hour. Precipitates were washed 3 times with lysis buffer, sub-
jected to SDS-polyacrylamide gel electrophoresis, and electrotransferred to nitrocellulose 
membrane (Schleicher & Schuell; Dassel, Germany). Membranes were blocked in 0.6% 
bovine serum albumine (BSA), incubated with appropriate antibodies, and developed utiliz-
ing enhanced chemoluminescence (ECL, NEN; Boston, MA). 
The following antibodies were used in this study: anti-Tee (06-561, Upstate Biotechnology; 
Lake Placid, NY), anti-TecSH331, anti-Dok-1 (M19, Santa Cruz (SC); Santa Cruz, CA), anti-
phosphotyrosine (PY99, SC), anti-HA (F-7, SC), anti-Lyn (Transduction Laboratories; 
Lexington, KY), anti-phospho-PKB (Ser473; New England BioLabs (NEB); Beverly, MA), anti-
PKB (NEB), anti- phospho-ERK1 ,2 (Thr202/Tyr204; E1 0, NEB), and anti-ERK1 ,2 (K-23, SC). 
GST-pull down experiments 
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For SH2-domain binding studies, SCF-stimulated Mo7e cells were lyzed in immunoprecipita-
tion buffer. Cleared lysates were incubated for 90 minutes with beads coupled to 1 0 mg of 
GST-SH2 fusion protein or to GST alone. Beads were washes three times with lysis buffer 
and resuspended in sample buffer. Proteins were separated by SDS-PAGE and blotted with 
anti-phosphotyrosine antibody. The GST-fusions with SH2 domains of the following proteins 
were used in this study: cAbl, Crkl, Fgr, Fps, GAP (both N- and C-terminal SH2 domains 
(N+C)), Grb14, Hck, Lyn, p85 subunit of PI3-K (SH2 N+C), PLCy-1 (SH2 N+C), She, SHIP, 
Src, Syk (SH2 N+C), Vav, and Yes. 
Results 
Tee is activated in erythroid cells and complexes with various proteins following SCF addition 
Tee has previously been shown to be activated by SCF in the human megakaryocytic cell line 
Mo7e18 • To investigate whether Tee is specifically activated upon c-Kit activation and to iden-
tify associating proteins, Tee was immunoprecipitated from the human erythroid progenitor 
cell line F36P stimulated with SCF, EPO, or GM-CSF, from Mo7e cells stimulated with SCF 
or GM-CSF, and from human erythroleukemic TF-1 cells stimulated with SCF. Subsequently, 
Tee and co-precipitating proteins were immunoblotted with anti-phosphotyrosine antibody 
(PY99). As shown in figure 1 a, phosphorylation of Tee in F36P cells is only detected follow-
ing SCF stimulation, but not following incubation of the cells with EPO or GM-CSF, even 
though these cytokines induced tyrosine phosphorylation of multiple proteins (figure 1 a, lower 
panel). An in vitro kinase assay confirmed that the tyrosine phosphorylation of Tee correlated 
with enhanced kinase activity of Tee (not shown). Interestingly, a prominant phosphorylated 
protein of 62 kD as well as proteins of 145-150, 140, and 56 kD were precipitated with Tee 
after SCF induction. The proteins of 145-150 kD were identified as c-Kit by Western Blot 
A F36P B. Mo7e TF-1 
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Figure 1. Tee is activated in erythroid cells and complexes with various proteins following SCF addition. 
A and B. Tee was immuneprecipitated from F36P, Mo?e, and TF-1 cells incubated with SCF (S; 5 minutes), EPO, or 
GM-CSF (E, GM; 10 minutes) at 37°C. The immuneprecipitates (15 x 1 o• cells each) were analyzed by Western blot-
ting with anti-phosphotyrosine (PY99; top panels) and anti-Tee (middle panels). Tee-precipitates from F36P cells 
were also analyzed with anti-Lyn (middle panel). As a control, whole cell lysates were analyzed with anti-phospho-
tyrosine (lower panels). Tee is specifically phosphorylated by SCF and complexes with c-Kit and proteins of 56, 62, 
and 140 kD following SCF addition (indicated by arrows). 
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analysis (not shown). Since p56Lyn is known to associate with Tec39, we tested whether the 
co-precipitating phosphoprotein of 56 kD was Lyn. Although the lower panel indeed shows 
that SCF treatment results in enhanced Tec-Lyn association, Lyn had a slightly faster mobili-
ty than p56. Therefore, the identities of p56 and p140 remain unknown. 
Tee is also selectively phosphorylated by SCF in Mo7e cells (figure 1 b). In these cells, a sim-
ilar pattern of co-precipitating proteins is observed, indicating that the same signaling com-
plex is formed after c-Kit activation in F36P and Mo7e cells. Although less clear, c-Kit and p62 
(marked with an asterisk) were also detected in the Tee precipitates of SCF-stimulated TF-1 
cells. The signal in these cells is less intensive, most likely due to the lower level of activat-
ed c-Kit when compared with F36P and Mo7e, as is apparent from the whole cell lysate con-
trols. 
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Figure 2. The p62 co-precipitating with Tee is p62Dok-1. 
A. Tee and Dok-1 were immuneprecipitated from whole celllysates of non-stimulated and SCF-incubated F36P cells 
and analyzed by Western blotting with anti-phosphotyrosine (PY99; top panel) and anti-Tee (lower panel). Two 
species of Dok-1 are phosphorylated by SCF (indicated by arrows), of which the upper one co-migrates with Tee-
associated p62. Proteins of 56 and 140 kD are observed in both Tee and Dok-1 precipitates of SCF-treated cells 
(indicated by arrows). 
B. Lysates of SCF-stimulated F36P cells were precleared with anti-Dok-1, followed by Tee immuneprecipitation, or 
vice versa. The lysates were analyzed by Western blotting with anti-phosphotyrosine (top panel) and anti-Tee (lower 
panel). Pretreatment of the lysates reduces the amount of phosphorylated p62/Dok-1, indicating that p62 is identical 
to the slower migrating species of Dok-1. 
The p62 co-precipitating with Tee is p62Dok-1 
The most prominent tyrosine phosphorylated protein in Tee precipitates is a protein of 62 kD. 
Recently, Dok-1, a docking protein of 62 kD, was cloned from chronic myelogenous leukemia 
progenitor cells and from v-Abl-transformed B cells22,44. In these cells, Dok-1 is constitutive-
ly phosphorylated. To examine whether Tee-associated p62 is identical to Dok-1, both Tee 
and Dok-1 were precipitated from SCF-stimulated F36P cells, blotted, and incubated with 
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PY99. Figure 2a shows that p62 exactly co-migrates with the slower migrating species of 
Dok-1. Strikingly, proteins of 140 and 56 kD co-precipitate with Dok-1, similar to what is 
observed when Tee is immunoprecipitated. These results suggest that (partially) identical 
complexes are precipitated with anti-Tee and anti-Dok sera. Reprobing of the blot with anti-
Tee serum showed that Tee was present in the Tec-immunoprecipitations (figure 2a, lower 
panel). However, Tee was never detected in Dok-1 precipitations, possibly due to sterical hin-
drance of the antibody. Therefore, we assume that the co-precipitating p56 and p140 associ-
ate with Dok-1 rather than with Tee. 
The anti-Dok-1 antibody could not be used in Western Blot analysis, but worked well in 
immunoprecipitations. To demonstrate that p62 is indeed Dok-1, lysates of SCF-stimulated 
F36P cells were first cleared with anti-Dok-1, followed by a Tee precipitation, and vice versa. 
If Tee and Dok-1 associate, the signal of p62/Dok-1 should be decreased in Tee- and Dok-1 
precleared precipitates. In fact, significantly less p62 co-precipitates with Tee in lysates pre-
cleared from Dok-1 (figure 2b, lanes 4 and 5), while there is almost no p62Dok remaining left 
in a Dok-1 precipitate after the lysate was precleared with anti-Tee (figure 2b, lanes 7 and 
8).Together, these data are consistent with the notion that the Tee interacting protein of 62 kD 
is identical to Dok-1. 
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Figure 3. Tee and Dok phosphorylation is dependent on PI3-K activity. 
F36P cells were incubated with different concentrations of the PI3-K inhibitors wortmanin (WM; 20 minutes; fig. A) or 
LY294002 (LY; 60 minutes; fig. B) at 3rC, after which the cells were incubated with SCF for 5 minutes. 
A. Tee immuneprecipitates were analyzed by Western blotting with anti-phosphotyrosine (top panel) and anti-Tee 
(lower panel). WM clearly inhibits Tee and Dok-1 phosphorylation. 
B. Lysates were incubated with anti-Tee and anti-Dok-1. Tee immune-precipitates were analyzed by Western blotting 
with anti-phosphotyrosine and anti-Tee, Oak-precipitates were analyzed with anti-phosphotyrosine. LY clearly inhibits 
Tee and Dok-1 phosphorylation. Whole celllysates (1 x 106 cells) were also analyzed with anti-phospho-PKB and 
anti-phospho-ERK as control for the specificity of LY. LY inhibits PKB phosphorylation but not ERK phosphorylation. 
C. 293 cells were transfected with expression vectors encoding Tee, Dok-1, or ~p85, or with empty vector(-). Tee 
and Dok-1 immuneprecipitates were analyzed by Western blotting with anti-phosphotyrosine (top panels) and anti-
Tee (lower left panel). Tyrosine phosphorylation of Tee and Dok-1 can be blocked by co-expression of dominant neg-
ative PI3-K (~p85). 
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Tee and Dok phosphorylation is dependent on P/3-K activity 
Like Tee, Dok-1 also contains a PH-domain at its N-terminus, suggesting that recruitment of 
both proteins to the c-Kit signaling complex could depend on PI3-K activation. To inhibit PI3-
K activity both the fungal metabolite wortmannin (WM) and the synthetic inhibitor LY294002 
(LY) were employed. Pretreatment of the cells with 20 nM WM (20 minutes) or 15 )..LM LY (60 
minutes) was sufficient to almost completely block the SCF-induced phosphorylation of Tee 
and the co-precipitating Dok-1 (figures 3a and 3b ). As controls, phosphorylation of the clas-
sical PI3-K target, protein kinase B (PKB), and ERK were assessed. At 15 )..LM LY, phospho-
rylation of PKB was completely blocked as determined with specific antibodies against phos-
pho-PKB (Ser473) (figure 3b) and phospho-PKB (Thr308) (not shown). In contrast, this con-
centration of LY had no effect on the SCF-induced activation of Erk1/2 (lower panel). These 
results demonstrate the specificity of the PI3-K inhibitors and suggest that PI3-K activation 
has to precede Tec/Dok phosphorylation, most likely to recruit these proteins to the signaling 
complex. In addition, since Erk1/2 phosphorylation is not affected by LY, it appears that SCF-
induced activation of the Ras-MAP kinase pathway is independent of Dok-1 phosphorylation. 
In addition to pharmacological inhibitors, a dominant negative PI3-K construct (11p85) was 
used to determine the role of PI3-K in the phosphorylation of Tee and Dok-1. Tee, Dok-1, and 
11p85 were transiently co-expressed in various combinations in 293 cells. Figure 3c shows 
that both Tee and Dok-1 are heavily phosphorylated on tyrosine residues when co-expressed. 
Interestingly, the phosphorylation of both Tee and co-precipitated Dok-1 is reduced when also 
L1p85 is transfected (lanes 1 and 2). Furthermore, immuneprecipitation of Dok-1 shows that 
also the phosphorylation of Dok can be blocked by co-transfection of 11p85 (lanes 4 and 5). 
This indicates that PI3-K activity is required for the phosphorylation of Tee and Dok-1 in 293 
cells. 
Dok-1 is a substrate of Tee and Lyn in 293 cells 
To study the interaction of Tee and Dok-1, transient transfection experiments were performed 
in 293 and COS cells. As shown in figure 4a, immunoprecipitation of Tee from transfected 
cells results in the detection of a single phosphorylated protein, corresponding to Tee (lane 
2). When Dok-1 is co-expressed (lane 3), a 62 kD phosphoprotein is co-precipitated, indicat-
ing that Tee and Dok-1 can form a complex in an overexpression system. However, relative-
ly little phosphorylated Dok-1 is precipitated with Tee in this system when compared to F36P 
and Mo7e cells. Notably, co-expression of Dok-1 reproducibly enhanced the phosphotyrosine 
content of Tee (compare lanes 2 and 3), suggesting that Dok-1 enhances the auto- or cross-
phosphorylation of Tee, or recruits an endogenous kinase that can phosphorylate Tee. The 
tyrosine kinase Lyn has been shown to phosphorylate Tec37 and it was detected in a com-
plex of Tee and Dok-1 in F36P cells (figure 1a). Therefore, Lyn was coexpressed with Tee and 
Dok-1 in 293 cells. Lyn increased Tee phosphorylation (figure 4a, compare lanes 2 and 4) and 
enhanced the intensity of Dok-1 detected by anti-phosphotyrosine antibodies in a Tee 
immunoprecipitation (compare lanes 3 and 5). The latter may be due to Lyn-induced 
increased Dok-1 phosphorylation and/or increased stability of the Tec/Dok-1 complex. To 
examine an effect of Lyn on the Tec/Dok-1 interaction, Tee was coexpressed with a Dok-1 
tagged at the N-terminus with the hemagglutinin (HA) epitope, which allowed detection of 
total Dok-1 on Western Blots. More HA-Dok was co-precipitated with Tee when Lyn was co-
transfected (figure 4b, lanes 3 and 4), suggesting that Lyn stabilizes the Tec/Dok-1 interac-
tion. To analyze whether the association of Tee and Dok-1 is similarly enhanced through SCF-
signaling, Tee was immunoprecipitated from F36P cells stably transfected with HA-Dok. 
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Activation of c-Kit indeed increased the association of Dok-1 and Tee (figure 4c). These data 
suggest that Lyn plays an important role in SCF-induced Tec/Dok-1 complex formation, which 
could be due to phosphorylation 
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Figure 4. Dok-1 is a substrate of Tee and Lyn in 293 cells. 
A. 293 cells were transfected with expression vectors encoding Tee, Lyn, or Dok-1, or with empty vector(-). Tee 
immuneprecipitates were analyzed by Western blotting with anti-phosphotyrosine (top panel) and anti-Tee (lower 
panel). Dok-1 co-precipitates with Tee, especially in the presence of Lyn. 
B. 293 cells were co-transfected with HA-tagged Dok-1 and Tee, together with(+) or without(-) Lyn. Lysates were 
incubated with anti-HA, anti-Dok-1, or anti-Tee, after which the precipitates were analyzed with anti-HA. Lyn stabi-
lizes the interaction between Tee and HA-Dok-1. 
C. F36P cells were stably transfected with HA-Dok-1. Tee was precipitated from lysates of non-stimulated (-) or SCF-
treated (+)cells, after which the precipitates were analyzed with anti-phosphotyrosine (upper panel), anti-HA (mid-
dle panel), and anti-Tee (lower panel). More HA-tagged Dok-1 is precipitated after SCF stimulation, indicating that 
the association of Tee and Dok-1 is stabilized within the c-Kit signaling complex. 
D. COS cells (upper panel) and 293 cells (lower panel) were transfected with empty vector(-) or a Dok-1 expression 
plasmid (+ ), or co-transfected with Tee and/or Lyn. Dok-1 immuneprecipitates were analyzed by Western blotting with 
anti-phosphotyrosine (top panel). In COS cells, both Tee and Lyn can phosphorylate Dok-1, while in 293 cells Dok-
1 is a better substrate for Tee than for Lyn. 
of Dok-1 allowing interaction of the Tee SH2-domain with the phoshotyrosines of Dok-1. 
To examine whether Lyn is able to phosphorylate Dok-1 directly, Lyn and Tee were coex-
pressed with Dok-1 in COS and 293 cells. In COS cells, both Tee and Lyn induced massive 
Dok-1 phosphorylation, while they had an additive effect when co-transfected (figure 4d, 
upper panel). Under these conditions, both Tee and Lyn co-precipitated with Dok-1 (indicated 
with arrows). In 293 cells, the SV40-driven promoter on the pSG5 plasmid is less active, 
resulting in a more modest expression of Tee and Lyn. In these cells, Dok-1 is a better sub-
strate for Tee than for Lyn (figure 4d, lower panel, lanes 3 and 4). Moreover, Lyn had no addi-
tive effect on Tee-mediated Dok phosphorylation (lane 5). Thus, although Lyn can phospho 
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Figure 5. Domains involved in Tec/Dok association. 
A. 293 cells were co-transfected with HA-Dok-1 and different Tee mutants. Tee immuneprecipitates were analyzed 
by Western blotting with anti-HA (top panel), anti-Tee (middle panel), and anti-phosphotyrosine (lower panel). The 
TH- and SH2 domains of Tee are crucial for the direct interaction with HA-Dok-1. 
B. Schematic representation of the Tee mutants used and their Dok-1 interaction- and phosphorylation properties. 
C. Schematic representation of full length HA-Dok-1, HA-Do~ Y5, and HA-Do~ Y1. Tyrosine residues (Y), the PH-
and PTB domains, and total number of amino acids are indicated. 
D. 293 cells were co-transfected with Tee and different HA-Dok-1 deletion constructs. Lysates were incubated with 
anti-HA for expression control and with anti-Tee. Precipitates were analyzed with anti-HA. Although the HA-Dok dele-
tion constructs are equally expressed (left panel), only full length HA-Dok and a reduced amount of HA-Do~ Y5 are 
detected in Tee precipitates (right panel), indicating that two domains in Dok-1 are involved in the binding to Tee. 
rylate Dok-1, its tyrosine phosphorylation appears to depend mainly on Tee activity. 
In conclusion, activation of c-Kit stabilizes the interaction between Tee and Dok-1, possibly by 
Lyn mediated Dok-1 phosphorylation. Subsequently, Tee phosphorylates Dok-1 to yield high-
ly tyrosine phosphorylated Dok-1. 
Domains involved in Tec/Dok association 
Given the interaction observed between Tee and Dok-1, we next examined which domains 
were involved. Wild type (wt) Tee and Tee deletion constructs (see figure 5b for a schematic 
representation) were co-expressed with HA-Dok-1 in 293 cells. Subsequently, Tee precipi-
tates were blotted and probed with anti-HA- and anti-phosphotyrosine antibodies. Wt Tee, 
TecDSH3, and TecDKD bind equal amounts of HA-Dok-1 (figure 5a, upper panel). In contrast, 
TecDPH is much more powerful in HA-Dok-1 binding, while no HA-Dok-1 is precipitated with 
TecDTH and TecDSH2. Similar results are obtained when the blot is probed with PY99, i.e., 
an equal Dok-1 phosphorylation by wt Tee and TecDSH3, enhanced phosphorylation with 
TecDPH, and no phosphorylation with TecDTH, TecDSH2. The only difference concerned 
TecDKD (no kinase activity), which failed in Dok-1 phosphorylation even though it precipitat-
ed HA-Dok-1, showing that indeed Tee kinase activity is responsible for the phosphorylation 
of HA-Dok-1. The detection of high levels of phosphorylated Dok-1 by TecDPH is most likely 
due to enhanced Dok-1 binding (upper panel). Expression of Tee-constructs was controled 
with an antibody against the TH-domain; therefore, TecDTH could not be detected (figure 5a). 
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Staining the blot with an antibody against the SH3 domain of Tee showed that TecDTH was 
expressed comparable to wt Tee (not shown). These data show that two independent 
domains of Tee, the TH and the SH2 domain, interact with Dok?1. 
Dok-1 is a docking protein that contains a PH domain, a phosphotyrosine binding (PTB) 
domain, 15 tyrosine residues, and 10 proline motifs (PXXP). The phosphorylated tyrosines 
can act as SH2-binding sites, while the PXXP motifs mediate binding to SH3 domains. To 
roughly map the region(s) of Dok-1 that associate with Tee, two progressive deletion con-
structs were created (see figure 5c). In HA-DokDY5 193 amino acids were deleted at the C-
terminus, which removes 10 tyrosine residues and 5 PXXP motifs. HA-DokDY1 consists of 
only the PH domain, one tyrosine and two PXXP motifs. The HA-Dok constructs were co-
transfected with Tee in 293 cells. Lysates were incubated with anti-HA antibody as control (fig-
ure 5d, left panel), and with anti-Tee to detect the Tec/Dok interaction (right panel). The inter-
action of Tee with full-length Dok-1 is easily detected, while no HA?DokDY1 is obseNed in 
Tee precipitates. HA?DokDY5 also associates with Tee, although at a low level, suggesting 
that two domains in Dok-1 cooperate in binding to Tee. Alternatively, multiple phosphoty-
rosines of Dok-1 are able to bind the SH2 domain of Tee. 
SH2 domains of distinct signaling molecules bind to phosphorylated Dok-1. We demonstrat-
ed that SCF induces the complex formation of Dok-1 with Tee and Lyn, and that Dok-1 is sub-
sequently phosphorylated on tyrosine residues. Phosphorylated tyrosines act as binding sites 
for SH2-containing proteins. To determine which signaling intermediates could bind to phos-
phorylated Dok-1, glutathione S-transferase (GST) fusion proteins containing the SH2 
domains from a range of signaling molecules were incubated with lysate from SCF-stimulat-
ed Mo7e cells. 
The SH2 domains of the Src-family members Src, Fgr, Hck, and Yes, the tyrosine kinase cAbl, 
the adapter Crkl, rasGAP(SH2 N+C), the p85 subunit of PI3-K(SH2 N+C), PLCg(SH2 N+C), 
and SHIP bind efficiently to phospho-Dok-1 (figure 6). However, the SH2 domains of Fps, 
Grb14, She, Syk(SH2 N+C), and Vav show little or no association with Dok-1, illustrating a 
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Figure 6. SH2 domains of distinct signaling molecules bind to phosphorylated Dok-1. 
GST-fusion proteins containing the SH2-domains of several signaling molecules were incubated with lysates of SCF-
induced Mo?e cells. As a reference for p62Dok-1, a Tee immuneprecipitate was included. The precipitates were ana-
lyzed by Western blot analysis with an antiphosphotyrosine antibody (upper panels}. The blots were stained with 
Ponceau s. as a control for the amount of added GST-fusion protein (lower panels). Phosphorylated Dok-1 binds to 
the SH2 domains of various signaling intermediates. 
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high level of substrate-specificity. Precipitates that contain Dok-1 also include proteins of 145-
150, 140, and 56 kD, although with different ratio's. It cannot be excluded that some of the 
GST-SH2 fusion proteins directly bind to c-Kit and thereby indirectly precipitate Dok-1. 
However, these results strongly suggests that Dok-1 can recruit a variety of signaling proteins 
and therefore that Dok-1 may play an important role in SCF-mediated signaling. 
Discussion 
Various studies have shown that SCF-mediated proliferation, survival, adhesion, migration, 
and differentiation depend on PI3-K activity16•24•26 • PI3-K yields PIP3 in the cell membrane, 
which can subsequently recruit PH-domain containing signaling molecules27 • One such pro-
tein activated by SCF is the tyrosine kinase Tee. We found that activation of c-Kit induces both 
Tee activation and the formation of a complex of Tee with c-Kit, Lyn, p62Dok-1, and two 
unidentified proteins of 56 and 140 kD, respectively. By using pharmacological inhibitors and 
overexpression of Lip85, a dominant negative PI3-K construct, we determined that both com-
plex formation and phosphorylation require PI3-K activity. The Lip85 transfection was done in 
a transient assay, since we failed to generate cell lines that stably expressed Lip85 or c-
KitY721 F, a c-Kit mutant unable to activate PI3-K. We propose a model for Dok-1 in SCF sig-
naling as shown in figure 7. This model involves the activation of PI-3K and Src-family mem-
bers (e.g. Lyn) following c-Kit stimulation. The PH-domain-containing proteins Tee and Dok-
1 are recruited to the plasma membrane where they co-localize with activated Lyn. Lyn asso-
ciates with Tee and promotes its kinase activity. Subsequently, Tee and/or Lyn phosphorylate 
Dok-1, creating binding sites for SH2-containing proteins. It is possible that such Dok-1-inter-
acting proteins are phosphorylated by Tee and/or Lyn as well. 
Tee and Dok-1 are partially associated in non-stimulated serum-starved F36P and Mo7e cells 
(figure 1 ), indicating that the interaction is relatively stable in vivo. In co-transfection studies, 
however, the Tec/Dok-1 association is rather weak, although Dok-1 is heavily phosphorylat-
ed by Tee when co-expressed (figure 4a and 4d, respectively). Using an HA-tagged Dok-1 
construct it was shown that c-Kit stimulation stabilizes the association between Tee and Dok 
(figure 4c). This implies that additional proteins are necessary to allow the formation of a sta-
ble complex. Our results suggest that Lyn is such a protein (figure 4b). Furthermore, Lyn also 
phosphorylates Dok-1 (figure 4d), while the SH2 domain of Tee is crucial for its association 
with Dok-1 (figure 5a). One possible mechanism explaining these results is that Lyn phospho-
rylates a subset of tyrosines in Dok? 1, including the one( s) that mediate( s) the interaction with 
Tee. In turn, Tee may phosphorylate another subset of tyrosines of Dok-1. To further clarify 
the role of Tee in the phosphorylation of Dok-1 in vivo, we tried to stably transfect F36P cells 
with a Tee construct lacking its kinase domain. However, in all clones obtained the expression 
level of this mutant was too low to act as a dominant negative. It can therefore not be exclud-
ed that Src-family members fully account for the phosphorylation of Dok-1 in vivo. During our 
studies, Tee was identified as a possible kinase for CD28-mediated Dok-1 phosphorylation, 
while a Dok-related protein (Dok-R or p56Dok-2) has been reported as a direct target of 
Lyn35,45 • These data are consistent with the conclusion that Dok-1 and Dok-related proteins are 
substrates for both the Tee- and Src-families of tyrosine kinases. 
Dok-1 was first identified as a tyrosine phosphorylated protein of 62 kD associated with p120-
RasGAP in fibroblasts transfected with v-Src46. In BCR-Abl transformed cells, Dok-1 also 
binds to RasGAP in a tyrosine phosphorylation-dependent manner. However, RasGAP was 
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not detected in Tee- and Dok-1-precipitates, although RasGAP was detectable in RasGAP 
precipitates and in whole cell lysate controls (data not shown). In contrast, we detected a tyro-
sine-phosphorylated protein of 140 kD in Tee or Dok-1 precipitates of SCF-stimulated cells. 
Interestingly, a protein of about the same size was shown to bind to Dok-R in EGF-stimulat-
ed cells45 • A protein that is activated by SCF and has a molecular weight of 150 kD is the inos-
itol (data not shown). In contrast, we detected a tyrosine-phosphorylated protein of 140 
cKit 
[
568Y 
721Y 
Erk 
Figure 7. Model for Tec/Dok-1 phosphorylation in SCF-induced signaling. 
See Discussion for details. 
kD in Tee or Dok-1 precipitates of SCF-stimulated cells. Interestingly, a protein of about the 
same size was shown to bind to Dok-R in EGF-stimulated cells45 • A protein that is activated 
by SCF and has a molecular weight of 150 kD is the inositol phosphatase SH I P-1. Therefore, 
we are currently investigating the role of this protein in the Dok-1 complex. In addition, the 
identity of p56 remains to be defined. Both p56Lyn and p52Shc are known to bind to Tee, but 
have another electrophoretic mobility than Oak-bound p56 (data not shown). 
Still little is known about the physiological role of Dok-1. Dok-1 is directly associated with v-
Abl and constitutively phosphorylated in chronic myelogenous leukemia cells44•47 • 
Furthermore, the extent of tyrosine phosphorylation of Dok-1 has been shown to correlate 
with the transforming capacities of a number of different oncogenes, including v-Src,. v-Fps, 
v-Fms, and v-Abl46 • Because of the frequently noted correlation between constitutive tyrosine 
phosphorylation of Dok-1 and cellular transformation it has been suggested that Dok-1 plays 
an important role in mitogenic signaling. This idea is in agreement with the observations that 
Dok-1 is phosphorylated in response to SCF and that SCF primarily serves as a potent pro-
liferation factor in hematopoietic progenitor cells. The results of other studies have suggest-
ed that Dok-1 may also play a role in cellular migration responses. Very recently, Noguchi et 
al showed that overexpression of wt Dok-1 enhanced insulin-induced migration, while this 
was not observed with DokY361 F, a Dok-1 mutant unable to bind Nck48 • Nck is an adapter 
molecule that links receptors to p21 cdc42/Rac-activated kinase (PAK) and the Wiskott-
Aidrich Syndrome protein (WASP)-WIP (WASP-interacting protein) complex, all of which con-
tribute to changes in the actin cytoskeleton49•50 . Furthermore, Rae has been shown to be acti-
vated by c-Kit via a Src- and PI3-K-dependent mechanism and plays an important role in 
SCF-induced proliferation of bone marrow derived mast cells24• One may speculate that the 
Tec/Dok-1 complex recruits and activates the components that regulate the (de) polymeriza-
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tion of actin filaments, thereby regulating cell migration. 
Dok-1 contains a phosphotyrosine binding (PTB) domain, 15 tyrosine residues, and 10 pro-
line motifs (PXXP) and has an overall structure related to the insulin receptor substrates (IRS) 
1-4 and GAB, all of which serve as docking molecules51 • By recruiting subsets of signaling 
molecules into an activated receptor-complex, docking molecules play a key role in the coor-
dination of the cellular response. Others have shown that p120RasGAP and Nck directly bind 
to Dok-1 22.48, while our results indicate that Tee as well as at least two unidentified proteins, 
associate to Dok-1. We further showed that many SH2 domains of proteins functioning in dif-
ferent signaling routes form a complex with Dok-1. These include the SH2 domains of Abl, 
Crkl, PLCy-1, SHIP, and the p85 subunit of PI3-K, all proteins known to be activated by 
SCF16·19•21 •52• Since Crkl is a direct target of BCR-Abl53, it is possible that Dok-1 plays a role in 
the recruitment of kinases (Tee, Lyn, Abl) and their substrates. With the notion that the 
pleiotropic effects of SCF are largely dependent on PI3-K, as is the phosphorylation of Dok-
1, we postulate that Dok-1 (and its phosphorylation control) is an important regulator of SCF-
induced signal transduction. 
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Abstract 
Regulation of survival, expansion and differentiation of erythroid progenitors requires the well-
controlled activity of signaling pathways induced by erythropoietin (Epa) and stem cell factor 
(SCF). In addition to qualitative regulation of signaling pathways, quantitative control may be 
essential to control appropriate cell numbers in peripheral blood. We demonstrate that 
Bruton's tyrosine kinase (Btk) is able to associate with the Epa-Receptor (EpoR) and Jak2, 
and is a substrate of Jak2. Deficiency of Btk results in reduced and delayed phosphorylation 
of the EpoR, Jak2 and downstream signaling molecules like Stat5 and PLCy1 as well as in 
decreased responsiveness to Epo. As a result, expansion of erythroid progenitors lacking Btk 
is impaired at limiting concentrations of Epo and SCF. In addition, lack of Btk results in 
increased sensitivity to TNF-related-apoptosis-inducing-ligand (TRAIL)-induced apoptosis 
and we show that SCF induces Btk to interact with TRAIL Receptor1. Taken together, our 
results indicate Btk to be a novel, quantitative regulator of Epo/SCF-dependent expansion 
and survival in erythropoiesis. 
Introduction 
Signals emanating from the receptors for erythropoietin (EpoR) and stem cell factor (c-Kit) 
are crucial to positively regulate erythropoiesis. Epo or EpoR knockout mice die at day 12.5 
of embryonic development with a lack of erythrocytes 1, while mice carrying mutations in c-Kit 
or SCF are severely anemic 2 • In vivo, physiological Epo concentrations are low, leading to 
apoptosis of about 20% of the erythroid cells present in bone marrow 3 . This apoptotic 
process may be further enhanced upon activation of 'death receptors' 4 of which Fas and 
receptors for TN Fa and TRAIL are expressed in erythroid progenitors s-7 . The observed apop-
tosis is probably caused by an interplay of apoptotic and survival factors. For instance, in 
myelodysplastic syndrome (MDS) the lack of erythrocytes has been attributed to a failure to 
respond to Epo as well as by enhanced sensitivity to death ligands 8·9 • 
Ex vivo, erythroid progenitors can be expanded in presence of Epo, SCF and gluco-
corticoids, while Epo induces differentiation to erythrocytes 10-12• Activation of the EpoR and c-
Kit results in phosphorylation of the receptors and activation of multiple signaling pathways 13-
15. Common signaling pathways involve Src-like kinases, PI3-Kinase, PLCy and MAPK, while 
Stat5 phosphorylation is only induced by Epo (for review see 16). Although the molecular 
mechanisms of Epo/SCF synergy in progenitor expansion are not known, it may involve the 
specific activation of co-operating downstream effector molecules, or changes in signaling 
strength and/or duration. For instance, PI3-Kinase activation of PKB/Akt is significantly high-
er after SCF stimulation and persists longer than Epa-induced PKB/Akt phosphorylation 10 , 
unpublished data). Inhibition of PI3-Kinase abrogates expansion of erythroid progenitors and 
induces differentiation instead 10 • 
PI3-Kinase activity generates phosphatidylinositol-3-phosphates (e.g. PIP3), which targets 
proteins with a pleckstrin homology (PH) domain to the plasma membrane. This includes 
members of the Tee family of cytoplasmatic tyrosine kinases i.e., Bmx/Etk, Btk, ltk, and Tee 
17
• Tee kinases are primarily expressed in hematopoietic lineages 18 • Btk represents the most 
extensively studied member of the family. Btk mutations or deficiency cause XLA (X-Iinked 
agammaglobulinemia) in humans and a block in B-cell development, accompanied by the 
milder XID phenotype (X-Iinked immuno-deficiency) in mice 19-21 . Btk controls B-cell receptor 
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signaling and sensitivity to apoptosis induction. In DT40 cells, Btk associates with Fas and 
inhibits Fas-induced apoptosis 22 , while Btk is required in the same cells for radiation-induced 
apoptosis 23 • Activation of Tee family kinases is largely dependent on the synergistic action of 
PI3-Kinase and a Src-like-kinase activity 24 , although alternative pathways have been sug-
gested 25 • The PH-domain of Tee kinases imposes membrane recruitment 26 , which results in 
phosphorylation on a tyrosine residue in the kinase domain (e.g. Y551 in Btk). The subse-
quent conformational change releases intramolecular inhibitory interactions and allows 
autophosphorylation within the SH3 domain (e.g. Y223 in Btk) and maximum kinase activity 
27
-
29
. Tee, as well as Btk, was also shown to associate with the non-Src-like-kinases Jak1 and 
Jak2 in COS cells and with Syk in B-cells 30.32 • Tee and Jak2 were shown to cross-phospho-
rylate each other 30•31 , but the physiological significance of this interaction has not been inves-
tigated. 
Expression of Btk and Tee in erythroid cells has been described 33·34• but so far only the role 
of Tee in c-Kit signaling has been studied in more detail 35 • The analysis of erythroid progen-
itors derived from wt and Btk deficient (Btk-) mice showed that Btk is required for progenitor 
expansion at low (i.e. physiological) growth factor concentrations. At the molecular level Btk 
enhanced Jak2 activity and loss of Btk resulted in reduced Epa-induced phosphorylation of 
the EpoR, Jak2, Stat5a/b and PLOy. In addition, Btk- progenitors are highly sensitive to 
TRAIL-induced apoptosis as they lack SCF-induced association of Btk with TRAILR1. 
Material and methods 
Antibodies, growth factors and p/asmids 
Rabbit antisera against Jak2, a mouse monoclonal antibody recognizing phospho-Stat5a/b 
(Tyr694-Stat5a; Tyr 699-Stat5b) and antibodies for TRAILR1/2 were obtained from Upstate 
Biotechnology. Rabbit antisera recognizing the mouse EpoR, p44/p42 ERK1/2, PLCy1, Btk, 
c-Kit and the anti-phosphotyrosine mouse monoclonal antibody PY99 were from Santa Cruz 
Biotechnology. Mouse monoclonals recogn1zmg phospho-p44/p42 MAP kinase 
(Thr202/Tyr204) were from New England Biolabs. Phospho-Btk(Tyr223) was obtained from 
Cell Signalling. Anti-actin antibody was obtained from Sigma. Recombinant human Epa was 
a gift from Ortho-Biotech, Tilburg, The Netherlands, dexamethasone was purchased from 
Sigma and Mouse Stem Cell Factor was a kind gift from Amgen. Recombinant Trail was 
obtained from R&D Systems. The complete open reading frame of Btk and Btk kinase dead 
(K430R, a kind gift of Dr. J. Borst, NKI, Amsterdam), Tee, Jak2, Lyn, c-Kit and the EpoR were 
cloned into the mammalian expression vector pSG5 (Stratagene ). Additionally, Btk was 
cloned into the retroviral vector pBabe-puro. 
Generation of p53-deficient, Btk-deficient eel/lines from bone marrow 
Btk-deficient mice 21 and p53 +/- mice 36 , both on a C57B6 background, were bred to obtain 
p53-/-, Btk- animals, which were genotyped by PCR 37 • Bone marrow was isolated from 6 
week old animals to be cultured in StemPro medium (Life Technologies) supplemented with 
Epo (2U/ml), SCF (100ng/ml) and dexamethasone (50!lM). Erythroid progenitors were 
expanded comparable to expansion of human erythroid progenitors from bone marrow 10 . 
Progenitors could be expanded for -14 days, before the cells in the p53 wt culture started to 
differentiate or die. In the p53-deficient cultures, a part of the progenitors continued to divide 
as blasts, similar to what was previously observed for erythroid progenitors expanded from 
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Figure 1, Epo and SCF induce Btk tyrosine phosphorylation. A: Primary, fetal liver derived progenitors were fac-
tor deprived and re-stimulated with Epo, SCF or Epo+SCF as indicated. Stimulation time is indicated in minutes. Btk 
phosphorylation was analysed using an anti-Y223 phospho-specific antibody. Total Btk was stained to confirm equal 
loading. (B, C) The immortalized, bone marrow derived, wt erythroid progenitor cell line 2B6 was factor deprived in 
presence of various concentrations of the PI3K inhibitor LY294002 (B) or the Src kinase inhibitor PP2 (C) as indicat-
ed and re-stimulated with Epo. Btk immune-precipitates were analyzed for phosphorylation using anti-phosphotyro-
sine antibodies (PY99; p-Btk is lower band) and stained for total Btk (B) or for phosphorylated proteins in total cell 
lysates (TCL) as a control (C). 
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p53-deficient mouse fetal liver 38 • The expanding erythroid progenitors were seeded in limit-
ing dilution and several clones were isolated and examined for their differentiation potential 
and factor-dependence. All clones were strictly dependent on Epo, SCF and Dex to maintain 
renewal-divisions. When cells were washed and re-seeded in erythroid differentiation medi-
um (StemPro supplemented with 5U/ml Epo and 1 mg/ml transferrin) all clones differentiated 
into hemoglobinised, enucleated erythrocytes within 72 hours as indicated by cell morpholo-
gy and hemoglobin measurement. The p53-deficient, Btk wt clones 2B4 and 2C6 and the 
p53-deficient, Btk- clones 3G4 and 3E8 were used for all experiments described. 
Cell lines, primary erythroid cultures, transfections and viral transductions 
COS and ecotropic Phoenix (cpE) cells were maintained in Dulbecco modified Eagle medium 
(DMEM; Life Technologies) supplemented with 10% fetal calf serum (FCS, Life 
Technologies). For COS transfection experiments, 106 cells were seeded in 60mm dishes, 
transfected with 12!-lg DNA for 3-4hrs, washed and harvested after 48hrs as previously 
described 35 • Primary fetal liver and bone marrow erythroid progenitors as well as erythroid 
bone marrow cell lines were cultured in StemPro-34TM medium (Life Technologies) supple-
mented with Epa (2U/ml), SCF (100ng/ml) and Dex (50!-LM), unless indicated differently. Cell 
cultures were maintained at 1.5-3x1 06 cells/mi. To induce terminal erythroid differentiation, 
cells were washed in PBS and reseeded at 2-3 x 106 cells/ml in StemPro-34TM medium con-
taining insulin (Ins, 4x1 04 IE/ml, Actrapid HM), the Dex antagonist ZK-112993 (3x1 0-6 M; 39 , 1 
mg/ml iron saturated human transferrin (Sigma) and various concentrations of Epa as indi-
cated. 
Viral transduction of the Btk- erythroid bone marrow cell line 3G4 was done as follows: cpE 
cells were transfected as described for COS cells. After 48hrs of transfection cells were treat-
ed with mitomycin C (1 O!lg/ml; Kyowa) for 1 h, washed 3 times with PBS, left untreated for 
4hrs, washed and 3G4 cells were added (0.5x106 cells per transfection) to be co-cultured in 
StemPro-34TM medium supplemented with growth factors as described above. After 48hrs, 
the erythroid cells were transferred from the cpE cell layer to a new dish and selected for sta-
ble transfectants with puromycine (2!-lg/ml; Sigma). To obtain single cell derived clones, cells 
were seeded in semisolid Stempro-34TM medium supplemented with Epa, SCF and dexam-
ethasone plus puromycin (2!-Lg/ml). 
Immune-precipitations and Western blotting 
Primary erythroid cells and the erythroid bone marrow cell lines were factor deprived in plain 
IMDM (Life Technology) for 4hrs at 5x1 06 and re-stimulated for 1 0' at 3rC (40-80x1 06/ml) with 
SCF (500ng/ml), Epa (5U/ml), TRAIL (200ng/ml), or combinations of factors at concentrations 
indicated in the figure legends. To stop the reaction, 10 volumes of ice-cold PBS were added. 
Cell lysis, immune-precipitation, SDS-polyacrylamide gel electrophoresis and Western blot-
ting were performed as described previously 35 • Membranes were stripped in 63mM Tris-HCI 
pH 6.1, 2% SDS and 1 OOmM ~-mercaptoethanol for 30' at sooc after which they were re-
blocked and re-stained. 
Hemoglobin content determination and cell morphology 
Small aliquots of the cultures were removed and analyzed for hemoglobin content by photom-
etry as described earlier 40 • The values described were the average of triplicate measure-
ments after normalization for cell number and mean single cell volume. For histological analy-
sis erythroid cells at various stages of cell culture were cytocentrifuged onto glass slides and 
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subsequently stained with histological dyes and neutral benzidine for hemoglobin as 
described 41 • Nucleated and enucleated erythrocytes (brown or yellow stained, small cells), 
partially mature or immature cells (larger cells with grey or blue cytoplasm) and dead cells 
(fragmented/condensed nuclei, disintegrated cells) were counted under a microscope, eval-
uating >600 cells on multiple, randomly selected fields per sample (see also 49• 51 ). Images 
were taken using a CCD camera and were processed with Adobe Photoshop. 
Membrane expression of various receptors 
Flow cytometric analysis was performed essentially as described previously 21 • Antibodies 
recognizing c-Kit, Ter119 and integrin£4 were obtained from Pharmingen. Biotynilated Epa 
(Bio-Epo) was made using the biotin labeling kit (Roche; #1418165) following the manufac-
turer's protocol. 
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Figure 2, Btk co-immune-precipitates with and is a substrate of Jak2. A-D: COS cells were transfected with 
pSG5-based expression constructs encoding the indicated proteins. Expression of all proteins was verified in 
Western blots using specific antibodies (data not shown). After 48hrs cells were stimulated with 5U/ml Epo (B) or 
500ng/ml SCF (lane 4, C; lane 4, D and E), harvested, lysed and Btk (A, C), EpoR (B), Jak2 (D) and c-Kit (F) were 
immune-precipitated. Upper panels represent immunoblots stained with anti-phosphotyrosine antibodies (PY99). 
The blots were re-stained with antibodies recognising the immune-precipitated proteins to check for equal loading. 
Arrows indicate the position of the immune-precipitated and co-immune-precipitating proteins. E: The erythroid cell 
line 286 was factor deprived in absence or presence of the Src -kinase family inhibitor PP2 as indicated and stimu-
lated with Epo. Epa-induced Jak2 phosphorylation was assayed on immunoblots using PY99 (upper panel). Lower 
panels represent blots re-stained with anti-Jak2 to confirm equal loading. (F) c-Kit immuneprecipitates were stained 
with anti-phosphotyrosine antibodies (PY99) and blots were restained with anti-c-Kit and anti-Btk antibodies, while 
total cell lysates were stained with anti-c-Kit and anti-Btk to check expression levels. 
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Results 
Btk is phosphorylated in response to Epo and SCF 
To address whether Btk has a functional role in Epo/SCF-dependent erythropoiesis, we test-
ed if Btk is tyrosine phosphorylated in response to Epa or SCF. Erythroid progenitors expand-
ed from E12.5 mouse fetal liver were factor-deprived and re-stimulated with Epa and SCF. 
Epa as well as SCF induced tyrosine phosphorylation of the Btk autophosphorylation site 
Y223 with similar kinetics and intensity while co-stimulation with both Epa and SCF slightly 
enhanced the initial intensity of Btk phosphorylation (Figure 1A). Phosphorylation of Btk was 
also detected with the anti-phosphotyrosine antibody PY99 (data not shown). Since activa-
tion of Btk in B-cells is dependent on PI3-Kinase and Src-like-kinases, we examined the pres-
ence of a similar mechanism in erythroid cells. R1 immortalized erythroid progenitors were 
factor deprived and re-stimulated in presence of increasing inhibitor concentrations suppress-
ing PI3-Kinase (LY294002; LY) or Src-like-kinase (PP2). Btk tyrosine phosphorylation was 
dose-dependently inhibited by LY with complete inhibition at 30-45).lM (Figure 1 B). Inhibition 
of Src-family-kinases with PP2 (0.1-5).lM) did not result in an inhibition of Btk tyrosine phos-
phorylation (lower band, top panel Figure 1 C). Inhibition of (unknown) tyrosine-phosphorylat-
ed proteins in total cell lysates by PP2 indicated that the inhibitor was functional. 
Unfortunately, the Src-kinase inhibitors can not be employed to examine whether SCF-
induced Btk phosphorylation is dependent on Src-kinases, since they directly inhibit c-Kit 
kinase activity (42 ; data not shown). In conclusion, Epa induces PI3-Kinase-dependent and 
Src-kinase-independent activation of Btk in erythroid progenitors. 
Btk interacts with the EpoR and Jak2 and is tyrosine phosphorylated by Jak2 
The Epa-dependent activation of Btk suggests that Btk may interact with the EpoR and/or 
Jak2. Btk was expressed in COS cells together with Jak2 and/or the EpoR. Jak2 efficiently 
co-immune-precipitated with Btk (Figure 2A). Btk also co-immune-precipitated with the EpoR, 
but was not able to phosphorylate the EpoR in the absence of Jak2 (Figure 28). Since Epa-
induced Btk phosphorylation is independent of Src-kinases, we tested whether Jak2 or other 
kinases associated with the EpoR-complex are able to phosphorylate Btk. A kinase-dead 
mutant of Btk(K430R) was expressed in COS cells together with Jak2, Lyn or c-Kit. Jak2 and 
Lyn co-immune-precipitated with Btk and phosphorylated Btk on tyrosine (Figure 2C). To ana-
lyze whether, in reverse, Btk can phosphorylate Jak2, a kinase-dead mutant of Jak2 
(K1114M) was expressed in COS cells together with Lyn, Btk, Tee, or c-Kit. While Lyn effi-
ciently phosphorylated Jak2, Jak2 was not phosphorylated by Btk (Figure 20). In contrast to 
reports by others 30·31 , Tee was also not able to phosphorylate Jak2 in COS cells. In conclu-
sion, Btk can co-immune-precipitate with the EpoR and Jak2, and Btk can serve as a sub-
strate for Jak2. This may explain the PP2-resistent, Epa-induced Btk phosphorylation since 
PP2 did not affect Epa-induced Jak2 tyrosine phosphorylation (Figure 2E). To test whether c-
Kit directly associates with and phosphorylates Btk, we co-expressed c-Kit with either Btk or 
Btk(K430R). While c-Kit co-immune-precipitated with wt Btk, this interaction required Btk-
activity, since c-Kit did not associate with Btk(K430R) and was inable to phosphorylate 
Btk(K430R) (Figure 2F). This suggests that SCF-induced phosphorylation of Btk employs 
additional kinases. 
Btk- erythroid progenitors are defective in proliferation, but not in differentiation 
Since we found Btk to be a substrate of Epo/SCF signaling, we compared factor-dependent 
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Figure 3. Btk- erythroid progenitors show enhanced differentiation at the expense of renewal. A: Btk- primary 
fetal liver progenitors were seeded in medium containing high (2U/ml Epa; 100ng/ml SCF) or low (0.5U/ml Epa; 
25ng/ml SCF) concentrations of SCF and Epa, maintaining normal concentrations of Dex, and cumulative cell num-
bers were determined. The different symbols represent two independent experiments using wt and Btk- erythroid 
progenitors as indicated. B: Histological analysis of wt and Btk- cells described under A at day 6 (arrow in A). The 
percentages of erythroid cells at different stages of maturity (as indicated) were scored for wt and Btk- cultures and 
plotted in a pie chart. C: Hemoglobin content (Hb I cell volume in arbitrary units) of cells as described under A was 
measured at days 4 and 6. D: Btk- bone marrow cell lines ectopically re-expressing Btk (BtkRE) and Btk- cell lines 
(Btk-) were treated as described in A. Open symbols represent BtkRE and closed symbols represent Btk- cells cul-
tured on low, high or no growth factors (NF; see A). E: Primary fetal liver progenitors were seeded in differentiation 
medium. Expression of Btk and the EpoR during differentiation was checked by Western blotting using Btk and EpoR 
antibodies. Equal loading was checked using an actin antibody. F: Cells were seeded in differentiation conditions at 
10, 0.1 and 0.01 U Epo/ml. Cumulative cell numbers were determined. Symbols indicate the different growth condi-
tions as well as wt and Btk- cultures. 
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survival, expansion and differentiation of wt and Btk- progenitors. Fetal liver cells from E12.5 
Btk- and wt littermates were cultured in medium supplemented with Epo, SCF and Dex. In 
both cultures, progenitors proliferated with similar kinetics (Figure 3A). Since standard growth 
factor concentrations (2U/ml Epo; 100 ng/ml SCF) exceed physiological concentrations to 
ensure long-term expansion of progenitors at maximal proliferation rate, we also examined 
expansion of wt and Btk- cells at lower concentrations of Epo (0.5 U/ml) and SCF (25 ng/ml). 
While wt progenitors could be expanded for at least 10 days at reduced growth factor con-
centrations, cultures of Btk- progenitors became stationary at day 6 (Figure 3A). Analysis of 
cell morphology and hemoglobin staining of Btk- cultures at day 6 showed an increase in 
mature erythrocytes at the expense of erythroid progenitors, as compared to wt cells (Figure 
3B). The same was evident by the much smaller average cell size exhibited by Btk- cells com-
pared to wt cells, determined using an electronic cell counter (data not shown). Concordantly, 
Btk- cultures showed an increase in hemoglobin levels compared to wt cultures (3-fold at day 
4; 11-fold at day 6; Figure 3C). In conclusion, Btk-deficiency abrogates the expansion capac-
ity of erythroid progenitors exposed to limiting concentrations of Epo and SCF, favoring ter-
minal differentiation at the expense of erythroid progenitor expansion. 
To study Btk- cells in detail, including biochemical assays, we established immortal cultures 
of p53-deficient Btk- and Btkwt bone marrow derived erythroid progenitors (see material and 
methods). At standard concentrations of Epo and SCF Btkwt (2C6) and Btk- (3E8) immortal 
erythroid cultures could be similarly expanded and retained a cell volume of -800fl. In con-
trast, decreased concentrations (see above) of Epo and SCF caused rapid cell size reduction 
and growth arrest in the Btk- progenitors. Re-expression of Btk in Btk- cells restored the 
expansion capacity and blast-like cell size at reduced growth factor concentrations (Figure 
3D). 
The observation that progenitor expansion was impaired in Btk- cells, while progenitors 
underwent terminal differentiation instead, suggests that Btk is not essential for differentia-
tion. However, Btk expression is maintained during terminal differentiation while EpoR 
expression decreases during the later stages of differentiation (Figure 3E). To investigate 
whether Btk is required during Epa-induced terminal erythroid differentiation, fetal liver 
derived, primary wt and Btk- progenitors were seeded in differentiation medium containing 
varying concentrations of Epo (1 0-0.01 U/ml). Although proliferation during differentation 
showed an expected dependence on the Epa-concentration, no differences between differ-
entiating wt and Btk- cultures were observed with respect to proliferation kinetics, hemoglo-
bin content or cell morphology (Figure 3E and data not shown). 
BFU-E BFU-E 
CFU-E (1 OOng/ml SCF) (25ng/ml SCF) 
wt Btk- wt Btk- wt Btk-
Exp1 701±32 1848 ±170 761±32 789±32 481±48 567±74 
Exp2 509±89 580±47 386±107 324±29 293±72 287±45 
Exp3 512±67 574±48 534±16 523±15 360±8 374±27 
colony numbers are per 105 mononuclear cells 
all values shown represent mean values and standard deviation from 3 individual animals. 
Table 1, Btk deficiency does not influence CFU-E and BFU-E formation. Fetal livers were isolated at E12.5 and 
wt and Btk- erythroid progenitors were assessed for their ability to induce BFU-Es and CFU-Es (as described in 
material en methods). 
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Figure 4, Btk-deficient cells contribute to stress erythropoiesis. (A) Total numbers ofTER119 positive cells were 
determined in bone marrow and spleen of 4 Btk+/Y (open bar), 6 Btk+/- (hatched bar) and 4 Btk-/Y (black bar) PHZ-
treated mice. (B) The ratio of LacZ+ cells in the myeloid (ER-MP20 (Ly-6C)high) and erythroid (TER119) compart-
ment of the bone marrow (BM), and in the B-lymphoid (8220) and erythroid (TER119) compartment of the spleen 
was determined in 4 Btk-/Y (black bars) and 6 Btk+/- (hatched bars) PHZ-treated mice (blast fraction only, i.e. FSC 
high). The numbers above the graph indicate the ratio of LacZ+ cells in the Btk+/- mice compared to the Btk-/Y mice. 
(C) The ratio of LacZ+ cells in the erythroid compartment (TER119) of anemic spleens was determined in different 
cell size fractions (large to small, i.e. with decreasing FSC and increasing SSG) in 4 Btk-/Y (black bars) and 6 Btk+/-
(hatched bars). The numbers above the graph indicate the ratio of LacZ+ cells in the Btk+/- mice compared to the 
Btk-/Y mice. 
Erythropoiesis in Btk-deficient mice is not compromised 
We next wanted to know whether Btk- mice display any erythroid phenotype during normal or 
stress erythropoiesis. Btk- and wt mice had similar numbers of circulating erythrocytes (8.6 ± 
0.6 x1 06/ml and 8.2 ± 0.8 x1 06/ml) and reticulocytes (3. 0 ± 0.3% and 3.1 ± 1.0%; n=4 ). Serum 
levels of Epo were below the detection threshold of 20U/I, corresponding to normal physio-
logical levels as can be expected when circulating red cells are normal. The number of ery-
throid progenitors (BFU-E and CFU-E) was determined in E12.5 fetal livers. We did not 
observe consistent differences between BFU-E and CFU-E in three subsequent experiments, 
using 3 Btk-deficient and 3 wt animals in each experiment (Table 1). 
Btk-deficient cells contribute to stress erythropoiesis 
To investigate the contribution of Btk-deficient cells to stress erythropoiesis, 4 Btk+ males, 4 
Btk- males and 6 Btk+/- female mice (11 to 13 weeks of age) were injected with 0.4% phenyl-
hydrazine (PHZ; 0.16ml/20g). PHZ was injected 3 times with 12hrs intervals and 72hrs after 
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the last injected the animals were sacrificed. Spleens and bone marrow (BM) were harvest-
ed and total cell numbers determined. As expected, PHZ-treatment led to similarly enlarged 
spleens in all respective mice (data not shown). The absolute numbers of TER119-positive 
cells in both BM and spleen from Btk+ and Btk- males were similar (Figure 4 ). Since, in the 
Btk-deficient mice, the Btk gene was inactivated by a targeted in-frame insertion of a /acZ 
reporter 21 , Btk expression can be monitored using the lacZ gene activity under the control of 
the endogenous Btk promoter plus regulatory elements. Btk is located on the X-chromosome. 
In Btk+/- females, X-inactivation therefore either disables the LacZ-targeted allele or the wt 
Btk allele, which allows in vivo competition experiments between cells expressing or lacking 
Btk within a single animal. 
We determined the number of LacZ+ cells in the TER119+ erythroid compartment in the BM 
and the anemic spleens, by loading cells with fluorescein-di-0-galactopyranoside substrate 
(Molecular Probes Europe) as previously described 21. As controls, we analyzed the myeloid 
(ER-MP20 (Ly-6C) high) compartment in the BM, in which there is no known selective disad-
vantage for Btk- cells, and the 8220+ B cell compartment in the spleen, in which Btk- cells 
are expected to be essentially absent 21 • We found that in Btk- males -90% of myeloid cells 
in the BM and B cells in the spleen were lacZ+. In Btk+/- animals the proportions of LacZ+ 
cells in the myeloid were half of those of Btk- males (46-49%), and LacZ+/Btk- cells did not 
contribute significantly to the B cell population in the spleen (figure 48), consistent with our 
previous findings 21 . 
Within the total erythroid population in BM and spleen, the proportions of lacZ+ cells in Btk+/-
females were close to half (-46%) of those found in the Btk- males, indicating that Btk is not 
critical for expansion or differentiation in the erythoid lineage. To quantify the contribution of 
Btk- cells to subsequent stages of erythropoiesis in detail, we determined the percentage of 
LacZ+ cells within the Ter119 positive population in 4 size classes, corresponding to increas-
ing maturation of erythroid cells. In Btk- males, the percentage of LacZ+ cells in the Ter119+ 
population decreased with increasing maturity, reflecting an apparent decrease in Btk 
expression levels of Btk during erythroid maturation. Strikingly, however, the number of LacZ+ 
cells decreased significantly further in Btk+/- females (from 46 to 24%; figure 4C), indicating 
that Btk- cells are impaired in expansion or survival when competing with Btk+/- cells during 
terminal differentiation in vivo. The same phenomenon has been observed in bone marrow 
from PHZ treated and untreated mice (data not shown). 
EpoR signaling is perturbed in Btk- erythroid progenitors 
To unravel how Btk-deficiency could impair Epo/SCF-dependent progenitor expansion, we 
analyzed EpoR and c-Kit signaling. Btkwt (2C6) and Btk- (3E8) immortalized progenitors were 
factor-deprived and restimulated with Epo (5U/ml). Epa-induced phosphorylation of PLCy1 
was completely abrogated in Btk- cells. Surprisingly, Epa-induced phosphorylation of the 
EpoR, Jak2 and Stat5, was also significantly reduced in the Btk- cells compared to wt cells 
(Figure 5A). Epa-induced Stat5 phosphorylation was similarly reduced in primary progenitors 
(Figure 58, data not shown). Re-expression of Btk in Btk- progenitors restored the phospho-
rylation levels of the EpoR, Jak2 and Stat5 to those in wt cells (Figure 5C). While Btk was 
also phosphorylated in response to SCF, SCF-induced phosphorylation of c-Kit was not 
impaired in absence of Btk (Figure 50). To rule out that the impaired Epa-induced signal 
transduction in Btk- cells was due to decreased cell surface expression of the EpoR, expres-
sion of the EpoR and c-Kit was determined by flow cytometry of non-permeabilized cells. 
Surface expression of the EpoR and c-Kit was identical between wt and Btk- erythroid pro 
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Figure 5, Btk- cells are perturbed in Epo-induced signaling. A-D: wt (Btkwt), Btk- (Btk-) and Btk re-expressing 
(BtkRE) bone marrow derived erythroid cell lines (A, C, D) and primary wt and Btk- fetal liver progenitors (B) were 
factor deprived and re-stimulated with Epo or SCF as indicated. Cells were lysed and the immune-precipitated pro-
teins as well as total celllysates (TCL) were analyzed by Western blotting. Upper panels represent blots stained with 
the anti-phosphotyrosine antibody PY99, except for the TCL which was stained with anti-phospho-Tyr694/699 
Stat5a/b. Lower panels represent the same blot re-stained with antibodies recognizing the immune-precipitated pro-
tein as indicated or with anti-totai-Stat5a/b for the TCL. E: Flow cytometric analysis of cell surface expression of c-
Kit, Ter119, integrina4 by specific antibodies and EpoR by biotinylated Epo in wt (thick black lines) and Btk- (thin 
black lines) erythroid progenitors. Expression levels are shown as histograms depicting also control stainings (dot-
ted lines) and addition of excess Epo (grey line) for EpoR detection. Mean fluorescence values varied less then 10% 
for each staining in three independent experiments indicating that wt and Btk- erythroid progenitors express similar 
levels or the respective cell surface markers. 
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genitors, using the erythroid markers Ter119 and integrina4 as controls (Figure 5E). 
Btk controls signaling kinetics. 
To examine whether the reduced response to Epa in 8tk- cells could be caused by altered 
signaling kinetics, the immortalized 8tkwt (2C6), 8tk- (3E8) and 8tk re-expressing (RE) ery-
throid cells were factor deprived, re-stimulated with Epa for 5, 10, 60 and 120 minutes, and 
Stat5 phosphorylation was assessed. Consistently, Stat5 was rapidly phosphorylated in 
response to Epa in wt and 8tk re-expressing cells, while phosphorylation in 8tk- cells was 
largely impaired. However, at late time-points similar levels of Stat5 phosphorylation were 
observed in all cell types (Figure 6A). Since Jak2 phosphorylates Stat5, Jak2 was immune-
precipitated from cell lysates generated at increasing time intervals following Epa stimulation 
of wt (2C6) and 8tk- (3E8) cells. Maximal phosphorylation of Jak2 was observed at 10 - 20 
minutes following Epa stimulation in wt cells and only at 40 minutes in 8tk- cells (Figure 68; 
note that exposure of the blots was adapted to show (de)activation kinetics for 8tk- and wt 
cells, requiring longer exposure of the PY-blots in the 8tk- panel). Also phosphorylation of the 
EpoR, though drastically reduced in Btk- cells, is less rapidly downregulated (Figure 6C; 
requiring again different PY-exposures of 8tk- and wt panels). Analysis of Epa-induced Stat5 
phosphorylation kinetics in primary erythroid progenitors confirmed the results obtained with 
the cell lines: Stat5 phosphorylation decreased after 20 minutes in wt cells, while it increased 
up to 90 minutes following Epa-stimulation in 8tk- cells (Figure 60). 
Btk regulates the ligand responsiveness of the EpoR 
Since 8tk controlled the efficiency of EpoR signaling in time, it may also control the respon-
siveness to critical Epo concentrations. Immortalized 8tkwt (2C6), 8tk- (3E8) and 8tk re-
expressing (RE) cells were factor-deprived and re-stimulated with Epo at concentrations 
ranging from 0.5 to 10 U/ml. Stat5 phosphorylation became detectable in wt and 8tk re-
expressing cells at 0.5 U/ml Epo, while similar levels were reached in 8tk- cells using 5U/ml. 
With increasing levels of Epo, the decrease in Epa-induced Stat5a/b phosphorylation in 8tk-
cells became markedly less apparent (Figure 6E). Together the data show that 8tk may have 
an important role in the regulation of signaling efficiency both in time as well as in response 
to suboptimal, physiological concentrations of Epo. 
Expansion of Btk- erythroid progenitors is inhibited by TRAIL 
Reduced sensitivity for Epo and hypersensitivity for 'death-ligands' is associated in several 
pathological conditions 9 • Notably, loss of 8tk has been shown to render 8-cells more sensi-
tive to Fas-induced apoptosis 22,43 • To examine whether the reduced responsiveness to Epo in 
8tk- cells affects 'death-ligand'-induced apoptosis in primary erythroid progenitors, we 
expanded primary wt and 8tk- erythroid progenitors from fetal liver in presence of various 
death inducing ligands. INFy killed both wt and 8tk- progenitors with identical kinetics while 
the addition of FasL (20ng/ml) or TN Fa (1 Ong/ml) under optimal and suboptimal proliferation 
conditions had no effect on wt or 8tk- cells (data not shown). However, under optimal prolif-
eration conditions the addition of 20ng/ml TRAIL impaired the expansion of 8tk- progenitors 
whereas wt control cells remained unaffected (Figure 7 A). Morphological analysis indicates 
the presence of pycnotic cells (Figure 78). On Western blots, 8tkwt and 8tk- cells express 
similar levels of TRAILR 1 indicating that increased receptor expression is not the cause of the 
enhanced TRAIL sensitivity (Figure 7C). Expression of TRAILR2 was not observed in ery-
throid progenitors (Figure 7C). 
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Figure 6, Btk- erythroid progenitors have a delayed Epo-induced Jak2 and Stat5 phosphorylation. A-E: wt 
(Btkwt), Btk- (Btk-) and Btk re-expressing (BtkRE) erythroid cell lines (A-C) or primary fetal liver progenitors (D) were 
factor deprived and re-stimulated with Epo for the indicated times. Cells were lysed and Jak2 (B) or the EpoR (C) 
was immune-precipitated. The immune-precipitations as well as total cell lysates (TCL) were analyzed by Western 
blotting. A, D: Blots were stained with anti-phospho-Tyr694/699 Stat5a/b (upper panels) andre-stained with anti-total 
Stat5a/b to check for equal loading (lower panels). B, C: Upper panels represent blots stained with anti-phospho-
tyrosine PY99, while lower panels represent the same blot re-stained with anti-Jak2 or anti-EpoR to confirm equal 
loading. PY-staining of these proteins in Btk- cells is much lower that in wt cells, Btk- panels were exposed much 
longer than wt panels, to enable proper comparison of kinetics of (de)activation. E: Erythroid progenitors were re-
stimulated with increasing concentrations of Epo as indicated. Upper panels represent blots stained with anti-phos-
pho-Tyr694/699 Stat5a/b and lower panels represent the same blot re-stained with anti-total Stat5a/b. 
It has been reported previously that Btk can interact with Fas 22 , while the Tee family member 
Bmx/Etk undergoes ligand-independent interaction with TNFaR2 44 • These interactions pro-
tected the cells from death ligand induced apoptosis and allowed TNFa induced cellular 
migration and tube formation. Therefore, we tested whether Btk can interact with TRAILR1 
and whether this interaction is dependent on either Epo or SCF. Progenitors expanded from 
wt fetal livers were factor-deprived and subsequently re-stimulated with Epo, SCF and/or 
TRAIL. Btk immune-precipitates were analyzed for the presence of TRAILR1. Both SCF and 
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TRAIL, but not Epo, induced an interaction of Btk and TRAILR1. In addition, co-stimulation of 
SCF and TRAIL resulted in a significantly enhanced TRAILR1 recruitment to Btk compared 
to SCF or TRAIL alone (Figure 70). This suggests that SCF may inhibit TRAIL-induced apop-
tosis through enhancement of an interaction between the TRAILR1 and Btk, which may coop-
erate with reduced Epa-responsiveness. 
Discussion 
Of all circulating blood cells, the maintenance of circulating erythrocytes at constant, optimal 
numbers is most important. The major erythroid survival and expansion factor erythropoietin 
(Epo) is available at suboptimal levels (<30 U/1) and only part of the progenitors survives in 
the bone marrow to produce mature erythrocytes. In this study we show that the cytoplasmic 
tyrosine kinase Btk is required for an optimal response of erythroid progenitors to Epo, and 
for SCF-mediated survival in presence of TRAIL. 
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Figure 7. Btk· erythroid progenitors are no longer protected by SCF from TRAIL-induced apoptosis. A: wtand 
Btk- fetal liver cells were seeded in medium containing Epo, SCF and Dex, in presence and absence of TRAIL 
(20ng/ml) and cumulative cell numbers determined. The data for both wt and Btk- progenitors under the different cul-
ture conditions were plotted using different symbols as indicated B: Cytospins were prepared from day 4 cultures of 
wt and Btk- cells in presence of TRAIL (arrow in A) and stained with neutral benzidine plus histological dyes. C: 
Western blots from cell lysates of wt and Btk- primary fetal liver erythroid progenitors and primary pro B-cells (kind 
gift of M. Busslinger, IMP) were performed using anti-TRAILR1 and anti-TRAILR2 antibodies as indicated. D: wt pri-
mary fetal liver progenitors were factor deprived and re-stimulated with Epo, SCF and/or TRAIL (200 ng/ml) as indi-
cated. Btk was immune-precipitated from cell lysates and analyzed by Western blotting. Btk tyrosine phosphoryla-
tion was analyzed using an anti-phospho-Tyr223-Btk antibody (upper panel), while co-immune-precipitation of 
TRAILR1 was checked with anti-TRAILR1 (middle panel). Equal loading was confirmed by re-staining the same blot 
with anti-total Btk (lower panel). 
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Btk is a target of Jak2 and controls the efficacy of EpoR signaling 
Stimulation of erythroid progenitors with Epo and SCF induced phosphorylation of Btk on its 
autophosphorylation site Y223, indicating that catalytic activity of Btk is enhanced after Epo 
and SCF stimulation. Interestingly, Jak2 and LYN could phosphorylate Btk. Similarly, the Btk 
family member Tee is mainly phosphorylated by Lyn, but can also be phosphorylated by Jak1, 
Jak2 or Syk 30.32 • Since the Src kinase inhibitors PP1 and PP2 directly inhibit c-Kit catalytic 
activity 42 ; data not shown), we did not investigate whether SCF-mediated Btk activation 
requires Lyn. This is, however, likely since c-Kit was not able to associate with kinase-defi-
cient Btk or to phosphorylate Btk directly (Figure 2), while c-Kit is constitutively associated 
with Lyn in erythroid cells 35 • Notably, Tee is phosphorylated by Lyn in response to SCF and 
the same mechanism may hold for Btk. 
Btk was expected to be required for the phosphorylation and activation of selected 
Epa-dependent signaling intermediates like PLCy, a known downstream target of Tec-kinas-
es. However, the role of Btk in the control of Epo responsiveness was surprising. In the 
absence of Btk, Epa-dependent phosphorylation of Jak2 and the EpoR required increased 
levels of Epo or prolonged exposure to Epo. Activation 
of the SCF receptor, in contrast, was not perturbed. These data suggest that Btk may acti-
vate a signaling pathway that acts as an enhancer of Jak2 activity. Such pathways have not 
been described to date, but Btk does control a number signaling pathways that could be can-
didates for such a function. First, Btk is required to activate PLCy, whose main effectors are 
classical PKCs of which only PKCa is expressed in erythroid progenitors 45 • We previously 
showed that inhibition of these classical PKCs does severely impair Epa-induced signal trans-
duction similar to what we observe in Btk- cells 45 • To test whether the potential absence of a 
PLC-PKC positive feedback loop in Btk- cells could be responsible for their impaired EpoR 
signaling, we examined whether direct activation of PKC could restore a wt-like Epa-respon-
siveness of EpoR signaling in these cells. Both bryostatin and phorbol-ester (PMA) did 
enhance Epa-induced phosphorylation of Jak2 and the EpoR in Btk- cells, but the degree of 
enhancement was not significantly stronger than in wt cells and did not fully restore the Btk-
signaling defect. Second, since Btk associates with Jak2, it may directly affect the Jak2 asso-
ciated protein complex. The Jak2-pseudokinase domain (Jak-homology region 2) is important 
in the regulation of Jak2 kinase activity 46• Its presence is required for inhibition of Jak2 in 
absence of cytokines and for cytokine inducibility of Jak2 activity and Stat5 phosphorylation. 
The exact mechanism of this regulation, however, has not been elucidated. In conclusion, 
quantitative regulation of cytokine-associated Jak2 may play a role in the Epa-responsive-
ness of erythroid progenitors and may be controlled by distinct mechanisms dependent on 
either PKC or Btk. 
Association of Btk with the TRAILR1 may regulate sensitivity to TRAIL-induced apoptosis 
Regulation of the apoptosis threshold is important during erythropoiesis and several apopto-
sis inducers have been implicated in erythropoiesis like TN Fa, Fasl or IFNy 9.4749 • In erythroid 
progenitors, caspase activation in absence of EpoR activation results in Gata-1 cleavage and 
apoptosis 50 • The cytoplasmic serine kinase Raf is required to prevent caspase activation in 
immature cells 51 • However, constitutive inhibition of caspases blocks erythroid differentiation 
51 as caspase activity is required in late stages of erythroid differentiation to cleave proteins 
involved in nuclear integrity and chromatin condensation 52. We show that Btk can associate 
with the TRAILR1 in response to SCF, which may protect against TRAIL-induced apoptosis. 
Similarly, Btk has been shown to inhibit Fas-induced apoptosis in DT40 8-cells, which was 
66 
Btk controls erythropoietin signaling and TRAIL sensitivity 
dependent on association of Btk with Fas 22 • We suggest that Btk mediated protection from 
apoptosis might involve a similar mechanism in both cell types, i.e. interaction of the respec-
tive death receptor with Btk. What remains puzzling is the observation that both Epo and SCF 
induce phosphorylation of Btk, while only SCF induces association of Btk with TRAILR1. This 
could be explained by spatial constraints, which would imply that the TRAILR1 and c-Kit are 
located in close proximity. More likely, the association of Btk with either the TRAILR1 or Fas 
requires an additional bridging molecule that is regulated in response to SCF, but not in 
response to Epo. Such a 'bridging' molecule could also impose specificity of Btk for distinct 
'death-receptors', like Fas or TRAILR1, in lymphoid or erythroid cells. In addition, the intact 
kinase domain of Btk is required for its association with Fas and probably also for its interac-
tion with TRAILR1 22 • Since wt and Btk- progenitors express similar levels of TRAILR1, the 
increased apoptosis induction in Btk-erythroblasts cannot be due to different 'death receptor' 
levels. 
Btk-deficiency impairs renewal and enhances differentiation at limiting cytokine levels 
Expansion of erythroid progenitors in the presence of Epo, SCF and Dex is abrogated in Btk-
progenitors at limiting concentrations of Epo and SCF. Although the attenuated EpoR signal-
ing and increased TRAIL-sensitivity of Btk- progenitors would have predicted increased apop-
tosis at limiting cytokine concentrations, we observed enhanced differentiation at the expense 
of renewal. Our recent results indicate that the role of EpoR signaling in early progenitors and 
maturing cells may be distinct in function. In early erythroblasts, signaling pathways triggered 
via intracellular P-Tyr docking sites in the EpoR contribute mostly to progenitor expansion, 
since erythroblasts from mice expressing a respective truncated EpoR undergo normal differ-
entiation, but are defective for expansion of erythoblasts (H. Beug et al, unpublished). These 
pathways include Epa-induced phosphorylation of Ron/Gab1 and activation of PI3-Kinase 
and MAPkinases (van den Akker, manuscript submitted). Furthermore, Epa-induced STAT5 
activation is required for survival during erythroid differentiation (upregulating Bci-XL), while 
lack of Stat5 in expanding progenitors causes differentiation at the expense of expansion in 
a Bci-XL -independent fashion (H. Beug et al, unpublished). Moreover, since activated cas-
pases contribute to execution of the late erythroid differentiation program where apoptosis is 
prevented by upregulation of Bci-XL 51 •53 , impaired protection against caspase activation in 
Btk- cells could contribute to differentiation rather than to apoptosis. This suggests that the 
lack of Btk may enhance differentiation utilizing both Epo- and SCF-activated signaling path-
ways. 
Human XLA patients or Btk- mice are not anemic and the mice do not present with increased 
spleen size (a hallmark for stress erythropoiesis) as do Stat5-/- mice 54 • Importantly, we ana-
lyzed Btk- mice for their response to hypoxia, which was similar to wt littermates. In vivo, Btk-
deficient cells showed a disadvantage over wt cells very late in maturation, but peripheral ery-
throcyte numbers and size were similar in wt and Btk- animals. Accordingly, we also found no 
indications for increased Epa-levels. Finally, numbers of early (BFU-E) and late (CFU-E) pro-
genitors were similar in fetal livers of wt and Btk- animals. 
In conclusion, Btk appears to be involved in the control of expansion, survival and differenti-
ation of erythroid progenitors via two distinct mechanisms: i) via the regulation of Epa-induced 
signal transduction pathways with proliferation as the cellular readout and ii) via control of 
TRAIL-induced apoptosis, which may involve SCF-dependent association of Btk with 
TRAILR1. Interestingly, the combination of a reduced Epa-response and enhanced sensitivi-
67 
Chapter 3 
ty to 'death-ligands' is a known pathological condition and occurs e.g. in myelodysplastic syn-
drome (MDS; 3·8·55). MDS constitutes a very heterogeneous hematologic disease group that 
occurs mainly in the elderly. Since a reduced response to Epo and 'death-ligand' sensitivity 
are common, this condition may be necessary but not sufficient to cause overt disease. 
Rather, additional genetic aberrations may be required for full development of MDS or even 
AML. Therefore, it will be interesting to examine whether Btk- mice are prone to develop 
leukemia upon further genetic challenges e.g. by retroviral insertion mutagenesis. 
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Abstract 
LFM-A 13, or a-cyano-~-hydroxy-~-methyi-N-(2,5-dibromophenyl)propenamide, was shown 
to inhibit Bruton's Tyrosine Kinase (Btk). We show that LFM-A 13 efficiently inhibits Epa-
induced phosphorylation of the erythropoietin receptor, Janus kinase 2 (Jak2) and down-
stream signalling molecules. However, the tyrosine kinase activity of immune-precipitated or 
in vitro translated Btk and Jak2 was equally inhibited by LFM-A 13 in in vitro kinase assays. 
Finally, Epa-induced signal transduction was also inhibited in cells lacking Btk. Taken togeth-
er we conclude that LFM-A 13 is a potent inhibitor of Jak2 and cannot be used as a specific 
tyrosine kinase inhibitor to study the role of Btk in Jak2-dependent cytokine signalling. 
Introduction 
Cytokine receptors are devoid of intrinsic kinase activity and require the association with 
cytoplasmic tyrosine kinases to transmit signals upon ligand binding. Janus tyrosine kinase 
2 (Jak2) activity is crucial for most cytokine receptors including the erythropoietin receptor 
(EpoR; 1). Epo binding to the EpoR induces a conformational change which juxtaposes the 
associated Jak2 kinases resulting in cross-phosphorylation, activation and subsequent phos-
phorylation of the EpoR and induction of multiple signalling intermediates (for review see 2). 
These include Stat5, protein kinase B (PKB), the Mitogen Activating Protein Kinase (Erk1/2) 
pathways but also tyrosine kinases like Lyn, a member of the Src-family, and Bruton's 
Tyrosine Kinase (Btk), a member of the Tee-family (3; Schmidt et al., in press). 
Tee-family members harbour an N-terminal pleckstrin homology (PH) domain, a proline rich 
(PR) domain, a SRC homology 3 (SH3) domain, a SRC homology 2 (SH2) domain and a 
kinase domain (SH1 ). Upon membrane recruitment via its PH domain, activation of Tee-fam-
ily members occurs through phosphorylation of tyrosine residues in the kinase domain by Src 
kinases (amino acid 551 in Btk; 4). This phosphorylation event is believed to release the intra-
molecular interaction between the PR and the SH3 domain releasing the kinase domain from 
structural restraints 5·6 • Trans-phosphorylation results in activation of the kinase and auto-
phosphorylation of a tyrosine within the SH3 domain (amino acid 223 in Btk; 4 ). Both mem-
brane recruitment and kinase activity are of paramount importance for Btk to function 7-9. Btk 
has been shown to play a role in PhospholipaseC-y1/2 activation 10. 12 and cytoskeleton organ-
isation via WASP 13 • Furthermore, it has been shown that Tee and Jak1 are able to cross-
phosphorylate each other, indicating that Tee family kinases may have a modulatory effect on 
Jak kinases or vica versa 14•15• 
Results and discussion 
To analyse the role of Btk in EpoR signalling, we used the chemical compound a-cyano-~­
hydroxy-~-methyi-N-(2,5-dibromophenyl)propenamide or LFM-A 13. This inhibitor was report-
ed to bind specifically to the catalytic pocket of the Btk kinase domain and not of other relat-
ed tyrosine kinases like Jak1, Jak3 and Src kinases 16 • Erythroid progenitors (R 1 0 cell line) 
were factor deprived in presence and absence of 1 00!-LM LFM-A 13, the recommended con-
centration for this inhibitor 16 , and subsequently stimulated with Epo or left unstimulated. Cells 
treated with LFM-A 13 during starvation did not show any abnormalities with respect to cell 
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Fig. 1. Epo-induced phosphorylation of EpoR, Jak2, Btk, Stat5 and Erk1/2 is inhibited when cells are pre-
treated with 100J.tM LFM·A13. 
R1 0 cells were factor deprived in plain lscoves medium (Invitrogen) for 4h in presence or absence of LFM-A 13 
(1 OOJ.tM) and subsequently stimulated with Epo (5U/ml; 10 min; 40-80x1 o•cells/ml) at 37"C. Ten volumes ice-cold 
PBS were added to stop the reaction. Preparation of cell extracts, immune-precipitations, SDS-polyacrylamide gel 
electrophoresis and Western blots were performed as described by 17• (A) The EpoR, Jak2 and Btk were immune-
precipitated to analyse Epa-induced phosphorylation on Western blots. Upper panels represent anti-phospho-tyro-
sine stained blots; lower panels represent the same blots re-probed with the antibody used in the immune-precipi-
tation (anti-EpoR, anti-Jak2 and anti-Btk) as indicated. In the EpoR immune-precipitate the position of size markers 
is indicated and arrows indicate the EpoR and known proteins co-immune-precipitating. Btk (lower band) is indicat-
ed with an arrow in the Btk immune-precipitate. (B) In the upper panels, Stat5 and Erk1/2 phosphorylation was 
detected with phospho-specific antibodies in whole cell lysates, lower panels represent the total amount of Stat5 and 
Erk1/2 detected with anti-Stat5 and anti-Erk1/2, respectively. Antibodies against the murine EpoR (#SC-697), Erk1/2 
(#SC-94), Stat5 (#SC-836) and phospho-tyrosine (PY99, #SC-7020) were purchased from Santa Cruz, phospho-
specific Erk1/2 (#91 06L) from Cell signalling, antibodies against mouse Jak2 (#06-255), phospho-specific Stat5 
(#05-495) from Upstate Biotechnology. Recombinant human Epo was a kind gift from Ortho Biotech (Tilburg, The 
Netherlands). LFM-A13 was manufactured by Boehringer lngelheim as described by 16• 
shape and viability compared to untreated cells (data not shown). While Epo efficiently 
induced phosphorylation of the EpoR, Jak2, Btk, Stat5 and Erk1/2, this was significantly 
reduced in the presence of 100J..LM LFM-A13 (Figure 1A, B). The co-immune-precipitating 
bands in the EpoR immune-precipitate representing Stat5 and She (Figure 1A; identified by 
specific antibodies) were absent when cells were pre-treated with LFM-A 13. Thus LFM-A 13 
severely impairs EpoR phosphorylation and recruitment of proteins. Since we found that Btk 
is required for efficient signal transduction by the ligand-activated EpoR (Schmidt et al., in 
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Fig. 2. LFM-A13 inhibits in vitro auto-phosphorylation of Btk and Jak2. 
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(A). Jak2 and Btk were immune-precipitated from factor depleted erythroid progenitors (R10) and tested for auto-
phosphorylation in an in vitro kinase assay. Sepharose G beads (Sigma) with immune-precipitated Jak2 and Btk 
complexes were split into 6 equal portions and subsequently submitted to an in vitro kinase assays as described by 
18) in presence of increasing concentrations LFM-A13 as indicated on the top. (B) Jak2 and Btk were immune-pre-
cipitated from cells non-stimulated(-) or Epa-stimulated(+; 5U/ml) and similarly submitted to an in vitro kinase assay. 
1 OOJ.!M LFM-A 13 was added to precipitates from stimulated cells. 
press), we did expect LFM-A 13 to inhibit Epa-induced signal transduction. However, the 
strong effect of LFM-A 13 on Epa-induced signalling could also be due to direct inhibition of 
Jak2 by LFM-A 13. To investigate whether LFM-A 13 could act directly on Jak2, Btk and Jak2 
were immune-precipitated from lysates of factor deprived cells and subjected to in vitro 
kinase assays in the presence of increasing amounts of LFM-A 13. Surprisingly, the kinase 
activity of Btk and Jak2 (auto-phosphorylation) appeared to be inhibited with similar dose-
response curves. Both kinases were already inhibited at 1 O!lM LFM-A 13, while complete inhi-
bition occurred at 20011M LFM-A 13 (Figure 2A). The same results were obtained when Btk 
and Jak2 were immune-precipitated from Epa-stimulated cells (Figure 28). Epo stimulation 
leads to Btk and Jak2 phosphorylation resulting in a lower pool of non-phosphorylated Btk or 
Jak2, hence explaining the lower auto-phosphorylation in the Epa-stimulated lanes. The data 
suggest that LFM-A 13 directly inhibits Jak2 kinase activity. 
However, it could still be possible that the effect of LFM-A 13 on Jak2 is mediated by Btk. If 
both proteins interact with each other, the presence of Btk in the Jak2 immune-precipitate 
could affect Jak2 auto-phosphorylation. To rule out Btk interference in the in vitro kinase 
assay, we used in vitro transcription/translation (ITT) to synthesise recombinant Jak2 that 
was subsequently subjected to an in vitro kinase assay in presence or absence of LFM-A 13. 
A Jak2 IP, Western blot 
Jak2 template: 
anti-Jak2 
R10 
+ control 
B Jak21P, in vitro autophosphorylation 
LFM-A13: -
Jak2 template: - + 
+ 
+ 
[32p] Jak2 .----.-M-KZK-" ---, 
Fig. 3. LFM-A13 inhibits auto-phosphorylation of recombinant Jak2 made via in vitro transcription/transla-
tion (ITT). 
The in vitro transcription/translation was carried out using the TnT® T7 coupled reticulocyte lysate system (#L4611; 
Promega) according to the manufacturer protocol. (A) Jak2 was immune-precipitated from ITT reactions in absence 
(lane1) or presence (lane2) of Jak2 template or from the erythroid progenitor cell line R1 0 and analysed for their 
presence on western blot using an anti-Jak2 antibody. (B) To test the effect of LFM-A13 on recombinant Jak2, 
immune-precipitated ITT Jak2 was subjected to an in vitro kinase assay in absence and presence of 100J.!M LFM-
A13 (lane 2 and 3). Lane 1 represents Jak2 immune-precipitate on ITT -lysate with no Jak2 template present. 
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Expression of Jak2 was detected by immunoblotting using anti-Jak2 antibodies. Jak2 was 
only present when the template was added to the ITT and the mobility of recombinant Jak2 
was the same as immune-precipitated Jak2 when compared to the erythroid progenitor cell 
line R 10 (Figure 3A). Auto-phosphorylation of in vitro synthesised Jak2 in an in vitro kinase 
assay was fully inhibited by 100J..LM LFM-A13 (Figure 3B). This proves that LFM-A13 directly 
inhibits Jak2 kinase activity. Finally, we tested the effect of LFM-A 13 in cells devoid of Btk. 
Immortalised cultures of erythroid progenitors established from Btk- or Btkwt, p53-deficient 
bone marrow, were factor deprived in presence or absence 1 OOJ..LM LFM-A 13 and stimulated 
with Epo or left unstimulated. Epa-induced phosphorylation of the EpoR is impaired in Btk-
deficient cells (Schmidt et al., in press; Figure 4A). However, the remaining Epa-induced 
phosphorylation of the EpoR is still blocked by LFM-A 13. Importantly, Epa-induced phospho-
rylation of Jak2, Stat5 and Erk1 /2, was clearly inhibited by 1 OOJ..LM LFM-A 13 in Btk-deficient 
cells (Figure 4A, B), giving further prove that the effect of LFM-A 13 is directly on Jak2 and 
independent of Btk. Finally we tested whether LFM-A 13 still showed some of its alleged 
specificity. COS cells were transfected with the kinases Jak2, Tee, Btk and Lyn. Half of the 
cells was treated with LFM-A13, the other half left untreated. Celllysates were harvested and 
examined for autophosphorylated kinase on Western blot. LFM-A 13 inihibited autophospho-
rylation of Jak2, Tee and Btk, but it did not affect Lyn kinase autophosphorylation (Figure 5). 
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anti-EpoR ~.. «• • ..;, 
+ 
+ 
Btk-
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Fig. 4. LFM-A13 inhibits Jak2, Stat5 and Erk1/2 phosphorylation in Btk-deficient erythroid progenitor cells. 
The murine erythroid cell lines 286 (Btkwt) and 3G4 (Btk-) were established from p53-deficient mouse bone marrow 
of wt and Btk-deficient mice respectively as previously described "; Schmidt et al., in press). These Btk-deficient 
cells were factor-depleted in presence and absence of 10011M LFM-A13 as indicated and stimulated with Epa 
(5U/ml; 10 min.) when indicated. (A) The EpoR and Jak2 were immune-precipitated and assayed for tyrosine phos-
phorylation (PY99; upper panels) and for the presence of the EpoR and Jak2 by specific antibodies. (B) Lysates of 
the Btk- cells (3G4) were assayed on Western blots using phospho-specific antibodies for Stat5 or Erk1/2. Lower 
panels indicate the same blots re-probed with anti-Stat5 or anti-Erk1/2 to check for equal loading. 
Thus, LFM-A 13 does not inhibit the activity of all tyrosine kinases. 
Both Jak2 and TEC-family kinases, among which Btk, are prominent cytoplasmic tyrosine 
kinases in hematopoietic cells and they co-operate in signalling pathways activated by e.g. 
cytokine receptors, the B-cell receptor and the Fcc receptor19• Moreover, Jak1 and Tee can 
associate and cross-phosphorylate each other 14 and we recently demonstrated that Btk sim-
ilarly associates with Jak2 (Schmidt et al.,in press). Since lack of Btk impairs EpoR signalling, 
the effect of LFM-A 13 on Epa-induced signal transduction was initially expected. However, 
since LFM-A 13 inhibited intrinsic auto-phosphorylation of cellular or recombinant Jak2 in in 
vitro kinase assays and severely decreased Epa-induced Jak2 phosphorylation in cells lack-
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ing Btk, we conclude that LFM-A 13 directly inhibits Jak2 phosphorylation independent of its 
effect on Btk. 
It was previously reported that the kinase activity of Jak1 and Jak3, close homologues of 
Jak2, was not inhibited by high concentration (139 to 278 f.LM) of LFM-A13 in in vitro kinase 
assays 16 . Importantly, the sequences of the kinase domains of Jak kinases are highly con-
served. LFM-A 13 incorporation into the catalytic site of Btk requires hydrogen bonds between 
the side chain of LFM-A 13 and Arg525 and Asp539 of Btk and a hydrophobic pocket for the 
aromatic ring. The kinase domains of Btk and Jak kinases both contain Arginine- and Aspartic 
acid residues at comparable positions but there are several differences with respect to the 
hydrophobic pocket trapping the aromatic ring of LFMA-13. 16 discussed the consequences 
of these differences with respect to LFM-A 13 binding affinity, but total understanding of this 
inhibition is still elusive. Jak1 and Jak3 kinase activity was shown to be unaffected by LFM-
A 13 16 but no data was shown for Jak2, leaving the possibility that Jak2 is the exception in 
the Jak kinase family with respect to LFM-A 13 sensitivity. 
In conclusion, we show that LFM-A 13 is not specific for Btk but also inhibits Jak2 kinase activ-
ity in vitro and in vivo. LFM-A 13 is proposed to be a useful anti-leukemic and anti-thrombot-
ic agent 20 . Although the successful use of STI571 to treat chronic myelogenous leukaemia 
proves that an inhibitor does not need to be specific to be effective21 , it is important that its 
specificity is known. Using LFM-A 13 to elucidate the role of Btk in signal transduction of Jak2 
dependent cytokine receptors could result in wrong conclusions due to simultaneous inhibi-
tion of Jak2 and Btk by LFM-A 13. 
WCL, COS cells 
Jak2 Tee Btk Lyn 
LFM-A13: - + - + - + - + 
anti-pTyr 
Jak2+ 
Btk + 
Tee+ 
Lyn + 
150 
100 
75 
50 
Fig.S. LFM-A13 inihibits Jak2, Tee and Btk, but not Lyn autophosphorylation in COS cells. COS cells were 
transfected with pSG5-based expression plasmids containing Jak2, Tee, Btk or Lyn, using calcium-phosphate pre-
cipitates as previously described 17• Two dishes were used for each construct and LFM-A13 (100!1M) was added 24 
h after transfection to one of the dishes. 48 h after transfection cells were lysed and celllysates were examined for 
phosphorylated proteins on a Western blot using the anti-phosphotyrosine antibody PY99. The position of the kinas-
es is indicated by arrows. The position and of size markers is indicated at the right hand side (molecular weight in 
kDa). 
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Abstract 
Erythropoietin (Epo) is required for cell survival during differentiation and for progenitor 
expansion during stress and normal erythropoiesis. While signaling pathways may couple 
directly to docking sites on the Epa-receptor, additional docking molecules expand the signal-
ing platform of the receptor. We studied the role of the docking molecules Gab1 and Gab2 in 
Epa-induced signal transduction and erythropoiesis. Inhibitors of phosphatidylinositide-3-
kinase and Src-kinases suppressed Epa-dependent phosphorylation of Gab2. In contrast, 
Gab1 activation is dependent on recruitment and phosphorylation by the tyrosine kinase 
receptor RON, with which it is constitutively associated. Activation of RON induces phospho-
rylation of Gab1, MAPK and PKB, but not Stat5. Activation of RON was sufficient to replace 
Epo in progenitor expansion, but not in differentiation. In conclusion, we elucidated a novel 
mechanism specifically involved in expansion of erythroblasts, involving RON as a down-
stream target of the EpoR. 
Introduction 
Erythropoietin (Epo) is required for survival, proliferation and differentiation of erythroblasts. 
It acts together with other growth factors and hormones to balance expansion and terminal 
differentiation of the erythroid compartment. For instance, stem cell factor (SCF, ligand of c-
Kit) cooperates with Epo to delay differentiation and enhance the number of progenitors1•2 • 
The EpoR is a homodimer constitutively associated with Janus tyrosine kinase 2 (Jak2). 
Ligand binding induces a conformational change of the EpoR-dimer3.4, resulting in activation 
of Jak2, phosphorylation of the EpoR on eight tyrosine residues and recruitment of multiple 
signaling molecules5·7 • Mice deficient in Epo, the EpoR or Jak2 lack definitive erythropoiesis8· 
11
• While this demonstrates a crucial role for Epa-induced Jak2 activation in erythropoiesis, 
the contribution of individual downstream signaling pathways to proliferation, differentiation 
and survival of erythroblasts is less clear. Notably, mice expressing a truncated EpoR, lack-
ing all tyrosine residues are not anemic12• This may implicate that additional proteins, like 
docking molecules, can form a complex with the EpoR to create a signaling platform with suf-
ficient specificity to regulate the balance of erythroid expansion and differentiation. 
Candidates for this function are the Grb2-associated-binder (Gab) family members. At pres-
ent three Gab family members have been identified, Gab1, Gab2 and Gab313·14 . Gab1 is ubiq-
uitously expressed, while expression of Gab2 and Gab3 is tissue specific. In the hematopoi-
etic system, Gab3 is expressed in B cells, T-cells as well as in the myeloid compartment, 
whereas Gab2 is expressed in all hematopoietic cells except forT-cells. Gab1-deficiency is 
embryonic lethal due to placental defects, while Gab1-/- embryos are also characterized by 
reduced size of the liver and defects in the migration of muscle precursor cells15•16 • In contrast, 
Gab2 deficiency results only in mild defects in mast cell and macrophage responses17•18 and 
Gab3-deficient mice show normal hematopoiesis19 • Gab2 and Gab3 lack the c-Met binding 
sequence (MBS) of Gab1 and may therefore not complement Gab1 in c-Met signaling. 
Furthermore, the high homology between family members suggests that complementation by 
the ubiquitously expressed Gab1 may occur in Gab2/3 knockouts. Upon tyrosine phosphory-
lation, Gab proteins recruit signaling intermediates among which She (Src-homology contain-
ing protein), Shp2 (Src-homology domain containing phosphatase), the p85 subunit of PI3K 
(phosphatidylinositol-3-kinase) and PLCy1/2 (phospholipase C)20•2\ Gab1 is phosphorylated 
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following stimulation of the EpoR 22. However, it has not been examined whether Jak2 is 
directly involved in this process or whether other kinases could be required for Gab1 phos-
phorylation. 
Gab1 is a direct substrate of the receptor tyrosine kinase c-MeF3• RON (mouse Stk), a close 
homologue of c-Met, is expressed in erythroblasts as both a full length (RONfl) and a short 
form (RONsf), of which RONsf lacks the extracellular domain. Notably, susceptibility for 
Friend virus-induced murine erythroid leukemia is fully dependent on the presence of RONsf 
expression24 • Friend virus induces Epa-independent growth of erythroblasts, via a mechanism 
that has not been completely resolved, but which involves binding of the viral protein gp55 to 
the EpoR and RONsf'5·26 • RON and c-Met are highly homologous at the multiple docking site 
of Gab1 interaction, which suggests a role for Gab1 in RON signaling. Activation of RON 
results in activation of PI3K and the mitogen activated protein kinase (MAPK) route27.28 , path-
ways implicated in expansion of erythroblasts29 and downstream effectors of Gab proteins22 • 
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Figure 1. Epo-induced phosphorylation of Gab2, but not Gab1 is dependent on P13K activity. A: The erythrob-
last cell line R1 was factor deprived (4hrs), left untreated (lane 1) or restimulated with Epo (5U/ml; 1 0') in presence 
of increasing amounts of the PI3K inhibitor LY294002. Gab1 and Gab2 were immune-precipitated from cell lysates 
and analyzed for tyrosine phosphorylation on Western blot. The same blots were stained with anti-Gab1 and anti-
Gab2 to control equal loading. Co-immune-precipitated Shp2 and She were detected by specific antibodies. Size 
markers (kDa) as well as co-immune-precipitating proteins are indicated next to the panels. B: Tyrosine phosphory-
lation of Gab1 and Gab2 in presence of increasing concentrations LY294002 was quantified by densitometric analy-
sis of the appropriate panels shown in (A). Intensity in absence of LY294002 was set at 100%. 
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We examined how Gab proteins function in Epa-induced signaling. We show that Gab2 is 
phosphorylated in response to Epa by a mechanism requiring a Src-like kinase and PI3K. 
In contrast, Epa-induced Gab1 phosphorylation occurs via a mechanism involving Epa-
dependent activation of RON. Direct activation of RON, using a TrkA-RON fusion receptor, is 
sufficient to substitute Epa in progenitor expansion, while it cannot substitute for Epa to sus-
tain differentiation to mature erythrocytes. 
Results 
Epa-induced phosphorylation of Gab1 and Gab2 is differentially dependent on Pf3K activity 
In accordance with previous observations, Gab1 and Gab2 are tyrosine phosphorylated in 
response to Epa in the erythroid cell line R1 (Figure 1A)2°·21 • Several phosphorylated proteins 
co-immune-precipitated with Gab1 and Gab2. Reprobing the same blots with specific anti-
bodies identified the adaptor protein She (50kDa) and the tyrosine phosphatase Shp2 (75 
kDa; Figure 1A). Epa-induced Gab1 and Gab2 phosphorylation was also detected in ery-
throblasts cultured from primary bone marrow and from fetal liver (data not shown). As anN-
terminal Pleckstrin Homology (PH) domain characterizes Gab-proteins, their recruitment and 
phosphorylation is expected to be dependent on PI3K-activity. R1 cells were factor deprived 
and restimulated with Epa in presence of increasing concentrations of the PI3K-inhibitor 
LY294002 (7.5 - 45 j..tM; Figure 1A). While Epa-induced Gab2 phosphorylation was dose-
dependently inhibited in presence of LY294002, Gab1 phosphorylation was to a large extent 
(>40%) resistant to inhibition by LY294002 (Figure 1A, B). Similarly, co-immune-precipitation 
of She with Gab2, but not with Gab1, was fully inhibited by L Y294002. The level of phospho-
rylated Shp2 detected in Gab1 immune-precipitates was reduced at the high concentrations 
of LY294002, which may be due to phosphorylation of Shp2 by LY294002-sensitive kinases. 
Together the data suggest that alternative mechanisms for Gab1 and Gab2 phosphorylation 
may exist. 
Gab1 is a substrate of RON and Lyn, Gab2 of Lyn only 
To investigate what kinases are involved in the phosphorylation of Gab1 and Gab2, we 
expressed Gab1 or Gab2 in COS cells together with various kinases involved in EpoR and c-
Kit signaling among which Jak2, Tee, Btk, Lyn, RONfl and RONsf. Expression of the various 
kinases was checked on a phosphotyrosine Western blot (Figure 2A). Next, Gab1 and Gab2 
were immune-precipitated and analyzed for phosphorylation (Figure 28, C). Expression of the 
Src-kinase family member Lyn resulted in phosphorylation of both Gab1 and Gab2. In addi-
tion, Gab1, but not Gab2 appeared to be a good substrate for RON. Moreover, RONfl and 
RONsf co-immune-precipitated with Gab1, but not with Gab2. Jak2, Tee and Btk did not effi-
cienctly phosphorylate Gab1 or Gab2, although lack of Gab-phosphorylation by Tee may be 
due to its low autophosphorylation signal (Figure 2A). To investigate whether Src-kinases are 
required for Gab1/2 phosphorylation in erythroblasts, we analyzed Epa-induced phosphory-
lation of Gab1 and Gab2 in immortal (R1) and primary erythroblasts (cultured for 5 days from 
fetal livers) pre-incubated with the Src-kinase inhibitor PP2 (5j..tM). Epa-induced Gab1 phos-
phorylation appeared resistant to the Src-kinase inhibitor PP2, while Epa-induced Gab2 
phosphorylation and co-immune-precipitation of Gab2-associated proteins was completely 
inhibited (Figure 20, E). 
The insensitivity of Epa-induced Gab1 phosphorylation to inhibitors of Src-kinases and PI3K 
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Figure 2. Distinct regulation of Gab1 and Gab2 tyrosine phosphorylation. A, B, C: COS 
cells were transfected with pSG5-based expression constructs encoding Gab1, Gab2 and various kinases as indi-
cated. After 48hrs cells were harvested. (A) Phosphorylation status of transfected kinases was detected on Western 
blots by antiphosphotyrosine antibodies (PY99). Similarly, Gab1 (B) or Gab2 (C) immune-precipitates were analyzed 
for tyrosine phosphorylation. Arrows indicate the position of Gab1, Gab2, RONsf and RONfl. Size markers are indi-
cated in kDa. Blots were restained with anti-Gab1 or anti-Gab2 as indicated. D, E: R1 erythroblasts (D) and fetal liver 
erythroblasts (E) were factor deprived for 4hrs in absence or presence of the Src-kinase family inhibitor PP2 (5fLM) 
as indicated. Cells were left unstimulated or were stimulated with Epo (5U/ml: 10'). Epa-induced Gab1 or Gab2 
phosphorylation was assayed on immunoblots using PY99 and equal loading was controlled by staining with anti-
Gab1 or anti-Gab2. Size markers are indicated in kDa. F: Gab 1 associates directly with RON in yeast two-hybrid 
assays. Gab proteins were coexpressed with RON, kinase dead RON (RONkd ) and Grb2 in the yeast reporter strain 
L40. Gab2+MBS encodes Gab2 protein with an insertion of the c-Met binding site (MBS). Associations were quan-
tified by ~-galactosidase liquid assay. 
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may result from the observed association of Gab1 and RON and phosphorylation of Gab1 by 
RON. To investigate whether Gab1 can interact with RON as it does with the RON family 
member c-MET, we carried out yeast two-hybrid (Y2H) interaction experiments23• The cyto-
plasmic domain of kinase active RON or kinase dead RON receptor (RON kd; K1114M) were 
expressed as bait together with full size Gab1 or Gab2 prey vector. Gab1, but not Gab2 asso-
ciates efficiently with activated RON, while both Gab1 and Gab2 bind the known interaction 
partner Grb2 (Figure 2F). The association with RON in yeast is phosphorylation dependent 
since we did not detect the binding with kinase dead bait. A 13 amino acid c-Met binding 
sequence (MBS) is responsible for the direct association of Gab1 with the c-Met receptor23 • A 
Gab2 construct in which the MBS of Gab1 is inserted can interact efficiently with RON indi-
cating that the direct association of Gab1 with activated RON is mediated via the MBS of 
Gab1. In conclusion, RON is able to phsophorylate Gab1, while Src-like kinases are able to 
phosphorylate Gab1 and Gab2. The ability of RON to recruit and phosphorylate Gab1 may 
be responsible for PI3K- and Src-family-independent phosphorylation of Gab1 in erythrob-
lasts. 
Epa induces tyrosine phosphorylation of RON 
If RON mediates Epa-induced Gab1 phosphorylation, it is expected to be a downstream tar-
get of Epa-signaling. The natural ligand for RON is MSP, although ligand-independent phos-
phorylation and activation has also been described (see discussion). To investigate factor-
dependent RON tyrosine phosphorylation, R1 erythroblasts were factor deprived and stimu-
lated with MSP or Epo. RON immune-precipitates were assayed for tyrosine-phosphorylated 
proteins. MSP failed to induce tyrosine phosphorylation of RON (Figure 3A). In contrast, RON 
was tyrosine phosphorylated in response to Epo. Tyrosine phosphorylated proteins of 
1 OOkDa, 70kDa and 50kDa were detected in the RON-immunoprecipitates from Epa-stimu-
lated cells. The lack of response to MSP was not due to an inactive batch of MSP, since MSP 
induced phosphorylation of transiently expressed RONfl in HEK293 cells (Figure 38). Note 
that Epo did not induce RON phosphorylation in cells lacking endogenous EpoR. To analyze 
factor-dependent recruitment of Gab1 to RON in erythroblasts, Gab1 was immune-precipitat-
ed from Epa-stimulated and non-stimulated lysates of primary and immortalized (R1) ery-
throblasts (Figure 3C, D). 
In contrast to the data obtained by Y2H, RON co-immune-precipitated with Gab1 in all con-
ditions tested (see discussion). We were not able to detect Gab1 in RON immune-precipi-
tates, since a strong background band interfered with specific detection of Gab1 (data not 
shown). To check whether Gab1 is dependent on RON for its phosphorylation, we analyzed 
Epa-dependent Gab1 and Gab2 phosphorylation in erythroblasts expand 
ed from E13.5 fetal livers of mice in which the intracellular part of RON, including the kinase 
domain and Gab1-docking domain was deleted (RON TK-/-) 30 • While Gab1 is phosphorylat-
ed in response to Epo in wt erythroblasts, it is not phosphorylated in RON TK+ cells, despite 
the fact that Gab1 expression in RON TK-/- cells is comparable to wt cells (Figure 3E). In con-
trast, Epa-dependent phosphorylation of Gab2 is increased in RON TK-/- erythroblasts com-
pared to wt cells (Figure 3F). In conclusion, the tyrosine kinase receptor RON is a target of 
EpoR signaling and the exclusive kinase required for recruitment and phosphorylation of 
Gab1. 
RON is phosphorylated by Jak2 and associates with the EpoR 
The EpoR activates several tyrosine kinases among which Jak2 and Lyn31 •32 • To identify kinas 
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Figure 3. Gab1 is an interaction partner and substrate of RON in erythroblasts. A: Immortalised (R1) and pri-
mary fetal liver derived erythroblasts were factor-deprived and subsequently stimulated with Epo (5U/ml; 1 0') or MSP 
(1 OOng/ml; 1 0'). Anti-RON immune-precipitates were analyzed for proteins phosphorylated on tyrosine using mono-
clonal PY99. Blots were stained with anti-RON to control that the phosphorylated protein comigrates with RON and 
to control loading. Arrows indicate the position of RON and the position plus molecular weight of phosphorylated co-
immune-precipitated proteins. Anti-RON did not stain a 150 kDa protein in immune-precipitates obtained with unre-
lated antibodies (e.g. anti-Btk; data not shown), indicating that the 150 kDa band is specific for the anti-RON immuno-
precipitate. B: HEK293 cells were mock transfected or transfected with pSG5-RONfl, serum-deprived and stimulat-
ed with Epo (5U/ml; 1 0') or MSP (1 OOng/ml; 1 0'). Anti-RON immune-precipitates were tested for RON phosphoryla-
tion as described for (A). The erythroblast cell line R1 (C) and fetal liver derived erythroblasts (D) were factor-
deprived and restimulated with Epo (5U/ml; 10'). Gab1 was immune-precipitated and blots were stained with anti-
phoshotyrosine antibodies (PY99) and antibodies against Gab1 and RON as indicated. E, F: Fetal liver-derived ery-
throblasts derived from RON TK-/- embryos and wt littermates were factor deprived and restimulated with Epo 
(5U/ml; 1 0'). Western blots containing Gab1 and Gab2 immune-precipitates were stained with anti-phosphotyrosine 
and with anti-Gab1 or anti-Gab2 to check equal loading. 
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es with the potential to tyrosine phosphorylate RON, we expressed a kinase-dead RON 
(RONkd) in COS cells together with the tyrosine kinases Lyn, Tee and Jak2. Lyn, Tee and 
Jak2 all co-immunoprecipitated with wt RONfl (figure 4A), while the RON-specific antibodies 
did not immune-precipitate these kinases from COS cells when RON was not co-expressed 
(data not shown). Kinase-dead RONfl was only phosphorylated in presence of Jak2 (Figure 
4B). Taking all other experiments into account this suggests, but not necessarily implies, that 
Jak2 also activates RON. 
It has been shown that RONsf associates with the EpoR, but no data were published for 
RONfP3• Therefore, the EpoR, RONfl and Jak2 were expressed in COS cells, which were 
stimulated with Epo before harvesting. Both Jak2 and RON co-immune-precipitated with the 
EpoR, both in presence and absence of Epa-stimulation (Figure 4C, data not shown). 
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Figure 4. RON forms a complex with the EpoR and is a substrate of Jak2. A, B: COS cells were transfected 
with pSG5-based expression constructs encoding RONwt (A) or kinase deficient RON (RON kd, B) together with 
Lyn, Tee and Jak2. Cells were harvested without factor stimulation. C: COS cells were transfected with RONwt 
together with the EpoR and Jak2, and stimulated with Epo (5U/ml) 10' before cell harvest. A, B, C: Two days after 
transfection the COS cells were lysed and RON (A, B) or the EpoR (C) was immune-precipitated. The immune-pre-
cipitated proteins were subjected to SDS-PAGE and immunoblotting. Size markers are indicated in kDa. Upper pan-
els represent blots stained with anti-phosphotyrosine antibodies (PY99), lower panels blots stained with anti-RON 
and/or anti-EpoR when appropriate. Arrows indicate the position of the expressed proteins. 
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However, Jak2 but not RON induced Epa-dependent EpoR phosphorylation. Co-expression 
of RON and Jak2 did not affect phosphorylation of the EpoR by Jak2, nor the association of 
RON and Jak2 with the EpoR. 
RON phosphory!ates Gab1 and activates the P/31</PKB and Erk1!2 pathway, but not Stat5 
We next examined the role of RON and Gab1 in expansion, differentiation and survival of ery-
throblasts. Since RON was not activated by MSP in erythroid cells, we constructed a Nerve 
Growth Factor (NGF)-responsive TrkA-RON fusion-receptor (Figure 5A), which was 
expressed in immortalized erythroblasts (R 1 ). TrkA-RON was equally well expressed in a 
large number of clones and NGF stimulation resulted in phosphorylation of TrkA-RON (data 
not shown). 
While Gab1, but not Gab2, was a substrate of RON in COS cells, NGF-induced acti 
vation ofTrkA-RON in R1 cells resulted in Gab1 and Gab2 tyrosine phosphorylation. NGF did 
not induce Gab1/2 phosphorylation in control clones, while Epo induced Gab1 and Gab2 
phosphorylation in all cultures (Figure 58). This implies that in the natural context of erythrob-
lasts both Gab1 and Gab2 are downstream tar 
gets of RON signaling. Since i) RON was able to associate with Lyn (Figure 4A, B) and ii) inhi-
bition of Src-kinases abrogated Epa-induced Gab2 phosphorylation in erythroblasts (Figure 
20, E), it is possible that RON-mediated Gab2 phosphorylation occurs via Lyn. The RON 
homologue c-Met was similarly shown to associate with Lyn upon activation by HGF34. Both 
NGF and Epo induced phosphorylation and association of 120 and 150k0a unknown proteins 
with Gab1 in TrkA-RON expressing cells (Figure 58). Finally, we tested whether activation of 
TrkA-RON induced some of the major signaling pathways activated by the EpoR. NGF, like 
Epo, induced phosphorylation of Erk1/2 and Protein Kinase B (PKB). In contrast, NGF failed 
to induce Stat5 (Figure 5C) or Stat3 tyrosine phosphorylation (data not shown). 
Activation of RON can substitute Epa in induction of progenitor expansion 
Expansion of erythroblasts, including the erythroblast cell line R1, is dependent on Epo, SCF 
and dexamethasone (Oex), while Epo induces differentiation into mature erythrocytes in 
absence of SCF and Oex. Exposure of erythroblasts to SCF and Oex in absence of Epo is 
unable to sustain renewal divisions29 • To examine the role of RON signaling in Epa-depend-
ent expansion and differentiation of erythroblasts, TrkA-RON expressing erythroblasts and 
control erythroblasts were seeded in medium with Epo, SCF and Oex or in medium supple-
mented with NGF, SCF and Oex. Vector-transduced control clones cultured in presence of 
NGF, SCF and Oex became pycnotic indicating that NGF does not exert any biological effect 
in control erythroblasts. In contrast, TrkA-RON expressing erythroblasts proliferated equally 
well in presence of NGF, SCF and Oex, compared to Epo, SCF and Oex (Figure 68), and 
retained a blast morphology under both conditions (Figure 6C). Both the TrkA-RON clones 
and the empty vector are still factor dependent as absence of factors resulted in no growth 
and rapid cell death (Figure 6C). This showed that activation of RON can replace the ligand-
activated EpoR in its function to enhance expansion of erythroblasts. Although we showed 
that RON can associate with the EpoR (Figure 4), Epa-independent proliferation ofTrkA-RON 
expressing progenitors is not due to NGF-induced phosphorylation of the EpoR (Figure 60). 
Activation of RON delays Epa-induced differentiation. 
We next examined whether activation of RON is able to support erythroid differentiation. 
TrkA-RON expressing- and control clones were seeded in differentiation medium without fac-
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tors, supplemented with Epo (2U/ml) or with NGF (100ng/ml). Cumulative cell number, cell 
size, hemoglobin accumulation and cell morphology was determined at regular intervals. 
While Epo induced transient proliferation, a gradual decrease in cell size and accumulation 
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Figure 5. Activation of TrkA-RON induces phosphorylation of multiple downstream targets A: A representa-
tion of the TrkA-RON fusion protein transduced into erythroblasts. The extracellular part of TrkA (amino acids in ital-
ics) was fused to the total transmembrane domain and intracellular tail of RON (amino acids in bold). B,C: TrkA-
RON-expressing and empty vector control cells were factor deprived and restimulated with Epo (5U/ml, 1 0') or NGF 
(100ng/ml, 10') as indicated. B: Western blots containing Gab1 and Gab2 immune-precipitates were stained with 
anti-phoshotyrosine antibodies and antibodies against Gab1 or Gab2. The position Gab1 and Gab2 is indicated by 
arrows, the position of size markers is indicated in kDa. C: Western blots containing whole cell lysates were stained 
for Ser473-phosphorylated PKB, Thr202/Tyr204-phosphorylated ERK1/2 and Tyr694/699-phosphorylated Stat5. To 
control for equal loading, the blot was restained with anti-ERK1/2 and anti-Stat5. 
of hemoglobin, NGF completely failed to do so both in the control and in the TrkA-RON 
expressing cells (Figure 7 A-C). TrkA-RON expressing cells rapidly died both in presence and 
absence of NGF (data not shown). Thus, activation of RON cannot substitute Epo in differen-
tiation. Since activation of TrkA-RON can replace Epo during self-renewal we examined how 
the proliferative signals from TrkA-RON compare to Epa-induced differentiation signals. We 
cultured TrkA-RON clones with Epo, or with Epo and NGF and assayed proliferation, cell size 
and hemoglobinisation. The exposure ofTrkA-RON expressing erythroblasts to NGF and Epo 
caused prolonged proliferation, delayed hemoglobinisation and blastoid cell size during the 
first 4 days of culture (Figure 70-F). The data indicate that signals from TrkA-RON dominant-
ly promote erythroid 'renewal divisions' but fail to sustain differentiation of erythroblasts 
(Figure 7G). Finally we examined whether the tyrosine kinase activity of RON and the activa-
tion of Gab1 are essential for the expansion of erythroblasts. Erythroid progenitors were 
derived 
from E13,5 fetal livers of RON TK-/-30 and Gab1-deficient16 mouse embryos and control litter-
mates and seeded in medium supplemented with Epo, SCF and Dex. All cultures expanded 
with similar kinetics for 14 days as previously shown for primary cells29·35 • Progenitors cultured 
for 5 days from RON TK-/- livers and wt littermates, or from Gab-deficient livers and wt litter 
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Figure 6. Activation of TrkA-RON can replace Epo in expansion of erythroblasts. A: Erythroblasts undergo 
renewal divisions in presence of Epa, SCF and Dex, while they differentiate to mature erythroblasts in presence of 
Epa. B: Empty vector (EV) and TrkA-RON transduced erythroblasts were seeded in medium containing no factors 
(0) or SCF and Dex supplemented with either Epa (2U/ml; e) or NGF (10ng/ml; D). Cells were counted daily and 
cell densities were maintained between 1.5-3x1 o• cells/mi. Cumulative cell numbers were calculated. C: The mor-
phology of the cells in the cultures described under B was examined at day 6. Both cultures contain proliferating 
blasts in presence of Epo/SCF/Dex. In presence of NGF/SCF/Dex control cultures (empty vector) contain pycnotic 
cells, while TrkA-RON expressing cultures contain proliferating blasts. In absence of factors both cultures contain 
pycnotic cells. D: TrkA-RON expressing cells were factor deprived (-) and stimulated with NGF (1 OOng/ml) or Epa 
(5U/ml). The EpoR was immune precipitated from cell lysates and analyzed on Western blot with anti-phosphotyro-
sine antibodies or specific antibodies to check for equal loading. 
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mates were seeded in differentiation conditions (5U/ml Epo, no SCF/Dex) and cell number, 
cell size and hemoglobin accumulation were detemined at 8 h intervals. In all cultures cells 
enucleated in 48 h as previously described35 and no differences in cell proliferation, cell size 
or hemoglobin accumulation were detected (data not shown). Thus, activation of RON and 
Gab1 appears not to be crucial, which may be explained by the increased Epa-induced Gab2 
phosphorylation observed in these cells (Figure 3F and data not shown). 
Discussion 
In the present study, we identified Gab1 and Gab2 as important players in Epa-induced "pro-
genitor expansion signaling", each being recruited and phosphorylated by a distinct mecha-
nism. Recruitment and phosphorylation of Gab2 is dependent 
on the activation of PI3K and Src-like kinase respectively, while Gab1 phosphorylation is fully 
dependent on the tyrosine kinase receptor RON, which appeared to be a specific target of 
EpoR signaling. 
Gab docking proteins are activated by distinct mechanisms 
As can be expected from proteins carrying a PH-domain, Gab2 is recruited to the PIP3-rich 
pockets in the membrane around the activated receptor. Gab2 can interact with Grb2, which 
in turn associates with tyrosine residue Y464 of the EpoR36 • However, the requirement of 
Grb2 to recruit Gab2 to the EpoR has not been analyzed. Possibly this interaction facilitates 
localization of Gab2 close to Lyn, reported to associate with tyrosine residues 464 and 479 
of the EpoR37 • The observation that the Src-kinase inhibitor PP2 suppressed Gab2 phospho-
rylation and the reported role for Lyn in EpoR signaling38•39 , make Lyn a likely kinase respon-
sible for Gab2 phosphorylation. In contrast, Gab1 phosphorylation is only partially affected by 
inhibitors of PI3K or Src-kinase and Gab1 appeared to be recruited by the tyrosine kinase 
receptor RON. The observation that Epa-induced Gab1 phosphorylation is absent in ery-
throblasts expressing a RON receptor lacking the intracellular part indicated that RON is 
absolutely required for Epa-induced Gab1 tyrosine phosphorylation. The partial dependence 
of Gab1-phosphorylation on PI3K activity suggests that recruitment of Gab1 to RON can be 
facilitated by the interaction between the PH-domain of Gab1 with local PIP3. Alternatively, 
RON may phosphorylate only part of the Gab1 tyrosines, while other tyrosine residues may 
be phosphorylated by PI3K-dependent kinases like Tee or Btk. We did observe some discrep-
ancies in the interaction between RON and Gab molecules in erythroblasts and in overex-
pression systems. First, the interaction between RON and Gab1 required RON kinase activ-
ity in Y2H experiments, while the interaction appeared constitutive in erythroblasts. Second, 
Gab2 was no substrate for RON upon overexpression in COS cells, while Gab2 was phos-
phorylated in response to TrkA-RON activation. To us these data represent the intricacy of the 
EpoR-signaling complex. RON can interact with Lyn (Figure 4A). In erythroblasts Lyn is abun-
dantly expressed and present in the EpoR complex. Apparently Gab2 can be phosphorylat-
ed by Lyn associated with either the EpoR or RON. Concordantly, the RON homologue c-
MET also associates with Src-kinases and its activation similarly induces phosphorylation of 
Gab1 and Gab240 • In addition, the interaction between RON and Gab1 may not only depend 
on interactions between phosphorylated tyrosine residues with the MBS and Grb2, but may 
be stabilized by additional scaffolding proteins. 
The question arises whether the distinct regulation of Epa-induced Gab1 and Gab2 is asso 
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Figure 7. Activation of TrkA-RON fails to support erythroid differentiation and delays differentiation in pres-
ence of Epo. A, B: TrkA-RON expressing erythroblasts were cultured in medium containing iron-loaded transferrin 
without additional factor (NF; 0), supplemented with Epo (2U/ml,e) or with NGF (10ng/ml, D). Total cell numbers 
(A) and mean cell volume (fl; B) are depicted. C: At day 4 of the experiment the hemoglobin content was measured 
(Hb/cell volume in arbitrary units) in empty vector transduced cultures and TrkA-RON expressing cultures seeded in 
absence of factor(-), or in presence of Epo or NGF. D-F: TrkA-RON expressing erythroblasts were seeded in differ-
entiation medium lacking growth factor (NF; 0), or medium supplemented with Epo (2U/ml, e) or Epo (2U/ml) plus 
NGF (10ng/ml, D). Cumulative cell number (D), cell volume (fl, E) and hemoglobin accumulation (Hb/cell volume, 
in arbitrary units; F) were determined at daily intervals. G: Schematic representation of the results. Empty vector 
transduced cultures as well as TrkA-RON expressing cultures can be expanded in presence of Epo/SCF/Dex and 
differentiate in presence of Epo. When Epo is substituted by NGF, TrkA-RON-expressing cultures can be expanded, 
while control cells become pycnotic. However, NGF fails to support differentiation ofTrkA-RON-expressing erythrob-
lasts. In combination with Epo, NGF delays differentiation of TrkA-RON-expressing erythroblasts. 
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ciated with a specific function. Gab1-deficient mice die at day 14 to 16 of development due 
to placental defects16 • At this time the liver is reduced in size. No obvious erythroid defect can 
be detected in Gab1-/- mice, but the liver defects exclude in vivo assessment of normal adult 
and stress erythropoiesis. We observed no difference in the in vitro expansion and differenti-
ation capacity of erythroblasts derived from E13 Gab1-/- fetal livers, nor in erythroblasts from 
RON kinase-deficient mice that fail to phosphorylate Gab1 (data not shown). However, 
Gab1-/- as well as RON TK-/- erythroblasts did show enhanced Epa-induced tyrosine phos-
phorylation of Gab2. In all other cells, Gab-proteins can complement each other, resulting in 
healthy mice lacking Gab2 and Gab3. Rather than independent functions, the EpoR appears 
to have two mechanisms that assure phosphorylation of either Gab1 or Gab2 and that may 
be tuned to ascertain different levels of signaling activity. 
RON is part of the EpoR signaling complex 
Although RON can be activated via its ligand (MSP), increasing evidence suggests that RON 
can also be activated by MSP-independent mechanisms through heterodimerisation. RON 
has been shown to interact with various receptors like c-Met, integrins and the common beta 
chain of the IL5, IL3 and GM-CSF receptor leading to cross-activation24•25.41-43 • Furthermore, 
hyaluronoglucosaminidase-2 (HYAL2) was found to be a functional inhibitor of RON. 
Sequestering of HYAL2 by the viral envelope protein of Jaagsiekte sheep retrovirus results in 
constitutive RON activity in absence of ligand44 • In this study we observed that MSP does not 
induce RONfl phosphorylation or downstream signaling in erythroblasts, while Epo stimula-
tion efficiently induced RON phosphorylation in the same cells. This occurred both in two 
independent cell lines derived from distinct genetic backgrounds and in erythroblasts expand-
ed from wt fetal livers of either CBA or 129P mice (data not shown). Thus, ligand binding is 
apparently not a prerequisite for RON activation in erythroblasts. Also upon over-expression 
of RONfl in the erythroblast cell line R1, tyrosine phosphorylation of RON was induced by Epo 
but not by MSP (data not shown), suggesting that there may be an inhibitory mechanism 
active in these cells as previously described for epithelial cells44• 
Our data show that Jak2 can phosphorylate RON in COS cells. Since Gab1 phosphorylation 
is dependent on Epo stimulation in erythroid cells and on RON-kinase activity in COS cells, 
it suggests that Epa-induced Jak2 activation not only leads to phosphorylation of RON but 
also to its activation. Furthermore, the data suggest that the EpoR, Jak2 and RON are part of 
one complex as RON is a substrate of Jak2. While mice deficient in Epo, its receptor and the 
associated kinase Jak2 die at day 13 of gestation due to a lack of erythrocytes, mice in which 
the EpoR lacks all tyrosine-docking sites in the EpoR C-terminal tail develop normally with-
out aberrations in erythropoiesis12• Previously it was suggested that signaling intermediates 
like She, Shp2 and PI3K could dock to Jak2 upon deletion of the C-terminal tail of the EpoR 
containing the eight phosphorylated tyrosine residues. However, since Epa-induced activa-
tion of Jak2 results in RON activation, which subsequently results in phosphorylation of Gab1 
(directly) and Gab2 (via Src-kinases), these docking molecules may be responsible for the 
recruitment of several signaling intermediates like She, Ship2 and PI3K independent of an 
intact EpoR C-terminus. 
RON is involved in renewal induction 
The ability of ligand-activated TrkA-RON to replace Epo stimulation in expansion of progeni-
tors but not in differentiation is in line with the role of the truncated avian homologue v-SEA, 
which also induces expansion of erythroblasts but not their differentiation45• However, while 
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expression of v-SEA is sufficient to induce renewal divisions in avian erythroblasts, signals 
emanating from an activated RON in mouse erythroblasts require cooperative signaling by c-
Kit and the glucocorticoid receptor to induce expansion. As RON is a downstream target of 
EpoR signaling, the mechanism of cooperation between NGF, SCF and dexamethasone will 
most likely be similar to cooperative signaling between Epa, SCF and dexamethasone but 
remains to be elucidated. TrkA-RON expressing erythroblasts exposed to NGF alone rapidly 
die indicating that RON signal transduction via Gab1/2, PI3K, Pkb and the MAPK route is not 
sufficient for these cells to survive. Exogenous (over)expression of a kinase always warrants 
a careful interpretation of the results since its regulation may not be subject to normal con-
trols. However, the fact that activation of TrkA-RON alone is not sufficient for survival or pro-
liferation of erythroblasts, but requires cooperation with SCF suggests that its function close-
ly mimics that of endogenous RON. 
While activation of RON can substitute EpoR-activation to maintain renewal divisions in coop-
eration with SCF and dexamethasone, it also transiently sustained renewal divisions under 
differentiation conditions in presence of Epa. Thus, the EpoR apparently activates both 
renewal- and differentiation-specific signaling pathways, which need to be carefully balanced 
to maintain the proper number of red blood cells. When this balance is disrupted by e.g. 
increased RON activity, a polycythemic or leukemic phenotype may arise, as it occurs in the 
SFFV infected mice. As shown, Epa induces several alternative routes to activate common 
targets like PI3K and the MAPK route. So far it is unclear how these complementary path-
ways contribute to EpoR signaling and how cellular output is affected upon changes in the 
balance of these integrated cascades. 
The data are consistent with the observation that RONsf is required for SFFV to induce ery-
throleukemia in mice. gp55 protein targets RONsf33 resulting in constitutive phosphorylation 
and activation of RON, and Epa-independent expansion of progenitors. Similar to the TrkA-
RON clones, SFFV-induced erythroleukemia still requires SCF for renewal-induction46 and 
permits Epa-induced differentiation to functional erythrocytes. One of the major Epa-induced 
signaling molecules that is not activated by RON is Stat5. The inability of ligand-activated 
TrkA-RON to support in vitro terminal differentiation of erythroblasts could be due to lack of 
Stat5 phosphorylation. Stat5-deficient erythroblasts, cultured in vitro in serum free medium, 
are deficient in Epa-induced differentiation due to the inability to activate the anti-apoptotic 
protein BciXL35 • Concordantly, mice deficient in Stat5 are impaired in their response to hypox-
ia. Upon hypoxia induction, Stat5-deficient mice suffer from anemia accompanied by apopto-
sis of erythroblasts47 • Yet, these mice have an enlarged spleen and expansion of erythroblasts 
in the spleen, suggesting impaired differentiation rather than a defect in expansion. These 
data suggest that Stat5 activation is essential for erythroid differentiation but not for expan-
sion. The fact that RON does not activate Stat5 may be reflected in its inability to induce dif-
ferentiation and survival during the onset of differentiation. 
Materials and methods 
Antibodies and growth factors 
Rabbit antisera recognizing Jak2 or Gab1 and a mouse monoclonal antibody recognizing 
phospho-Stat5 (Y694-Stat5A/Y699-Stat5B; #05-495) were obtained from Upstate 
Biotechnology (Lake Placid, NY); rabbit antisera recognizing the mouse EpoR, RON, TrkA or 
p44/p42 Erk1/2 and the anti-phosphotyrosine mouse monoclonal antibody PY99 from Santa 
97 
Chapter 5 
Cruz Biotechnology (Santa Cruz, CA; sc-697; sc-322; sc-14024; sc-94; sc-7020 respective-
ly); rabbit antisera recognising phospho-PKB (Ser473; #9271) and mouse monoclonal anti-
bodies recognising phospho-p44/p42 Erk1 /2 (Thr202/Tyr204; #91 01) from Cell Signaling 
Technology (Beverly, MA). Rabbit antiserum recognizing Gab2 was a kind gift from Dr. T. 
Hirano (Osaka University, Japan). Human MSP was obtained from R&D systems, recombi-
nant human Epa was a gift from Ortho-Biotech (Tilburg, The Netherlands), dexamethasone 
was purchased from Sigma (Zwijndrecht, The Netherlands) and SCF was obtained from the 
supernatant of producer CHO-cells. 
Plasmids and oligonucleotides 
The complete open reading frame of RONfl (a kind gift of Dr. Breathnach, lnstitut de Biologie-
CHR, Nantes, France), Tee, Jak2, Lyn, EpoR, Gab1 and Gab2 were cloned into the mam-
malian expression vector pSGS (Stratagene, La Jolla, CA) and the retroviral vector pBabe-
puro when indicated. The kinase dead form of RON, K1114M, was generated using the 
QuickchangeTM Site-directed Mutagenesis Kit (Stratagene) with the following oligonu-
cleotides: 5'-CCAATG TGC CAT CGA TTC ACT AAG TCG CA-3 and 5'-GCT CTC CAG CGC 
CGT CCA CTT CAC A-3'. To construct TrkA-RON the extracellular domain of the TrkA-recep-
tor was expanded via PCR (from TrkA-Met48) using forward primer 5'- GCG AAT TCA TGC 
TGC GAG GCG GAC GGC GC-3' and reverse 5'-GCG ATA TCC TTC TTC TCC ACC GGG 
TCT CC-3' after which the fragment was cut with EcoRI and EcoRV. The RON transmem-
brane/intracellular domain PCR product was amplified using forward primer 5'-GCG ATA TCC 
TCC TTG GTA TCC TGC TGC CT-3' and reverse primer 5'-CGC TCG AGC TAA GCA GGT 
CCA GCC CAA GA-3' and digested with EcoRV and Xhol. Both fragments were simultane-
ously ligated into the EcoRI/Sa/1 site of the retroviral vector pBabepuro creating the TrkA-
RON fusion receptor (Figure SA). The prey plasm ids VP16-Gab1, VP16-Gab2 and VP16-
Gab2+MBS have been described23 • 
Yeast two-hybrid analysis 
The Yeast strain L40 was used for the Yeast-two-Hybrid transformation assays49 • It contains 
his3 and lacZ as reporter genes. Bait plasmids BTM-RON and BTM-RONkd code for the 
kinase active and kinase inactive cytoplasmic part of the human receptor tyrosine kinase 
RON, respectively. This cytoplasmic part was fused to the LexA DNA-binding and dimeriza-
tion domain. Sequences encoding amino acids 983 to 1400 ofwt RON or RON K1114M were 
amplified by PCR (using 5'-GGA ATT CCG GAG GAA GCA GCT AGT TCT TCC-3' and s·-
AAA AAA GTC GAC TCA AGT GGG CCG AGG AGG CTC-3') and cloned into pBMT as 
EcoRI-Sa/1 fragments. The ~-galactosidase assay measures LacZ reporter gene activity to 
quantify the interaction of bait and prey proteins. Yeast was grown in liquid culture and opti-
cal density measured at A-=600 nm, pelleted and cracked open by a freeze-thaw-technique in 
liquid nitrogen. b-galactosidase activity was determined calorimetrically using the compound 
ONPG (o-Nitrophenyi-~-D-Galactopyranosid) as a substrate (A-=420 nm). The following for-
mula was used to calculate relative b-galactosidase activity: 1000 X OD 420 /( t X V X OD 
600). t =time (min), V =Volume (ml). 
Cell lines, primary cells, transfections and viral transductions 
COS, HEK293 and ecotropic Phoenix (<pE) cells were maintained in Dulbecco modified Eagle 
medium (DMEM; Life Technologies, Paisley, UK) supplemented with 10% fetal calf serum 
(FCS; Life Technologies). For COS and HEK293 transfection experiments, 1 million cells 
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were seeded in 60mm2 dishes and after 3-4hrs (COS cells) or 24hrs (293 cells) transfected 
with 1211g DNA as previously described50 • After 24hrs the cells were washed once with PBS 
(phosphate buffered saline) and new medium was added. Cells were harvested 48hrs after 
transfection. Primary fetal liver erythroblasts as well as the murine erythroblast cell line R1 
(generated as described before)29 were cultured in StemPro-34TM medium (Life 
Technologies) supplemented with Epo (0.5U/ml), SCF (100ng/ml) and Dexamethasone 
(501-LM). Cell cultures were maintained at 1.5-3x1 06 cells/mi. Viral transduction of the erythrob-
last cell line R1 was performed as described by Bakker et al. 51 • To obtain single cell derived 
clones, cells were seeded in semisolid Stempro-34TM medium supplemented with Epo, SCF 
and dexamethasone as described above plus puromycin (21-Lg/ml). To induce differentiation 
erythroid cells were washed two times with PBS and reseeded in StemPro-34TM medium 
supplemented with 5U/ml Epo and 0.5mg/ml iron-saturated human transferrin (lntergene). 
During differentiation cells were kept at 2-5x1 06 cells/ml 
Hemoglobin content determination and cell morphology 
To measure the hemoglobin content in cells, 3 x 50 111 aliquots of the cultures were taken and 
processed for photometric determination of hemoglobin as described before51 • To analyze cell 
morphology 50!11 samples were taken from culture, cytocentrifuged onto slides and stained 
with histological dyes and neutral benzidine for hemoglobin52• Images were taken using a 
CCD camera and processed with Adobe Photoshop. 
Immune-precipitations and Western blotting 
Primary erythroid fetal liver cells and the erythroblast cell line R1 were growth factor deprived 
for 4hrs in plain IMDM (Life Technology), while HEK293 cells were serum deprived for 24hrs 
in plain DMEM. The erythroblasts (40-80x1 06/ml) were stimulated at 3rc with SCF (11-Lg/ml; 
5'), Epa (5U/ml; 10'), MSP (100ng/ml; 10') or NGF (100ng/ml; 10') as indicated, the HEK293 
cells and COS cells were stimulated for 1 0' with 100 ng/ml MSP or Epo (5U/ml). Reactions 
were stopped with excess ice-cold PBS. Cells were washed twice with ice-cold PBS, lysed in 
ice-cold lysis buffer53 , incubated on ice for 1 0', nitrogen frozen and stored at -sooc until usage. 
Lysates were thawed on ice cleared by centrifugation at 4°C at 15,000rpm. Immune-precipi-
tations, SDS-polyacrylamide gel electrophoresis and Western blots were performed as 
described previously 53. Membranes were stripped in 63mM Tris-HCI pH 6.1, 2% SDS and 
1 OOmM ~-mercapto-ethanol for 30' at 50oc after which they were re-blocked and re-stained. 
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Abstract 
Fanconi anemia (FA) is an autosomal recessive disorder in which the mechanisms underly-
ing the disease are only partially understood. FA is commonly accompanied with anemia due 
to bone marrow hypoplasia. To analyze cytokine-dependent survival, expansion and differen-
tiation of hematopoietic progenitors lacking Fanconi proteins, we compared erythropoietin 
(Epa) signaling in erythroid progenitors derived from mice lacking Fanca or Fa neg, or from wt 
littermates. Epa-induced phosphorylation of Stat5 and Erk1/2 was severely reduced and 
delayed in progenitors lacking Fanca or Fancg. As a consequence, Epa-induced up- or down-
regulation of target genes like p21 WAF, GILZ, SOCS3, Spi2.1 and BciXL was reduced. In con-
trast to these downstream signaling intermediates, Epa-induced phosphorylation of the Epa-
receptor and its associated kinase Jak2 were not affected. Stem Cell Factor-induced c-Kit 
activation and downstream Erk1/2 phosphorylation was equally efficient in wt or Fanca or 
Fancg-deficient cells. The expansion capacity of erythroid progenitors lacking Fanca or 
Fancg proteins was reduced, but only after prolonged culture (>7 days). Although mice lack-
ing Fanconi proteins are healthy, the observed mechanism could contribute to a predisposi-
tion for anemia in FA, that may become apparent in the context of additional mutations. 
Introduction 
Fanconi anemia (FA) is an autosomal recessive disease characterized by developmental 
abnormalities, bone marrow failure and cancer predisposition. Patients with FA present at the 
clinic at early age (median 7 years) with decreased platelet counts and aplastic anemia. 
Before the age of 40, 81% of cases further progresses to total bone marrow failure or other 
hematological abnormalities, which is the major cause of death. FA cells show a large range 
of abnormalities including hypersensitivity to clastogenic and growth inhibiting effects of DNA 
cross-linking agents like mitomycin C, spontaneous chromosome breakage and an increased 
sensitivity to apoptosis inducers TNFa and IFNy1. 
FA is a heterogeneous disease and so far eleven complementation groups have been identi-
fied2·3. FANCA, C, E, F and G may partly reside in the cytoplasm, but they aggregate to form 
a nuclear core complex together with the biotin ligase FANCL 4'542. This complex recruits and 
ubiquitinates FANCD2, a process that requires FANCP939. Mono-ubiquitination of FANCD2 is 
critical for its interaction with BRCA 1 and affects DNA repair and S-phase checkpoint 
response 6-8• FANCJ has a unknown role late in this process. As is evident from mice lacking 
Fanca, Fancc or Fancg and from in vitro studies on cell lines derived from FA patients, the 
hypersensitivity to DNA crosslinkers results from the inability to form a Fan coni core-complex 
in the nucleus9. The Fane-deficient mice do not have bone marrow failure or an enlarged risk 
of acquiring solid tumors as described for FA progression. However, upon additional loss of 
p53 fancc-deficient mice develop a large variety of tumors, including leukemia43. To date the 
relation between genomic instability and the molecular mechanism of (aplastic) anemia is not 
clear. Bone marrow transplantation experiments revealed a reduced repopulation capacity of 
Fancc-deficient stem cells 10 and growth factor-induced proliferation and differentiation of 
Fancc-deficient bone marrow cells is reduced compared to wt littermates 11 ·12. Although IFNg-
induced gene expression and apoptosis is enhanced in FA lymphoid and fibroblastoid cell 
lines 13-15, IFNy-induced STAT1 tyrosine phosphorylation is severely reduced in FANCC-defi-
cient cells 16 and IFNy treatment of Fancc-deficient mice did not lead to bone marrow failure 
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17
• Therefore, increased sensitivity to IFNy remains controversial and the cause of bone mar-
row failure remains elusive. 
Both Fancc- and Fanca-deficient hematopoietic progenitors have a high rate of spontaneous 
apoptosis 18·19 • Epa-receptor (EpoR) activation suppresses apoptosis and allows differentia-
tion of erythroid progenitors. The EpoR, like INFyR, is a member of the cytokine family and 
signals via the Jak-Stat pathway. FA patients presenting with anemia have high Epo serum 
levels that fail to rescue anemia. 20'21 • We found that Epa-induced Stat5 and Erk1/2 phospho-
rylation in Fanca- and Fancg-deficient erythroid progenitors was severely reduced. Epo/SCF-
dependent expansion of Fanca- and Fancg-deficient mouse erythroid progenitors was initial-
ly normal, but an increased differentiation rate abrogated progenitor expansion significantly 
earlier than the expansion of respective wt progenitors. 
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Figure 1. Colony formation of Fanca-deficient progenitors is not decreased in number nor hypersensitive to 
the apoptosis inducers IFN-g and TNF-a. Fanca-deficient and wt bone marrow cells were seeded in semisolid 
medium supplemented with SCF, IL-3, IL-6 and Epo in absence or presence of various concentrations of the apop-
tosis inducers TNF-a (A) or IFN-y (B). The depicted colonies numbers represent mainly CFU-GM with an insignifi-
cant contribution of BFU-Es. Values represent mean and standard deviation of three experiments. 
Results 
Bone marrow of Fanca-deficient cells is not hypersensitive to IFNy and TN Fa. 
FANCC deficient lymphoblastic cell lines are significantly more sensitive to IFNg- and TNFa-
induced apoptosis. Furthermore, FA bone marrow shows increased spontaneous apoptosis. 
To examine whether bone marrow of Fanca-deficient cells is hypocellular and/or hypersensi-
tive to inflammation factors, we isolated bone marrow from week 8 Fanca-deficient mice and 
wt littermates. Colony numbers were determined in semi-solid medium supplemented with 
SCF, IL-3, IL-6 and Epo (see M&M). In addition, increasing concentrations of IFNy and TN Fa 
were added. Although progenitor numbers in Fanca-deficient animals were consistently lower 
than in wt animals, the difference was not significant. In addition, no significant difference was 
observed between wt and Fanca-deficient mice with respect to IFNyand TNFa sensitivity of 
progenitors (Figure 1 ). 
Fanca- and Fancg-deficient erythroid progenitors have a lower expansion capacity. 
Mice deficient in Fanca or Fancg do not develop spontaneous anemia. However, since 
Fancc-deficient stem cells were shown to have a reduced capacity to sustain hematopoiesis 
in serial transplantations or upon inflicting long term hematopoietic stress 10'12 , the expansion, 
survival or differentiation kinetics of hematopoietic stem cells may be impaired under stress 
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Figure 2. The expansion capacity of Fanca- and Fancg-deficient erythroid progenitors is significantly lower 
than in wt cells. A: Wt (black triangles), Fanca (white diamonds) or Fancg (white squares) deficient fetal liver ery-
throid progenitors were seeded in medium containing SCF, Dex and Epo. Cells were counted daily and cell densi-
ties were maintained between 1.5-3 million cells/mi. Cumulative cell numbers were calculated. B: An independent 
experiments using wt (black diamons), Fang+/- (black triangles) and Fancg-/- (white squares) fetal liver cells. C: 
Aliquots of the experiment described in B were taken on the indicated time points. The cells were fixed and stained 
with propidium Iodine to distinguish life from dead cell populations. Cells with subG1 DNA content wt (+/+), heterozy-
gous(+/-) and Fancg-deficient (-/-)cultures are depicted as a percentage of the total population. D: Cell numbers of 
the cultures depicted in B were differentiated for size: 3.75-5 11m roughly corresponds to erythrocytes, 5-7 11m to late 
erythroblasts, 7-9 11m to early erythroblasts and 9-12 11m to erythroid progenitors (pro-erythroblasts) 
conditions. Compensatory physiological processes may veil such defects in vivo. Therefore 
we checked in vitro expansion of erythroid progenitors as a measure of stress-erythropoiesis 
22
'
23
• Synchronous differentiation of expanded progenitors can reveal subtle differences in dif-
ferentiation kinetics. Fetal liver cells from E13 Fanca-/-, Fancg-/- and wt littermates were iso-
lated and seeded in StemPro medium supplemented with Epo, SCF and dexamethasone as 
described 23 . Although erythroid progenitors from wt and deficient mice initially expand with 
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similar kinetics, expansion of the Fanca or Fancg-deficient erythroid progenitors stopped 
remarkably earlier than their wt counterparts (figure 2A, B). We did not detect increased cell 
death in Fane-deficient cells (figure 2C). Instead, the relative number of cells reduced in size, 
corresponding to maturing cells that do not contribute to expansion, increased (Figure 20 and 
morphological analysis not shown). This shows that the expansion capacity of Fanca- and 
Fancg-deficient progenitors is exhausted significantly sooner compared to wt progenitors due 
to increased differentiation at the expense of renewal divisions. Upon induction of differenti-
ation in presence of Epa, we did not observe any difference in proliferation, cell size regula-
tion, hemoglobinization and cell morphology at various Epa-concentrations between Fanca or 
Fancg-deficient and wt cells (data not shown). 
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Figure 3. Fancg-deficient erythroid progenitors are hypersensitive to MMC. A: Erythroid progenitors from 
Fancg-deficient and wtfetallivers were expanded in presence of increasing concentrations of MMC as indicated (in 
nM) and total numbers of blasts (>8.5 Jlm) were calculated. B: 12 and 24 hours following addition of MMC cell 
aliquots were stained with PI and the percentage of cells with a subG1 DNA-content was determined. 
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Erythroid progenitors expanded from Fancg-1- deficient mice are MMC-sensitive 
To examine the sensitivity of expanded erythroid progenitors for apoptosis-inducers, we 
added increasing concentrations of FAS-Iigand, TRAIL, IFNa and mitomycin C (MMC) to 
day3 expanding cultures. Fancg-deficient cells and their wt counterparts were similarly insen-
sitive to FASiigand, TNFa and IFNa. In a 5 day assay, concentrations of 100ng/ml FAS-Iig-
and, 20 mg/ml TRAIL and 104U/ml IFNa did not suppress progenitor expansion (data not 
shown) in concordance with previously obtained results for wt cells (Schmidt et al, in press). 
The same concentrations did inhibit cell growth of susceptible control cells. However, expan-
sion of Fancg-deficient progenitors was affected at 2nM MMC (figure 3A), while wt cells were 
only inhibited at 50nM MMC (figure 38). Cell death was measured by flow cytometry of pro-
pidium iodine (PI) stained cells. Reduced expansion was paralleled by an increase of cells 
with a sub-G1 DNA-content (figure 3C). In conclusion, loss of Fancg rendered the cells at 
least 10 times more sensitive to MMC induced cell death. 
Stat5 and Erk1!2 phosphorylation is severely decreased in Fancg and Fanca knockout ery-
throid progenitors 
Impaired activation of Stat-proteins has been described previously in Fancc-deficient mice 
and in FANCC deficient human cell lines. We analyzed Epo-induced phosphorylation of Stat5 
and other signaling intermediates like Erk1/2. Fetal liver cells from Fancg-/- and wt littermates 
were expanded for 4 days to a homogenous population of erythroid progenitors. Cells 
expanded from a wt and 2 Fancg-deficient livers were starved and re-stimulated with Epo for 
increasing times. Stat5 phosphorylation was analyzed on Western blot. Epo induced STAT5 
phosphorylation in wt and Fancg-/- cells, but phosphorylation in the Fancg-/- cells is severe-
ly reduced and delayed (figure 4A). As direct comparison of band intensities between two dif-
ferent blots/gels is impossible we performed second experiment in which samples are 
arranged differently to allow direct comparison at each time point. At each moment following 
Epa-stimulation of the cells Stat5 and Erk1/2 phosphorylation are clearly suppressed in both 
Fancg-deficient (figure 48) and Fanca-deficient erythroid progenitors (figure 4C). Stat5 
expression seems to be lower in the knockout mice versus the wt, but not to an extent that 
could explain reduced phosphorylation. This is not due to unequal loading, as the Erk1/2 pro-
tein levels, detected on the same blot, are not changed. 
Reduced Stat5 and Erk112 phosphorylation is maintained at lower Epa concentration levels 
The concentration of Epo used during stimulation is unphysiologically high. The question aris-
es whether the observed drop in phosphorylation of Stat5 and Erk1/2 is also observed with 
lower, more physiological, concentrations of Epo. Erythroid progenitors expanded from fetal 
livers were factor deprived and re-stimulated with increasing amounts of Epo (0-30 U/ml) after 
which Stat5 and Erk1/2 phosphorylation was assessed in celllysates. Stat5 and Erk1/2 phos-
phorylation were decreased in the Fanca-deficient cells compared to wt erythroid progenitors 
at all concentrations of Epo (figure 40). Moreover, a plateau of maximum phosphorylation 
was reached in the knockout cells with 1-3 U/ml Epo while phosphorylation of Stat5 and 
Erk1/2 still increased with higher Epo concentration in wt cells. A plateau in wt cells was not 
observed within the concentration range used. The same results were obtained using Fancg-
deficient erythroid progenitors (data not shown). This shows the response of erythroid pro-
genitors to Epo is also aberrant at lower more physiological Epo concentrations. 
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Figure 4. Stat5 and Erk1/2 phosphorylation is reduced in Fanca and Fancg deficient erythroid progenitors. 
A-C: wt (+/+)and Fancg (A, B) or Fanca (C) deficient(-/-) fetal liver erythroid progenitors were factor deprived for 4 
hrs and re-stimulated with Epo (5U/ml) for the indicated time points. Cells were lysed and whole cell lysates (WCL) 
were analyzed by Western blotting. D: Wt (+/+)and Fanca deficient(-/-) fetal liver erythroid progenitors were factor 
deprived for 4hrs and re-stimulated with various concentrations of Epo (0-30U/ml) for 1 0'. Cells were lysed and whole 
celllysates were analyzed by Western blotting. The Blots were stained with anti-phopho-Tyr694/699-Stat5a/b or anti-
phospho-Thr202/Tyr204-Erk1/2. As a loading control the same blots were re-stained with anti-totai-Stat5a/b or anti-
totai-Erk1/2 as indicated. 
DNA damage causes reduced EpoR signaling 
To examine whether reduced Epa-induced Stat5 phosphorylation is an artefact of in vitro 
expansion of Fane-deficient erythroid progenitors, we stimulated freshly isolated bone mar-
row cells from wt and KO mice with Epa and examined Stat5 activation in an EMSA assay. 
Surprisingly, Stat5 activation in Fancg-deficient cells was similarly efficient as in wt littermates 
(figure 5A). This suggests that reduced signaling efficiency is due to cell culture conditions. 
To examine whether accumulation of DNA damage in cell culture could be responsible for the 
observed signaling defects, we treated wt erythroid progenitors expanded from fetal liver with 
sublethal doses of MMC for 24 hours and subsequently factor deprived the cells (4hrs) and 
restimulated the cells with Epa. While the total expression levels of Erk1/2 and Stat5 were 
constant, Epa-induced phosphorylation of Stat5 and Erk1/2 was impaired after treatment of 
erythroid cells with MMC concentrations of 10 and 25nM (Figure 58). Thus, DNA-damage 
may be directly responsible for decreased Epa-responsiveness of erythroid progenitors in 
Fane-deficient erythroid progenitors. 
Jak2 phosphorylation, EpoR phosphorylation and membrane expression is unchanged. 
Jak2, the cytoplasmic tyrosine kinase constitutively associated with the EpoR, has a crucial 
role in Epa-induced signaling. The EpoR is one of its prime targets, enabling Stat5 recruitment 
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Figure 5. Impaired signaling is induced upon in vitro culture of Fane-deficient cells or upon induction of sub-
lethal DNA damage in wt cells. (A) Bone marrow cells were isolated from Fancg-deficient mice and wt littermates, 
seeded in medium serum-free medium without factors for 4hrs and stimulated with indicated cytokines for 1 0'. 
Nuclear extracts were assayed in a Stat5 EMSA, using a bcasein probe. Only the shifted band is shown. (B) 
Erythroid progenitors expanded from wt fetal liver were exposed to MMC as indicated for 24hrs in presence of fators 
as required for progenitor expansion. Cells were factor deprived (4hrs) and restimulated with Epo (1 0'). Western blots 
with celllysates were probed with phospho-specific antibodies for Erk1/2 and Stat5 and for total Erk and Stat5. 
and subsequent phosphorylation of Stat5 by Jak2. Therefore, we checked the phosphoryla-
tion status of Jak2 and the EpoR. Erythroid progenitors expanded from fetal livers were fac-
tor-deprived and re-stimulated with Epo. The EpoR and Jak2 were immune-precipitated from 
cell lysates and analyzed for phosphorylation of tyrosine residues. Progenitors expanded 
from Fanca-/-, Fancg-/- and wt fetal livers showed equally efficient Epo-induced phosphory-
lation of Jak2 and the EpoR (figure 6A). Erythroid progenitors, wt or deficient in Fanca or 
Fancg, were similarly restimulated with SCF to analyze signal transduction by SCF. Both the 
efficiency of SCF-induced c-Kit phosphorylation and SCF-induced Erk1/2 phosphorylation 
was equally efficient in all cell types (figure 6B). This indicates that Fanca- or Fancg-deficien-
cy does not impose a general deficiency to activate e.g. Erk1/2 and Stat5 in erythroid progen-
itors but that it is specific for EpoR signal transduction. 
Impaired signal transduction could be due to low cell membrane expression of the EpoR. 
EpoR membrane expression was estimated by the amount of Epo-binding sites on the mem-
brane measured by flow cytometry using biotinylated Epo. EpoR membrane expression was 
similar in wt, Fanca-/- and Fancg-/- cells (figure 6C), indicating that the reduced Stat5 and 
Erk1/2 phosphorylation by Epo is not caused by a reduced EpoR expression on the mem-
brane. The signal was specific for the EpoR as an excess of non-biotinylated Epo resulted in 
abrogation of the fluorescent signal. 
Stat5 induced gene transcription is disregulated in Fanca and Fancg 
Next we checked whether the reduced phosphorylation/activation of Stat5 and Erk1/2 affect-
ed Epa-induced gene transcription. The mRNA levels of known or previously established Epo 
target genes in erythroid progenitors, p21WAF, Socs3, Spi2.1, Bc/XL and G/LZwere analyzed 
by real-time PCR following factor deprivation and subsequent re-stimulation with Epo for 1 
and 3hrs in wt and Fanca-deficient cells. Epo-induced regulation of these target genes was 
severely reduced or totally abrogated in Fanca-deficient erythroid progenitors (figure 7). 
Expression of ribonuclease-inhibitor (RI) served as a control. A second control, atubulin, 
remained constant indicating proper expression levels of the controls. In conclusion, reduced 
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Figure 6. EpoR, Jak2 and c-Kit tyrosine phosphorylation after Epo or SCF stimulation is unchanged in Fanca 
and Fancg deficient fetal erythroid progenitors. A, B: wt (+/+)and Fancg (A) or Fanca (B) deficient(-/-) fetal liver 
erythroid progenitors were factor deprived for 4 hrs and stimulated with Epo (5U/ml; 10') or SCF (500ng/ml; 5') as 
indicated. Cells were lysed and the EpoR, Jak2 and c-Kit were immune-precipitated. Immune-precipitates were ana-
lyzed through Western blotting. Upper panels represent blots stained with anti-phospho-tyrosine (PY99), lower pan-
els represent the same blot stained for the immune-precipitated protein as a loading control. C: EpoR membrane 
expression of fetal liver erythroid progenitors was checked by screening Epo binding sites on the membrane using 
biotinylated Epo. EpoR expression in wt cells (dashed line), expression in Fanca or Fancg deficient cells (undashed 
line). Black lines depict cells treated with biotinylated Epo, while the grey lines depict cells treated with biotinlylated 
Epo in presence of 1 0 times excess of non-biotinylated Epo to ensure specificity. 
and delayed activation of Epa-induced signaling molecules in Fanca-deficient erythroid pro-
genitors is mirrored by impaired activation of target genes. 
Discussion 
One of the early symptoms of Fanconi disease is anemia. Here we provide evidence that 
Fanca- and Fancg-deficient erythroid progenitors have an attenuated in vitro expansion 
capacity and that Epa signaling is disturbed in erythroid progenitors expanded from Fanca-
and Fancg-deficient fetal livers. This reduced signaling efficiency is reflected in reduced 
mRNA expression of Epa-induced target genes. Among those are known targets of Stat5 like 
BciXL, Socs3 and p21waf but also Epo-downregulated targets like GILZ. 
Reduced expansion capacity and increased sensitivity to MMC. 
Fanca- or Fancg-deficient erythroid progenitors are initially not affected in their expansion 
rate. However, the ability of the erythroid progenitors to undergo renewal divisions in 
response to Epa, SCF and Dex 23 is abrogated after circa 7 days, while wt cells can be 
expanded for more than two weeks. Analysis of the cell population revealed that reduced pro-
genitor expansion in vitro was associated with enhanced differentiation and not with 
increased apoptosis. In vivo, total bone marrow progenitor numbers are reduced in Fanca-
deficient mice, suggesting that the number of intrinsic divisions a hematopoietic progenitor 
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Figure 7. Epa-induced downstream transcription targets are reduced in Fanca and Fancg deficient erythroid 
progenitors. Wt and Fanca or Fa neg deficient erythroid progenitors were factor deprived for 4hrs and re-stimulat-
ed with Epo for 3hrs. Values represent maen and standard deviation of at least 4 experiments. At the indicated time-
points (0, 1, 3hrs) aliquots were taken from the stimulated cells for RNA isolation. mRNA levels of p21, SOCS3, 
Spi2.1, BciXc, Tubulina, Ribonuclease Inhibitor (RI) and GILZ were determined by real-time-PCR. Fold induction of 
Epa-induced genes was normalized against the unchanged mRNA's in time of Rl and is depicted as a function of 
the specific RNA levels of non-stimulated wt cells. 
can make is reduced. Depletion of progenitors and stem cell populations has been reported 
in relation with Fane deficiency 12·24•25. 
FA is characterized by genomic instability and the inability to cope with oxidative stress as it 
occurs at the atmospheric 02-tension. DNA-damage and oxidative stress, phenomena that go 
hand in hand, could be directly responsible for the observed loss of 'renewal capacity'. They 
activate stress responses like increased ATM and ATX activity and increased expression of 
p53. Enhanced levels of p53 associated with loss of Fane-protein have been reported 26. 
Increased p53 levels stop cell cycle progression in order to enable DNA repair. Subsequently, 
cells become senescent or apoptotic, when p53 is increased over a prolonged period of time 
at moderate or high levels. Hematopoietic progenitors can undergo apoptosis, but they do not 
undergo senescence and appear to undergo differentiation instead. In the erythroid lineage, 
p53 was shown to enhance differentiation and to abrogate proliferation of erythroid progeni-
tors 28'29, while loss of p53 is a crucial step in Friend virus-induced erytholeukemia 27. Notably, 
lack of p53 abrogates the hypersensitivity of Fancc-deficient cells for MMC, but also for TN Fa 
and IFNy, suggesting that the observed increased levels of p53 may be involved in bone mar-
row aplasia in FA 26. 
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Reduced EpoR signalling in Fanca and Fancg deficient erythroid progenitors 
Both Stat5 and Erk1/2 are downstream targets of the EpoR. Stat5 is a direct substrate of 
Jak2, while ERK requires Jak2-dependent activation of signaling intermediates like Ras and 
Raf. We found that tyrosine phosphorylation of Jak2 and the EpoR as well as EpoR mem-
brane expression was unaffected in erythroid progenitors deficient in Fanca or Fancg. Thus, 
the Fane-proteins do not control receptor function per se, but rather the recruitment or acti-
vation of downstream signaling intermediates. This is not unique for the EpoR as it was pre-
viously reported that Stat1 activation by IFN-y is impaired in FANCC lymphoblastoid cell lines 
16
·
31
. Since SCF-induced ERK-phosphorylation is not affected, the signalling defect in Fane-
deficient hematopoietic cells may be specific for Janus-kinase-dependent cytokine receptors. 
It has been suggested that Fancc is directly involved in recruitment of Stat1 to the receptor. 
Fanca, Fancc and Fancg interact to form one complex in the cytosol 4·32. Possibly, this com-
plex is involved in recruitment and activation of Stat-proteins upon IFN-y or Epa activation. 
However, Stat5 activation induced by Epa, IL3 or GM-CSF was not affected in freshly isolat-
ed bone marrow cells, only in expanded progenitors. Since Epa-induced activation of Stat5 
and Erk1/2 was also impaired in wt cells upon induction of sublethal DNA damage, it is more 
likely that DNA-damage accumulated during culture and possibly oxidative stress are respon-
sible for reduced signaling. Reactive oxygen species inactivate phosphatases by oxidation of 
cysteins in the reactive center. As a result, an increase of ROS mostly enhances signal trans-
duction. However, other signaling routes, like Rae-mediated Rho activation and reorganiza-
tion of the cytoskeleton is inhibited by ROS. Notably, induction of ROS induces hyporespon-
siveness ofT-cells by changing the structure of the T-cell receptor 35. 
The observation that Epa-induced Stat5 activation is not impaired in freshly isolated bone 
marrow cells suggests that the reduced phosphorylation of Stat5 and Erk in response to Epa 
in erythroid progenitors expanded from fanca- and fancg-deficient fetal livers is a cell culture 
artifact. However, it may be a very relevant artifact since the high atmospheric oxygen ten-
sion in which the cells are cultured impose a significant increase in DNA-damage that fane-
deficient cells are unable to cope with. Laboratory mice that are not exposed to DNA-dam-
age inducing agents probably never accumulate genomic stress comparable to expanded 
erythroid progenitors, while human individuals develop hematopoietic defects during the first 
or second decade of life. 
In addition, the absence of anemia, in mice but also in the first years in human, may be due 
to the cooperation of several regulatory or complementary mechanisms. First, reduced Stat5 
activation resulted in reduced expression of CIS and Socs3 and by consequence in attenu-
ated negative feed-back regulation. Second, reduced Epa-signalling may be compensated by 
other factors. For instance, Mice lacking the C-terminal part of the EpoR are not affected in 
in vivo erythropoiesis 36, which was shown to be due to cooperation of Epa with unknown 
serum factors 37. Finally, we showed that phosphorylation of Stat5 and Erk1/2 at 1 U/ml in wt 
cells is comparable to the phosphorylation induced by 30 U/ml in Fanca- or Fancg-deficient 
cells. FA-patients have increased Epa-serum levels, however, it is questionable whether mice 
that are not anemic have increased Epa-levels, since Epa production is driven by the 02-ten-
sion in blood. We analysed Epa-levels in several wt and Fanca- and Fancg-deficient mice, 
which was always below the detection level of 20 U/1 (data not shown), indicating that Epa 
levels in seemingly healthy Fane-deficient mice are not increased above normal physiologi-
cal levels. 
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In conclusion, we observed a decreased potential of progenitor expansion and impaired Epa-
induced signal transduction in Fanca and Fancg deficient erythroid progenitors, but these 
phenomena do not impair erythropoiesis in mice. The data suggest that the observed defects 
develop during cell culture due to the inability to cope with the environment (i.e. mutagens 
and elevated oxygen tension). However, the process that may have been accelerated during 
in vitro culture may ultimately also take place in vivo. Notably, in humans, anemia may only 
occur in the second decade of life, which suggests that additional events are required in addi-
tion to the observed congenital defects. 
Material and methods 
Antibodies and growth factors 
Rabbit antisera recognising Jak2 and a mouse monoclonal antibody recognising phospho-
Stat5 (Tyr694-Stat5A; Tyr 699-Stat5B) were obtained from Upstate Biotechnology; rabbit anti-
sera recognising the mouse EpoR, c-Kit, p44/p42 MAP kinase and the anti-phosphotyrosine 
mouse monoclonal antibody PY99 from Santa Cruz Biotechnology; mouse monoclonal anti-
bodies recognising phospho-p44/p42 MAP kinase (Thr202/Tyr204) from New England 
Biolabs. Recombinant human Epo was a gift from Ortho-Biotech (Tilburg, The Netherlands), 
dexamethasone was purchased from Sigma (Zwijndrecht, The Netherlands) and SCF was a 
kind gift of Amgen. TNF-a and IFN-y were purchased from R&D laboratories. MitomycinC 
from Kyowa Hakko Kogyo, Tokyo, Japan. 
Primary erythroblast cultures 
Primary fetal liver erythroblasts were obtained from day E 12-13 fetal livers and cultured to a 
homogenous erythroid progenitor pool in serum free conditions using StemPro-34TM medi-
um (Life Technologies) supplemented with Epo (0.5U/ml), SCF (100ng/ml) and Dex (50!lM) 
23. Usage of different concentrations of growth factors is indicated in the figure legends. Cell 
cultures were maintained at 1.5-3x1 06 cells/ml and a homogenous erythroblast culture was 
obtained within 4 days. To induce differentiation the erythroblasts were washed twice with 
PBS and reseeded in StemPro-34TM medium supplemented with 5U/ml Epo and 0.5mg/ml 
iron-saturated human transferrin (lntergen ). During differentiation cells were kept at 2-5x1 06 
cells/mi. 
Bone marrow colony formation 
Bone marrow cells were isolated from 8 weeks old wt or Fanca deficient mice via bilateral 
aspiration of femurs. Cells were resuspended in lscove's medium supplemented with 20% 
fetal bovine serum as described by Koomen et al.40 • Progenitor colony-forming assays were 
performed in triplicate, plating 2x 1 04 cells/35-mm well according to manufacturer's instruc-
tions in methylcellulose media (Methocult GF M3434; Stem Cell Technologies). The cultures 
were done with or without various concentrations of recombinant murine TN F-a (0-1 OOng/ml) 
or IFN-y (0-100ng/ml). Colonies were counted after 7 days. 
Immune-precipitations and Western blotting 
Primary erythroid fetal liver cells were growth factor deprived for 4hrs in plain IMDM (Life 
Technology). The erythroid progenitors (40-80x1 06/ml) were stimulated at 3rC with SCF 
(1!lg/ml; 5'), or Epo (5U/ml; 1 0') as indicated. To stop the reaction, 10 ice-cold volumes of 
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PBS were added. Cells were washed twice with ice-cold PBS and lysed in ice-cold lysis buffer 
(20mM Tris-HCI pH 8.0, 137mM NaCI, 1 OmM EDTA, 50nM NaF, 1% (vol/vol) NonidetP-40, 
10% (v/v) glycerol, 2mM Na3Vo4, 1 mM Pefabloc (Roche), 50j..tg/ml aprotinin, 50j..tg/ml leu-
peptin, 50j..Lg/ml bacitracin and 50j..Lg/ml iodoacetamide) on ice for 10', nitrogen frozen and 
stored at -80°C until usage. Lysates were thawed on ice cleared by centrifugation at 4 oc at 
15,000rpm. Immune-precipitations, SDS-polyacrylamide gel electrophoresis and Western 
blots were performed as described previously 38 • Membranes were stripped in 63mM Tris-HCI 
pH 6.1, 2% SDS and 1 OOmM b-mercaptoethanol for 30' at 50°C after which they were re-
b locked and re-stained. 
Flow cytometry 
To measure EpoR expression on the erythroblast membrane, Epa was biotinylated following 
the biotin labeling kit protocol from Roche (#1418165). Cells were starved for 4 hours in plain 
I MOM (life technology) and washed twice with ice cold PSA (Phosphate buffered saline sup-
plemented with 0.05% Sodium-azide and 1% Fetal calve serum; 2 min., 1800rpm). 
Erythroblasts, 1.0x1 06 per sample, were subsequently incubated with 0,5U BioEpo in 50ml, 
supplemented with 5U/ml non-biotinylated Epa when appropriate, for 30 min at 4°C, washed 
with 1 ml ice cold PSA, incubated in 1.5 mg in 50ml streptavidin-phycoerythrin conjugate at 
4°C, washed with 1 ml PSA and supplemented in 0.5ml PBS. Fluoresence was measured by 
flow cytometry. 
To distinguish between life and dead cells, the DNA content was determined. 0.5 to 1.0x1 06 
cells were fixed and permeabilised with ice-cold methanol (0.5ml; 30') washed 2 times with 
PBS and incubated for 30' with 0.5% w/v RNAse A in PBS under constant shaking. DNA was 
stained with propidium Iodine (50j..tg/ml in PBS) and Fluoresence was measured by flow 
cytometry. 
Real time PCR and Nothern blotting 
Cells were factor deprived for 4hrs in plain I MOM and re-stimulated with Epa (5U/ml) for 0, 1 
and 3hrs, cells were lysed in lysisbuffer (0.5% NP40, 1 OmM Tris-HCI pH7.5, 140mM NaCI, 
1.5mM MgCI2, 20mM dithiothreitol (OTT), 40U/ml RNAsin) and nuclei were removed by cen-
trifugation (6000 rpm for 3 min. at 4 °C). Supernatant was adjusted to 1% SDS, 1 OmM EDTA 
and 400j..tg/ml ProteinaseK and incubated for 30 min. at 3rC. Total RNA was extracted with 
phenol/chloroform/isoamylalcolhol (25:24: 1) and precipitated with isopropanol. 15j..Lg RNA 
was separated on formaldehyde-containing agarose gels. To generate eDNA, 1 j.lg total RNA 
was denatured and annealed to 2j..Lg random hexamers (Amersham Pharmacia) at 65°C for 
5', followed by 1 0' at room temperature. After addition of first-strand buffer (250mM Tris-HCI, 
pH8.3, 375mM KCI, 15mM MgCI2), 40j..tM dNTPs, 200mM OTT, 40U RNasin and 200U 
Superscript II RNase H- reverse transcriptase (Invitrogen), the reaction was incubated at 
42°C for 2hrs, heated to 95°C for 3' and then quick-chilled on ice. The eDNA was diluted 1:10 
to 1 :200 prior to PCR amplification. The primer-sequences used for the amplification (5' to 3' 
order; forward, reverse): p21: ACC AGA GGG AGC CTG AAG ACT, ACC AGA GGG AGC 
CTG AAG ACT; BciXI: TGG TCG ACT TTC TCT CCT AC, TCA CTA CCT GCT CAAAGC TC; 
SOCS3: TCA AGA CCT TCA GCT CCA A, TCT TGA CGC TCA ACG TGA AG; GILZ: TGC 
GGA GTA CCT CAC AGA G, TCC TTG TCA GCG AAA GTA CCA; Spi2.1: ACT GCC TTG 
GCC CTC CTG TC, TGC CTG TGC TGA TCT GTA CC; Tubulin: TGC AGC GTG CTG TGT 
GCA TG, TCC TCT CGA GCC TCA GAG AA; Ribonuclease Inhibitor (RI): TCC AGT GTG 
AGC AGC TGA G, TGC AGG CAC TGA AGC ACC A. The real-time PCR was done with 
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TaqMan technology (PE Aplied Biosystems Model 7700 or 7900 sequence detector). The 
reactions were performed in a volume of 25).11 of a mixture containing 4).11 of the respective 
eDNA dilution, primers at 5).LM and 12.5).11 of 2X SYBR green PCR Master mix (PE 
Biosystems) containing Amplitaq Gold® DNA polymerase, reaction buffer, dNTP mix with 
dUTP, passive reference and the double stranded DNA (dsDNA)-specific fluorescence dye 
SYBR green I. The amplification program consisted of 1 cycle of 50°C with 2' hold, 1 cycle of 
95°C with 1 0' hold, followed by 40 cycles of denaturation at 95°C for 15", annealing at 62°C 
for 30" and extension at 62°C for 30". The CT-values of Rl and tubulin were used to normal-
ize the values. 
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Chapter 7 
Introduction 
In this thesis I describe the identification and characterisation of proteins that function down-
stream of the receptors for erythropoietin (Epo) and stem cell factor (SCF), to gain insight into 
mechanisms that control Epo- and SCF-controlled expansion, survival and differentiation of 
erythroid progenitors. In particular, I describe (1) how the responsiveness to Epo may be con-
trolled, which can be relevant to the occurence of anemia, and (2) factors that control progen-
itor expansion, which may be relevant to leukaemia. in line with this I characterized several 
Epo and/or SCF downstream targets with a regulatory role in Epo/SCF signalling, among 
which the kinases RON (Epo), Btk (Epo, SCF) and Tee (SCF) and the docking molecules 
Dok-1 (SCF), Gab1 (Epo) and Gab2 (Epo, SCF). We found that a functional Btk kinase as 
well as the Fanconi-pathway are required for efficient signal transduction upon EpoR ligand 
binding. 
In addition, we elucidated a novel Epa-induced mechanism specifically involved in expansion 
but not in differentiation of erythroblasts, involving the tyrosine kinase receptor RON as a 
downstream target of the EpoR. We show, directly and indirectly, that the activation of PH-
domain containing proteins like the docking molecules DOK-1, Gab1 and Gab2 or the Tee-
family kinases Tee and Btk play a role in control of expansion but not differentiation. Activation 
of these proteins (Gab1, Gab2 by RON) or DOK-1 (by SCF) cannot sustain differentiation 
while deficiency of Btk, Gab1 or Gab2 results in normal differentiation. As stated PI3K is cru-
cial for expansion (see introduction), the data in this thesis suggests that the PI3K down-
stream activated proteins Tee, Btk, DOK1 and Gab1/2 are important mediators of this PI3K-
induced expansion of erythroid progenitors. 
Epa-responsiveness: the modulators. 
We and others have found proteins, like PKC, that can modify the amplitude of EpoR activa-
tion, 1·2 • It was found that EpoR, Jak2 tyrosine phosphorylation as well as downstream sig-
nalling was decreased in presence of inhibitors of PKC and PI3K. The responsible down-
stream events for this modulation were not identified. Nevertheless, it shows that i) EpoR 
responsiveness to Epo can be modulated at the level of initial receptor activation and ii) that 
Epo binding to the EpoR is not the only initiating event in EpoR activation. This creates a sub-
tle switch that may specifically regulate erythroid progenitor numbers (expansion or differen-
tiation). We found several other proteins that modulate Epo responsiveness (e.g. Btk, 
Fanconi A and Fanconi G in chapters 3 and 6 respectively). 
Deficiency of Fanca or Fancg results a reduction of Epa-induced Stat5 and ERK1/2 activa-
tion, however, a reduction of Jak2 or EpoR tyrosine phosphorylation is not observed. In con-
trasts, Btk deficiency, similar to inhibition of PKC, results in severe reduction of Epa-induced 
signal transduction. Interestingly, PKC activators could not rescue Epa-responsiveness in Btk 
deficient erythroid progenitors, suggesting that PKC and Btk may have distinct modes of 
action on the Epa-responsiveness of the erythroid progenitor. On the cellular level, the lower 
Epa-responsiveness in cells deficient in Btk or active PKC caused a decrease or total 
absence of erythroid progenitor expansion 1 (chapter 3), confirming that these proteins may 
function as a molecular switch regulating erythropoiesis. Fanca and Fancg absence causes 
specific Epa-downstream pathways to be aberrantly activated (Stat5 and Erk1/2), but does 
not interfere with Jak2 or EpoR activation. Although the reduction in Stat5 and Erk is signifi-
cant, no effect of Fanca and Fancg deficiency on the process of erythropoiesis in vivo was 
observed (chapter 6). However, in vitro self-renewal capability of the erythroid progenitors 
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was depleted significantly earlier. Therefore, the modulatory role of Fane proteins may 
become visible in vivo during stress conditions like hypoxia, which is currently persued in the 
laboratory. 
Receptor activation is regulated by several mechanisms, which could in principle be the tar-
gets of the modulators we described. First of all, the targets of these modulators could be 
phosphatases regulating Jak2 kinase activity like SHP1, SHP2 or membrane spanning phos-
phatases like PTP-1 B 3 and proteins regulating the levels of reactive oxygen species that 
affect phosphatase activity. The regulation of phosphatase activity and ROS production has 
been found to be inversely correlated in the regulation of EGF-receptor kinase activity. 
Lowering the phosphatase activity as well as inducing ROS production resulted in lower 
threshold for EGF-receptor activation 4 • A similar mechanism may be present in erythroid pro-
genitors. However, upon addition of the broad phosphatase inhibitor pervanadate during star-
vation and subsequent Epo stimulation, no prolonged or enhanced Epa-induced signalling 
was observed (data not shown). Nevertheless, It would still be interesting to see the effects 
of ROS levels on EpoR responsiveness, especially as one of the genes regulated by Epo and 
GCs is VDUP1, which is a negative regulator of the antioxidant TRX5• Second, modulators of 
EpoR responsiveness may recruit and/or activate proteins in the receptor complex important 
for proper organisation of the complex. Family members of the multi-PDZ domain proteins 
like MUPP1 could associate with c-Kit or the EpoR in erythroid progenitors to recruit many 
additional proteins. Furthermore, The Stat Interacting Protein 1 (StiP1) interacts with unphos-
phorylated Stat proteins and Jak2, which may pre-associate Stats with cytokine receptor com-
plexes. With its 12 WD40 domains, StiP1 may also recruit numerous other proteins 6• It will 
be important to isolate and characterize these and similar proteins and their interacting pro-
teins to understand how the activity of PKC and Btk or events downstream of Fanconi pro-
teins alter their function. Third, regulation of internalisation and degradation of the receptor 
may influence receptor signalling. Cell membrane expression of the EpoR was unchanfed 
under all conditions studied that showed reduced EpoR signalling (decreased PKC activity, 
Btk activity; absence of Fanconi proteins). Therefore we speculate that differences in the 
EpoR complex as it is present in the cell membrane may be the priming sequence to the 
EpoR signalling attenuation. To understand what these differences are we need to know the 
EpoR membrane complex composition and compare this with the composition upon interfer-
ence with the modulators. 
In conclusion, the process of erythropoiesis can be fine-tuned by various modulators that 
influence the responsiveness of the erythroid progenitors to Epa, suggesting a complex reg-
ulatory mechanism controlling the total number of erythrocytes produced. 
Docking molecules 
The Epa-receptor as well as c-Kit are tyrosine phosphorylated upon stimulation by their 
respective ligands. This enables recruitment of various proteins with Src-homology-2 
domains (SH2-domains) and phospho-tyrosine-binding domains (PTB) that bind to specific 
phosphorylated tyrosines in the receptor, which is one of the initiation steps for ligand-induced 
signal transduction in the cell. Among these recruited proteins are proteins that recruit dock-
ing molecules that themselves again contain tyrosines that are phosphorylated leading to 
additional recruitment of proteins creating a protein network. How these docking molecules 
participate in erythropoiesis is at present unknown. Many interaction partners and down-
stream events have been described for the docking molecules studied here (DOK-1; chapter 
2, Gab1/2; chapter 5) or reported in literature (IRS-1 7). Interestingly there is quite some over-
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lap between EpoR/c-Kit directly recruited proteins and Gab or DOK family member recruited 
proteins. For instance recruitment of adaptors like Grb2, She, CRKL, CRK, PLC-gamma 
kinases like PI3K, LYN, Tee family members, Yes, Abl and phosphatases like SHP2 have 
been reported to be recruited by both c-kit and the EpoR as well as the docking molecules 
Dok, Gab1 and Gab2 (chapter 2; for review see 8"10 ) • Thus alternative routes to the recruit-
ment and activation of for instance PI3K and MAPK routes are present The function of these 
alternative activation routes is not clear. They could be important for signal enhancement 
through the recruitment of additional signalling intermediates. In addition, they could play a 
role in signal maintenance and duration through differences in 
downregulation/degradation/internalisation between the receptor and the docking molecules, 
though no knowledge to this extent has been obtained yet. Interestingly though, deleting all 
the c-terminal tyrosines (8) in the Epa-receptor (which is still capable of binding Jak2) does 
not interfere with in vivo erythropoiesis 1\ while Jak2 deficient mice fail to generate mature 
erythrocytes. This suggests that i) recruitment of specific proteins to the c-terminal part is not 
crucial for essential signal transduction pathways or that compensation via other pathways is 
possible and ii) that Jak2 binding and activation is the crucial event in erythropoiesis. 
Although it is known that this truncated EpoR (EpoR-H) does not activate Stat5, the effect on 
other signal transduction pathways, like PI3K and MAPK, in erythroid progenitors is unknown. 
BFU-E and CFU-E formation is normal in EpoR-H mice. However, the erythroid progenitors 
have a reduced expansion in serum-free conditions that can be restored by adding serum 
from EpoR-H mice 12• Hence, unknown serum factors cooperate with Epo that modulate EpoR 
signalling. Interestingly, erythroid expansion is not absent in these progenitors indicating that 
there is a way to circumvent the necessity of the EpoR c-terminal tail, which could be activa-
tion of docking proteins that recruit more or less the same signalling intermediates as the 
receptor. We found a Jak2 dependent, but EpoR c-terminal tail independent, pathway that 
activates via RON (Stk) the docking molecules Gab1 and Gab2, both do not bind to the c-ter-
minal tail of the EpoR. This alternative route leading to signalling intermediate recruitment 
may suffice to enable erythropoiesis in the EpoR-H mice. We found that erythroid progenitors 
lacking the RON/Stk-kinase domain and Gab1 phosphorylation are not affected in expansion 
of erythroid progenitors. It would be interseting to cross the RON-kinase deficient mice with 
EpoR-H mice to see whether this abolishes mutual complementation. 
It was shown in this thesis that the homologous proteins Gab1 and Gab2 are differentially 
recruited to the EpoR/cKit signalling complex (chapter 5). This creates robustness of the sys-
tem as similar responses can be generated via distinct signals that may complement each 
other. Notably, Epa-induced Gab2 phosphorylation was increased in Gab1- and RON-kinase 
deficient cells (chapter 5). It has not been investigated whether the distinct pathways also 
induce different phosphorylation patterns of Gab1 and Gab2. For functional analysis, the 
expression of multiple homologues in a single cell means that both have to be inactivated, 
e.g. by crossing both KO mice, by using combined siRNA approaches or by the use of dom-
inant negatives. Gab1-/-;Gab2-/- double knockout cells are being generated, but already the 
Gab2+/-,Gab1-/- mice die too early to examine definitive erythropoiesis (U. Schaeper, pers. 
comm). As a potential dominant-negative Gab-molecule, we generated a truncated Gab1 pro-
tein that only retained the PH-domain and the MET-binding domain. Preliminary experiments 
showed that interference with all Gabs abrogates the ability of the cell to undergo renewal 
divisions in response to Epo and SCF. 
PI3K and PH domain proteins are keys to expansion 
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The main challenge of studying signal transduction by a receptor complex or signalosome is 
to unravel the complexity, the integration of signals and the regulation of responsiveness and 
specificity of signal transduction occurring at any level during growth factor stimulation, and 
to relate this to functional output. A good example of a signalling molecule that is crucial for 
Epo/SCF-induced progenitor expansion and of which the regulation is complex and at the 
same time robust is PI3K. PI3K kinase docks to Y719 of c-Kit 13 to Y481 of the EpoR 14·15 but 
also to several tyrosines in Gab2, Gab1 and the IRS family 7·8 • PI3K has also been reported 
to bind to c-Cbl 16 , which can interact with the EpoR, c-Kit as well as Dok-1 16•17 (chapter 2). 
Thus, it appears that Epa and SCF-induced PI3K activity can be regulated via various pro-
teins. Why are there so many pathways that can activate and recruit PI3K. Are the addition-
al pathways necessary for signal augmentation in order to reach a threshold activity needed 
for distinct biological output, or do we look at evolutionary complementation and/or redundan-
cy functioning as a "backup plan". Indeed, the enormous plasticity of signalling complexes 
becomes evident as loss of one PI3K binding site, for instance Gab1, in the signalosome is 
absorbed by shifting the balance to another site, like Gab2, with minimal effects on the 
process of erythropoiesis 11 •13•18 (chapter 5). This suggests a binding site equilibrium state prob-
ably dependent on different variables like post-translation modifications, conformational 
changes, local protein concentration etc. that can be maintained due to the many pathways 
leading to PI3K activation and downstream signalling. This leads to a robust system capable 
of coping with changes in this system by changing from one PI3K-activating protein to the 
other PI3K-activation protein maintaining PI3K activation levels (Chapter5, 11 ·13·18). Moreover, 
with respect to the levels of PI3K activation we showed that Epa and SCF co-stimulation 
results in a longer and enhanced PKB activation suggested to be the result of enhanced PI3K 
activation. 
The level of PI3K activation appeared to be a critical event in expansion and delay of differ-
entiation. P85a deficient mice have transient fetal anemia and decreased numbers of ery-
throid progenitors (both CFU-E and BFU-E). Furthermore, expansion on Epa and SCF was 
severely reduced compared to wt cells19 • As apoptosis was not observed, the anemia is 
explained by the lack of Epa, SCF, GR-induced progenitor expansion in favour of differentia-
tion. P85-/- adult mice are not anemic, which supports the hypothesis that this expansion of 
the erythroid progenitor is not required for steady state erythropoiesis (see also chapter 1 ). 
Instead, it is only required when erythropoiesis has to produce maximal numbers of erythro-
cytes for the body to function, like in the fetal liver and during hypoxic stress. Hence, no dif-
ference was detected upon comparing differentiation of p85-/- fetal liver erythroid progenitors 
on Epa. This is in agreement with the data in chapter 3 where deficiency of the PI3K down-
stream target Btk results in abrogated expansion, while differentiation is normal. The obser-
vations in p85-/- mice also show that low PI3K activity does not affect differentiation. 
Concordantly, we found that inhibition of PI3K with 15!J.M LY294004 abrogates Epo/SCF-
induced expansion of human and mouse erythroid progenitors in favour of differentiation 20 • 
This, combined with the p85-/- data, indicates that the level of PI3K activation is of paramount 
importance for Epo/SCF-induced erythroid progenitor expansion. 
As PI3K is crucial for expansion it is important to know its regulation and downstream effec-
tors. PI3K activity results in PIP3 generation leading to recruitment of PH-domain containing 
proteins to the signalosome. These PH-domain proteins may subsequently recruit more PI3K 
leading to more PI3K activation, as shown for the Gab family in various cell lines 3·21 •22 • In this 
thesis we describe that PI3K activity is the important event prior to Epa- and SCF-induced 
activation of the PH domain containing proteins of the Tee-family members, Gab family mem-
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bers, Dok-1 and PKB (via PDKs; chapter 2, 3 and 5). We prove that Tee family member Btk 
deficiency results in abrogation of expansion during stringent renewal conditions (chapter 3). 
The phenotype could only be observed with limiting growth factor concentrations and is less 
severe when compared to PI3K inhibition with LY 294002, indicating that Btk modulates 
expansion but that it is not the only decisive factor downstream of PI3K that regulates expan-
sion. As described in Chapter 5, Epa-signalling through RON is sufficient for expansion but 
not for differentiation. RON activates both Gab1 and Gab2, which both promote PI3K-recruit-
ment and activation. Our group showed that activation of PKB, an important kinase down-
stream of PI3K, ensures the nuclear exclusion of FOXO-family members and enhances 
translation via eiF4E, both important pathways to sustain progenitor expansion(39; Godfrey 
Grech, manuscript in preparation), making PKB an important inhibitor of differentiation. 
The data in this thesis in conjunction with other data show that the cooperation between Epo 
and SCF depends on the recruitment of PH-domain containing proteins regulated by the lev-
els of activated PI3K. Expansion of erythroid progenitors depends on different proteins down-
stream of PI3K which may be Btk, the Gab family, DOK-1 and PKB. We speculate that levels 
of PI3K activation by Epo or SCF alone are not sufficient for this expansion and that a certain 
threshold of PI3K activity must be reached. Whether this PI3K-activity threshold for progeni-
tor expansion is required for a specific downstream pathway or for a number of them is not 
known. We showed that lack of one of these pathways impairs the ability of erythroid progen-
itors to expand. To understand the process of expansion and the contribution of these pro-
teins, it is of importance to investigate the individual functionality of PI3K downstream sig-
nalling components and target genes in erythroid progenitors in order to discriminate the 
essential players. This is currently done in our laboratory at the transcriptional, translational 
and signal transduction level. 
Stat5 and erythropoiesis. 
An important signalling protein specifically activated by Epo but not by SCF is Stat5. We 
found that RON can cooperate with SCF to replace Epo during expansion but is not able to 
induce differentiation alone. This difference could be lack of Stat5 activation by RON. How 
does Stat5 regulate the process of erythropoiesis? Control of cell death is an important medi-
ator of erythropoiesis (see also chapter 3, 5 and 6) and the most important role for Epo in ery-
thropoiesis may be prevention of apoptosis through activation of Stat5 leading either directly 
or indirectly to up-regulation of anti-apoptotic proteins like BciXL or Bcl2 23"25. Indeed, inhibit-
ing apoptosis through ectopic expression of BciXI results in Epa-independent differentiation 
in serum free conditions. The data favour the model that differentiation is a default, 
autonomous path 24 in which control of apoptosis is the regulatory event. Prevention of apop-
tosis can occur at several levels, first of all through the upregulation of anti-apoptotic proteins 
like Bcl2 and BciXL The cellular equilibrium between these anti-apoptotic proteins and pro-
apoptotic proteins like Bax and related proteins is a decisive step in the induction of apopto-
sis. Indeed, selective deletion of BciXL in erythroid progenitors results in haemolytic anemia 
and profound splenomegaly due to apoptosis of differentiating erythroblasts40. BciXL and Bcl-
2 are target genes of Stat5 both in erythroid system as well as in other hematopoietic lineag-
es41,42,43,44· though no Stat5 binding sites were identified in the enhancer45. Indeed, Stat5 defi-
cient erythroid progenitors have lower BciXL protein levels 23. In line with this, Stat5 deficient 
mice have fetal anemia due to apoptosis of differentiating erythroblasts and show increased 
spleen weights, a hallmark of stress erythropoiesis and an indication that the organism tries 
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to compensate the lack of erythrocytes by increasing the numbers of erythroid progenitors 
(expansion/renewal 23). This compensation ensures that the adult mice are not severely ane-
mic and proves that the Stat5-/- erythroid progenitors, like BciXL deficient mice, retain their 
intrinsic ability to expand and to differentiate. The role of Stat5 during erythropoiesis can thus 
be linked to survival thereby allowing differentiation. Furthermore, the data suggest that Stat5 
has no role in expansion or the actual process of differentiation. Stat5 deficiency does not 
totally abrogate erythroid progenitor survival as the adult Stat5-/- are not severely anemic, 
indicating that compensation through stress erythropoiesis is successful. Furthermore, it indi-
cates the presence of other Epa-induced survival routes. However, the fact that i) Stat5 defi-
cient erythroid progenitors are inhibited in expansion when cultured in serum free conditions, 
ii) that Stat5 interacts with GR to induce genes specifically expressed under expansion con-
ditions, suggests a role for Stat5 in expansion (46.47 ; personal communication (beug)). The pre-
cise role of Stats in erythropoiesis is still elusive. It would be interesting to cross the Stat5-/-
mice with mice expressing BciXL throughout erythropoiesis in order to see whether Stat5 is 
only needed for erythroid progenitor survival. Co-stimulation of erythroid progenitors with 
serum and Epo induces Stat3 activation, while Epo alone does not (26; personal observation), 
suggesting that compensation via Stat3 can rescue erythroid progenitors from apoptosis to 
some extent. Indeed, serum can augment erythroid progenitor expansion of cells with trun-
cated EpoR to wt levels 12 indicating that additional serum components cooperate with the 
EpoR. Interestingly, constitutive Stat1 and Stat3 activation has been found in SFFV-P infect-
ed cells 27 that differentiate in absence of Epo, underlining a potential role for these proteins 
in survival. Combining Stat5 deficiency with a deficiency in other Stat family members may 
shed light on this putative compensation. Moreover, it was shown that additional Stat5 inde-
pendent BciXL and Bcl2 up-regulating pathways exits in the Stat5 deficient mice during differ-
entiation 23· It would be interesting to cross the Stat5 deficient mice with mice disregulated in 
erythroid expansion (like ATF-1, GRdim/dim, p85a-/- or Btk-) as these mice probably lack the 
compensatory mechanism that rescues the Stat5 deficient mice from severe anemia. 
An additional mechanism to regulate the number of erythrocytes is by modulating cell death 
via death receptors. In chapter 3, erythropoiesis is normal in the Btk deficient (Btk-) erythrob-
lasts. However, the apoptotic agent TRAIL, increased sensitivity to apoptosis in the Btk- ery-
throid progenitors. This uncovers that Btk controls TRAIL-induced apoptosis in erythroid pro-
genitors. Notably, it is SCF that controls association of Btk with the TRAIL-R1, which shows 
that also SCF has a role in surivival of erythroid progenitors. This introduces a second SCF-
induced anti-apoptotic mechanism in erythroid progenitors, together with SCF-induced inhibi-
tion of caspase activity through raf-1 5 • The anti-apoptotic mechanisms of Btk appears to be 
similar to the anti-apoptotic role of Btk in B-cells, where it binds and inhibits the FasL death 
receptor 28 • 
Friends virus induced erythroleukemia and RON(Stk) 
Spleen focus forming virus (SFFV) or Friend virus is present in two forms SFFV-A and SFFV-
P. Susceptibility to both viruses depends on the presence of a short form of Stk (Mouse homo-
logue of RON). The two forms of RON are normally expressed in mouse and man 29·30 and are 
involved in erythroid expansion signalling (chapter 5). Infection with either form of the virus 
results in Epa-independent erythroid progenitor expansion due to the activation of the short 
form of RON by the viral protein GP55 31. We observe that activation of RON can substitute 
for Epo signalling in expansion, indicating that GP55 activated RON can be a primary event 
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in the observed Epa-independent expansion of erythroid progenitors. RON activation results 
in Gab1, Gab2 and subsequent PI3K and MAPK activation, but not in Stat3 or Stat5 phospho-
rylation. Normally, Epo induces Stat5 activation and not Stat1 and Stat3 (in serum free condi-
tions). GP55-A and P introduction have been shown to result in Stat3 and Stat1 phosphory-
lation independent 27 or dependent of Epo 32 suggesting activation of one or more Jak family 
members. Although the RON family member, c-Met, has been shown to activate Stat3 in sev-
eral cell lines 33·34 , we do not find Stat3, Stat5 or Jak2 phosphorylation after RON stimulation 
(chapter 5, data not shown). However, we did not check whether RON induces the phospho-
rylation of Stat 1 or other Jak family members like Tyk, Jak1 or Jak3. Furthermore, gp55 acti-
vated RONsf/Stksf may be different from RON/Stk full length. In addition, these experiments 
were all done in presence of serum factors, while our experiments were done in serum free 
conditions. Indeed, GP55-P induces constitutive activation of Jak1 35·36 • Concordantly, both 
GP55 proteins probably activate one or more members of the Jak family resulting in the 
observed Stat phosphorylation. Although the difference between GP55-P and GP55-A 
induced signalling is poorly understood, it is clear that GP55-A infected erythroid progenitors 
still require Epo to differentiate while GP55-P erythroid progenitors differentiate Epo inde-
pendent. GP55-P, but not GP55-A, interacts with the EpoR through the transmembrane 
region, which is speculated to result in constitutive EpoR signalling 37• We found that activa-
tion of RON is not sufficient to allow differentiation as cells go into apoptosis (chapter 5). This 
proves that GP55-P induces some additional signalling event required for survival of the ery-
throid progenitor during differentiation. Though this signalling event is presently unknown, it 
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Figure 1, c-Kit is distributed equally on the cell membrane in small clusters. A-B: The erythroid progenitor cell 
line 1/11 was factor deprived for 4 hours in plain medium after which aliquots (1.0x1 0' cells) were taken to analyze c-
Kit, Transferrin and CD49e membrane expression. Cells were fixed, incubated with antibodies recognising the extra-
cellular parts of c-Kit (2B6), Transferrin and CD49e as indicated and re-incubated with a FITC-Iabelled secondary 
antibody. A: 1.0x1 0' cells were spotted on slides through centrifugation and fluorescence (membrane expression) 
was analyzed using Confocal microscopy. 1-2: anti-c-kit; 3-4: anti-integrinCD49e, 5: secondary antibody only con-
trol, 6: transferrin. B: the rest of the cells were analyzed by flow cytometri analysis to control proper staining. The 
black line represents c-kit, the dashed line integrin CD49e, the spotted line transferrin and the grey line the second-
ary antibody only control. 
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could include the observed Stat activation. However, as both GP55-A and GP55-P induce Stat 
family member phosphorylation, the studies must concentrate on which members of the Stat 
family are transcriptionally active and which Jak kinases are activated. Furthermore, these 
and novel signalling events of GP55-A and GP55-P need to elucidated and compared. For 
instance it would be interesting to study the levels of BciXL in GP55-P versus GP55-A as 
upregulation of this anti-apoptotic protein is crucial for survival during onset of differentiation. 
Interestingly, expansion of erythroid progenitors ectopically expressing BciXL still requires 
Epo. Combining both RON constitutive activation (resulting in Epa-independent expansion) 
and BciXL upregulation could suffice for GP55-P total Epa-independence and may explain the 
difference between GP55-A and P. 
Future directions: the signalosome 
The work presented in this thesis elucidate new signalling components necessary for proper 
Epo and SCF-induced survival and expansion or "self-renewal" of erythroid progenitors 
(chapter 2, 3, 5, 6). 
It is still unclear whether the EpoR and c-Kit are present in one complex or whether they are 
in distinct functional complexes. Preliminary data show that c-Kit is distributed in numerous 
clusters on the membrane of erythroid progenitors (figure 1 ). Whether c-Kit, RON, the EpoR 
or TRAILR1 distribution is similar and if this distribution changes with varying conditions is at 
present unknown. Indeed shuttling of receptors in the membrane has been observed48 , which 
is another potential regulatory mechanism. 
Knowing all this, it becomes important to describe the composition of the c-Kit and EpoR com-
plex in the membrane setting during different conditions. Membrane complex isolation could 
be used to identify new proteins but also to compare the complex between the normal and 
aberrant state, for instance in Fanconi, MDS, specific knockouts or after incubation with 
inhibitors. In an attempt to obtain these complexes, we recently applied "an old" technique for 
new purposes namely the detergent-free lysis of cells through nitrogen cavitation (described 
by 49 ). Antibodies recognising the extracellular part of the receptor whose complex one wish-
es to study are bound to magnetic beads. These antibody-bound-beads (ABBs) are subse-
quently bound to the cell. Proper binding of the ABBs to cells can be assessed with light 
microscopy and fluctuated for c-Kit-ABBs between 1-3 beads/cell (data not shown). Cells are 
disrupted by rapid nitrogen release after decompression from a 60bar environment incuba-
tion stage. Preliminary data shows that lysis via nitrogen cavitation creates sufficient enough 
particles to isolate distinct complexes (data not shown) but also that there is a clear enriche-
ment in precipitated proteins compared to detergent based precipitation (figure 2). The pro-
teins within this complex may be identified with mass spectrometry. 
Advantages of N2-cavitation are (i) that only plasma-membrane associated complexes are 
precipitated, which avoids dilution by intracellular located receptors (which can be quite sig-
nificant as for instance the EpoR is for 95% located intracellularly),(ii) that the complex is 
studied as situated in the membrane, where signal transduction starts, iii) that not only direct 
binding partners of this receptor are isolated but also proteins which are not directly bound 
but present in the complex, iv) in addition, the technique may be suitable to isolate proteins 
that need the membrane for stable association and which are lost with detergent-mediated 
lysis. Nevertheless, as we isolate a certain size of membrane fragments. This is adjustable 
by varying the nitrogen uptake of the cell through increasing or decreasing the pressure. 
Proteins which do not have a function in this complex are also isolated, particularly proteins 
131 
Chapter 7 
A c-KitiP 
Western: NF SCF 
anti-p-Tyrosine 
anti c -Kit r::=::::J 
8 c-KitN2C 
100 
75 
50 
NF Epo SCF beads 
Erythroid progenitor cell line (1/11) 
250 
150 
100 
75 
50 
Figure 2, c-kit isolation via nitrogen cavitation leads to an enrichement of precipitated proteins when com-
pared to detergent based c-kit isolation. A: 1111 cells were factor deprived for 4 hours and consequently re-stim-
ulated with SCF as indicated. Cells were lysed via mild NP-40 based lysis buffer, c-Kit was immune-precipiated and 
subjected to SDS-PAGE and Western blotting. B: The erythroid progenitor cell line 1111 was factor deprived for 4 
hours in plain medium after which c-Kit-ABBs or unbound beads were added and incubated for 10 min. (4'C). Cells 
were re-stimulated with SCF (5min.) or Epo (1 0 min.) at 37 'C as indicated and lysed via N2C. Lysates were sub-
jected to SDS-PAGE and Western blotting. A, B: Upper panels represent blots stained with anti-phospho-tyrosine 
antibodies (PY99), the lower panels represents the same blots stained with anti-c-kit to check equal loading. Size 
markers are indicated in kDa, asterisks indicate co-immune-precipitating proteins, the arrow marks the size of c-Kit 
and the bands at 50kDa are antibody heavy chains. 
that are abundantly present in the cell membrane. The number of common, non-receptor 
related proteins in part depends on the size of the isolated membrane fragments, the cell line 
used and/or the present developmental stage of the cell. To define and exclude contaminat-
ing proteins, additional receptor complexes that are not associated with the EpoR or cKit will 
be isolated by the same method from the same cells and the proteins present in these non-
related receptor isolates will be compared. We assessed that the integrin receptor complex 
CD49e (VLA-4) is a good candidate to function as a non-related control and total protein 
stains of c-Kit and CD49e membrane-receptor complexes, precipitated onmagnetic beads, 
showed largely dissimilar patterns of proteins when separated by size (data not shown). 
We hypothesize that receptors function in a so-called signalling complex or a 'signalosome', 
with the potential to influence each other's function. This is underlined by several obeserva-
tions: i) we and others 38 found that the EpoR and c-kit are associated in primary erythroid 
progenitors (data not shown), ii) Epo induced the activation of the tyrosine kinase receptor 
RON, which was found to interact with he EpoR (chapter 5), iii) SCF induces the interaction 
between Btk and the death receptor TRAILR1 thereby suggesting that TRAILR1 may also be 
part of this signalosome (chapter 3 ), iv) both SCF and Epo induce the recruitment and phos-
phorylation of docking molecules like Gab1, Gab2 (chapter 5) and Dok1 (chapter 2), v) these 
docking molecules themselves are able to bind numerous proteins again (chapter 2, 5). 
Furthermore, in the light of receptor synergy, cooperation or inhibition, future experiments 
should be directed on studying the cellular behaviour and signalling properties of a cell in rela-
tion to the different stimuli simultaneously received. Indeed, the contribution of other, at pres-
ent unknown, signals in vivo may be crucial in understanding aberrant responses to growth 
factors. For instance, the observation that TRAIL induces cell death in Btk- cells but not in wt 
cells is indicative of the necessity to find the remaining components of the signalling platform. 
It further shows that single receptor studies may not reveal the true function or aberration of 
a certain cell type in which this receptor is expressed. 
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Summary 
Epo and SCF are essential growth factors during erythropoiesis. Epo is crucial for differenti-
ation but also required in cooperation with SCF to induce expansion of erythroid progenitors. 
This expansion is regulated via PI3K dependent mechanisms. This thesis focuses on the 
molecular events downstream of PI3K necessary for appropriate activation of receptor com-
plexes and downstream signalling pathways to control expansion, differentiation and/or sur-
vival of erythroid progenitors. 
Chapter 1 states our current knowledge about the process of erythropoiesis, starting with a 
general introduction describing the importance of growth factors/receptors and a description 
of the hematopoetic system. It gives an overview of the various growth factors important at 
various stages of erythroid development and generally focuses on the EpoR/c-kit signalling 
complex, its signal transduction and the consequences of signal transduction for differentia-
tion, expansion and survival or apoptosis of erythroid progenitors. 
The importance of PI3K prompted us to investigate the role of TEC-family kinases. This 
kinase family harbours a PH-domain that imposes PI3K-dependent membrane recruitment. 
Chapter 2 describes the role of the founding member of the Tee kinase family namely TEC in 
c-Kit signalling. In erythroid cells, Tee is tyrosine phosphorylated after SCF but not with Epo 
stimulation in a PI3K dependent manner. Tee, together with LYN, is responsible for the phos-
phorylation of DOK-1 a multi-tyrosine containing docking protein of 60kDa. DOK-1 can poten-
tially interact with Abl, Crkl, SHIP, and PLCy-1. p62Dok-1 may function as an important scaf-
fold molecule in c-Kit-mediated signaling. The activation of this docking protein, a PI3K 
dependent event, is speculated to be involved in signal enhancement. 
Chapter 3 deals with a different Tee-family member, Bruton's Tyrosine Kinase (Btk), which 
appeared to be a novel target of Epo and SCF signalling. Btk is shown to be tyrosine phos-
phorylated after Epo and SCF stimulation and this phosphorylation event is PI3K dependent. 
Btk-deficient primary fetal liver erythroid progenitors as well as bone marrow and fetal liver-
derived erythroid progenitor cell lines show reduced Epa-induced signal transduction, which 
could be rescued by re-expressing Btk. The reduced signaling results in reduced expansion 
in sub-optimal growth factor conditions and hypersensitivity to TRAIL-induced apoptosis. 
However, if the attenuation of signal transduction is linked to the observed phenotype in Btk 
deficient erythroblasts and how Btk and its downstream effectors mediate part of the Epa-
responsiveness and SCF-mediated apoptosis is sill elusive. 
Chapter 4 describes the characterisation of the alleged Btk inhibitor LFM-A 13, presently used 
as an anti-leukemic drug in mouse studies. We prove that LFM-A 13 not only inhibits Btk, but 
also efficiently inhibits JAK2. Jak2 and Tee-family members are important kinases in many 
hematopoietic cell systems as integral parts of cytokine signaling. Although LFM-A 13 may be 
a useful inhibitor in some experiments, it is not suitable to examine the role of Tec-kinases in 
Jak2 dependent cytokine receptor systems. 
The requirement of PI3K for expansion of erythroid progenitors also prompted us to examine 
docking molecules recruited in response to PI3K-activity, since they can mediate activation of 
numerous signalling pathways that will all be PI3K-dependent. 
Chapter 5 describes the differential recruitment and phosphorylation of Gab1 and Gab2 upon 
stimulation of the EpoR. Recruitment of Gab2 is PI3K-dependent and Src-kinase inhibitors 
prevent its phosphorylation. In contrast, Gab1 is recruited and phosphorylated by the tyrosine 
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kinases receptor RON. RON tyrosine phosphorylation is found to be a downstream event of 
Epo but not SCF signaling. Since RON associates with Src-like kinases, activation of RON 
results in the phosphorylation of the docking proteins Gab1 and Gab2 and subsequent acti-
vation of PKB and the MAPK route. RON signalling can replace Epo signalling during expan-
sion of erythroid progenitors but was not able to sustain differentiation on its own. Epa-
induced differentiation was delayed upon co-activation of exogenous expressed RON. We 
prove that RON is a normal player in the EpoR signalosome and the kinase responsible for 
Epa-induced Gab1 phosphorylation. 
Finally we examined Epa-induced signal transduction and Epo/SCF-dependent expansion 
plus Epa-dependent differentiation in erythroid progenitors deficient in Fanconi-proteins. 
Fanconi proteins have been implicated in DNA-repair, which has been linked to decreased 
cytokine signaling. In chapter 6 we investigated the effect of Fanca and Fancg deficiency on 
Epo and SCF signaling. We found that deficiency results in attenuated Epa-induced Stat5 and 
Erk signalling, while EpoR and Jak2 phosphorylation as well as c-Kit signal transduction 
remains untouched. As expected, lower Stat5 and Erk activation results in flawed Epa-regu-
lated target gene expression. In addition, we observed reduced capacity of the erythroid pro-
genitor to expand. We speculate that both the reduced signaling and the expansion defect 
are a product of hypersensitivity to (oxygen) ROS leading to enhanced DNA damage and 
impaired receptor signaling. 
In Chapter 7 I discuss the data in the context of normal and aberrant erythropoiesis that 
expansion is dependent on the level of PI3K activity and the subsequent recruitment of PH-
domain proteins. Most likely there is a threshold value that controles the balance between dif-
ferentiation and expansion. Next, the role of Stat5 and the putative role of RON are discussed 
in the light of differentiation and Friend-virus induced erythroleukemia respectively. Since all 
experiments elude to the existence of a large receptor complex in which the EpoR, the SCF-
receptor c-Kit, but also RON, docking molecules and additional kinases are associated, we 
set out to isolate and characterise the EpoR/c-Kit receptor complex. The aim of these stud-
ies is the identification and characterisation of proteins involved in the regulation of receptor 
responsiveness and signalling specificity as described in this thesis. Preliminary data and 
future plans are presented. Receptor complexes were isolated in their membrane context 
using N2-cavitation instead of detergents to disrupt cells. This technique allows for specific 
isolation of receptor complexes at the outer cell membrane without severe interruption of 
membrane structure 
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Epa en SCF zijn de belangrijkste groei factoren tijdens de erythropoiesis. Epa is cruciaal voor 
de differentiatie van de erythroide voorlopercel tot rode bloedcel, terwijl Epa in samenwerk-
ing met SCF leidt tot expansie van diezelfde voorlopercel. De expansie is gereguleerd door 
PI3K afhankelijk mechanismen. De thesis spitst zich toe op die PI3K-afhankelijk processen 
welke belangrijk zijn om Epa en SCF de juiste signalen af te Iaten geven in erythroide voor-
lopercellen (e.g. expansie, differentiatie of overleving). 
Hoofdstuk 1 geeft de huidige stand van kennis betreffende erythropoiesis weer. Een 
algemene introductie op groeifactoren en op de ontwikkeling van de rode bloedcel vanuit 
voorlopercellen in het beenmerg wordt gevolgd door een overzicht van verschillende 
groeifactoren en hun effect op erythropoiese. De nadruk wordt vooral gelegd op het EpoR/c-
Kit complex en de signaaltransductie veroorzaakt door Epa en SCF binding aan de respec-
tievelijke receptoren. De link tussen signaaltransductie en cellulaire respons wordt gemaakt, 
met de kanttekening dat hier nag verrassend weinig van bekend is. In dit Iicht wordt oak de 
cooperatie tussen de verschillende receptoren besproken. 
Hoofdstuk 2 beschrijft de rol van de tyrosine kinase Tee in c-Kit signaaltransductie. Tee is de 
naamgever is van de Tec-familie van tyrosine kinases. In erythro"lde cellen wordt Tee PI3K-
afhankelijk gefosforyleerd op tyrosine residuen na stimulatie van de cellen met SCF. Tee is 
samen met Lyn verantwoordelijk voor de tyrosine fosforylatie van Dok-1, wat een multi-tyro-
sine docking eiwit is. Dok-1 kan vervolgens een groat aantal verschillende eiwitten binden, 
waaronder: Abl, Crkl, SHIP en PLCy-1. Dok-1 zou dus een belangrijk eiwit kunnen zijn voor 
SCF ge"lnduceerde signaaltransductie en zou eventueel oak de amplitude en duur van SCF-
geinduceerde signaal transductie kunnen versterken (een signaal versterker). 
Hoofdstuk 3 beschrijft de functie van een ander lid van de Tec-familie in erythroide voorlop-
ercellen, namelijk Btk. Btk wordt zowel na SCF en na Epa stimulatie van erythroide voorlop-
ercellen op tyrosine gefosforyleerd op een PI3K-afhankelijke manier. De Epa geinduceerde 
signaaltransductie is sterk verzwakt in erythroide voorlopers die het Btk-gen missen, maar 
kan worden hersteld door Btk weer tot expressie te brengen in deze cellen. De gereduceerde 
signaaltransductie resulteert in verminderde expansie (versnelde differentiatie) van ery-
thro"lde voorlopercellen en een overgevoeligheid voor TRAIL ge"lnduceerde apoptose. Btk 
blijkt dus een rol te spelen bij de preventie van apoptose door SCF en heeft een positieve 
werking op Epo-ge"lnduceerde signaal transductie, via nag onbekende wegen. 
Hoofdstuk 4 beschrijft dat de Btk rem mer LFM-A 13 niet aileen specifiek Btk remt maar oak 
de tyrosine kinase Jak2. In dit hoofdstuk Iaten we zien dat LFM-A 13 de Jak2 kinase activiteit 
net zo efficient remt als de Btk kinase activiteit. Jak2 en Tec-familie-leden zijn belangrijke 
kinases in veel verschillende hematopoietische cellen en functioneren als integrale eenheden 
van cytokine signaal transductie. Het feit dat Jak2 oak geremd wordt door LFM-A 13 
impliceert dat deze inhibitor slechts beperkt gebruikt kan worden om de rol van Tec-family-
leden te onderzoeken in de signaaltransductie van Jak2 afhankelijke cytokine receptoren. 
Hoofdstuk 5 geeft de rol van de tyrosine kinase receptor RON weer in erythroide voorloper-
cellen. Fosforylatie van RON op tyrosine volgt op activatie van de EpoR en het daaraan 
gebonden Jak2 kinase. Fosforylatie en activatie van RON resulteert in de fosforylatie van 
Gab1 en Gab2, bekende docking moleculen (signaaltransductie versterkers) in Epo-ge"ln-
duceerde signaaltransductie. Directe activatie van RON kan Epa vervangen om samen met 
SCF expansie van voorlopercellen te induceren, maar activatie van Ron is niet voldoende om 
de erythroide voorlopercellen te Iaten uitrijpen tot rode bloedcellen. In combinatie met Epa 
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zorgt RON voor vertraagde differentiatie wat een specifieke rol van RON in expansie beves-
tigt. 
Naast een karakterisatie van componenten van de Epa- en SCF-ge'induceerde signaaltrans-
ductie hebben we Epo-ge"lnduceerde signaaltransductie onderzocht in een model voor 
Fanconi Anemie. Fanconi eiwitten zijn betrokken bij DNA-herstel en beschermt de cell tegen 
oxidatieve stress. In hoofdstuk 6 beschrijven we dat deficientie van Fanca en Fancg leidt tot 
sterk verminderde fosforylatie van Stat5 en Erk in respons op Epa. Activatie van de EpoR en 
Jak2 in respons op Epa en van c-Kit in respons op SCF is echter niet aangetast. Zoals 
verwacht leidt deze verzwakte Epa signaal transductie tot verlaagde expressie van Epo-
gereguleerde genen. Deficientie van Fanca en Fancg leidt oak tot een verlaagde capaciteit 
van de erythroide voorloper cellen om te expanderen. In discussie speculeren we dat zowel 
de verzwakte signaal transductie als het defect in expansie een gevolg kunnen zijn van toen-
emende DNA schade. 
Hoofdstuk 7 bevat een integrale discussie van de verzamelde data. We introduceren de 
hypothese dat er een drempelwaarde aan PI3K activiteit nodig is voor expansie van voorlop-
ercellen. Veel PI3K activiteit geeft expansie terwijl lage PI3K activiteit niet voldoende is om 
differentiatie uit te stellen. Verder geven we aan hoe de verschillende eiwitten beschreven in 
de voorgaande hoofdstukken hierin een rol kunnen spelen. Aan het einde wordt de hypothese 
geopperd dat receptoren in complexen voorkomen en dat deze signaal platvormen opge-
bouwd zijn uit een dynamische verzameling verschillende receptoren en effectoren. Een 
nieuwe manier om deze complexen te onderzoeken wordt ge'introduceerd. 
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Abbreviations 
Btk 
CIS 
Dex 
Dok 
Epa 
EpoR 
Erk 
FA 
Fane 
Gab 
GILZ 
GP55 
Grb 
IFN 
IL 
Jak 
LFM-A13 
N2C 
NGF 
PI3K 
PKB 
PKC 
PLC 
Ron 
SCF 
SFFV 
She 
Shp 
socs 
Stat 
Stk 
Tee 
TNF 
TRAIL 
abbreviations 
Brutons Tyrosine Kinase 
Cytokine Induced SH2 containing protein 
Dexamethasone 
Downstream Of tyrosine Kinases 
Erythropoietin 
Erythropoietin Receptor 
Extracellular signal Regulated Kinase 
Fanconi Anemia 
Fanconi 
Grb2 Associated Binder 
Glucocorticoid Induced Leucine Zipper 
GlycoProtein 55 
Growth Receptor Binder 
Interferon 
lnterleucine 
Janus kinase or Just Another Kinase 
a-cyano-b-hydroxy-b-methyi-N-(2,5-dibromophenyl)propenamide 
Nitrogen Cavitation 
Nerve Growth Factor 
Phospho-lnositoi-3-Kinase 
Protein Kinase B 
Protein Kinase C 
Phospholipase C 
Stem Cell Factor 
Spleen Focus Forming Virus 
Src Homology 2 domain Containing protein 
Src Homology domain containing Phosphatase 
Suppressor Of Cytokine Signalling 
Signal transducer and Activator of Transcription 
Stem-cell derived Tyrosine Kinase 
Tyrosine kinase Expressed in hepatocellular Carcinoma 
Tumor Necrosis Factor 
TNF-a Related Apoptosis Inducing Ligand 
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Zoals gebruikelijk zal ik nu de signalosoom van de werkvloer beschrijven; zonder de support 
van dit netwerk had het boekje niet bestaan. Dit signalosoom bestaat uit mensen welke mij 
hebben be"lnvloed en gestimuleerd, met en zonder succes. Dit laatste werd dan vooral 
geweten aan koppigheid en eigenwijsheid voortkomende uit mijn noordelijke afkomst. 
lnderdaad ben ik in de literatuur een beschrijving voor de Friesche volks-karakter tegen 
gekomen en ik citeer: " .... Vastgegroeide systeemmenschen waren ze weer met hun 
gehechtheid aan de voorvaderlijke inzettingen in de latere middeleeuwen met hun eigen wet-
ten en prat op hun voorrechten met hun quasi-charter van Karel den Grooten. En nog heden 
ten dage is de Friesche onbuigzame, ietwat eigenzinnige, koppige karakterkracht ten spreek-
woord. Op het ge/aat van den Fries vindt men, zoo/ang hij tenminste niet vurig wordt, weinig 
teekenen van wat er omgaat in zijn zie/. Ze/fs zijn woord is ges/oten, hij geeft noch door 
accent, noch door pauze zijn diepste gevoelens bloat. Overigens is hij nadenkend en breed, 
zijn ja is a/tijd overwogen, en het neen - waarvoor hij niet zoo bang is a/s de Genestet - is 
hem een beredeneerde afwijzing, a/ geeft hij er ook zijne redenen niet bij. Kortom perse-
vereerende, actieve, emotioneele naturen. ..... " (Van Ginneken, De sociologische structuur 
der Nederlandsche taal). Dus ik heb mezelf niet verloochend in deze, ook al is er reeds wat 
lndonesische vermenging opgetreden! Overigens, die vermenging doet er eigenlijk niet veel 
toe als men bedenkt dat cultuur een fenomeen is welke men tegen wil en dank opgelegd kri-
jgt door de betreffende cultuurgroep alwaar men woont. De definitie van cultuur: "The system 
of shared beliefs, values, customs, behaviours, and artefacts that the members of society use 
to cope with their world and with one another, and that are transmitted from generation to 
generation through learning.". Hoewel ik dus met aile plezier zekere adviezen zou willen vol-
gen, weerhoudt mijn culturele opvoeding mij van te veel volgzaamheid. Dit uitte zich in het 
niet luisteren naar Martine over hoe ik het beste een western kan doen tot de "ja, in jouw 
wereld werkt dat misschien zo" opmerkingen van lvo tijdens de werkdiscussies. 
Dit te hebben geschreven, zijn Marieke en Thamar samen met Martine, lvo en Bob natuurlijk 
wei de eerste mensen die ik wil bedanken voor het feit dat ik dit boekje kon maken en schri-
jven. Marieke, jou wil ik graag bedanken voor je grenzeloze enthousiasme waarmee je mij 
hebt ontvangen en wetenschappelijk hebt opgevoed op de 13e, helemaal tot en met het 
drukken van dit boekje. In een adem noem ik dan ook direct Thamar die een welkome dis-
cussie gast was op mijn/ons kamertje en die voor mij als een soort "hoe doe ik het volgende 
experiment" handboek heeft gefungeerd. Martine, de hoeveelheid "western-blot" film-boeken 
die je als super analiste hebt staan op het lab neemt wei haast de vorm van een bibliotheek 
aan. lk heb met veel plezier met je samengewerkt, en een groat deel van dit boekje was er 
niet geweest als ik jouw paar extra handen niet had gehad! Iva wil ik graag bedanken voor 
het doorlezen van al mijn verschillende manuscripten en/of versies daarvan en voor al de kri-
tische discussies binnen en buiten de werkdiscussies, ze waren inspirerend, waardevol en 
prettig. Bob, bedankt voor de kritische blik op het werk; ik heb geprobeerd mete focussen op 
de belangrijke zaken. 
lk kan wei zeggen dat ik in een erg gezellige kamer zat waarvan de bewoners, Bart, Geert-
jan en later Walbert altijd gereed waren de laatste experimenten, wilde theorieen, politiek, de 
kamer temperatuur, voetbal, voetbal, voetbal en menig ander onderwerp te bediscussieren, 
onder het genot van een koffie natuurlijk (het liefst gehaald door Bart). Natuurlijk waren er ook 
de aparte gemene delers zoals nostalgisch gepraat met Bart over bestemming Azie (lk zal de 
toto's van Ankor Wat eens op mijn site zetten), en meer werk gerelateerd, de erythroid pro-
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genitor met Walbert (de stoelen race tot aan de kantine; het eeuwige gepin:"ah, je gaat weer 
10 euro pinnen?") en geen gemene deler met Geert-Jan (NAC is tach geen club, kom op!! 
Misschien is het geen toeval en eigenlijk maar beter dat je in je nieuwe werkkring niet meer 
over voetbal kunt praten). Soms mis ik wei je opbeurende woorden, Geert jan: "is je eerste 
artikel al gepubliceerd"; "ben je al met je boekje begonnen"; "de tijd begint tach wei te drin-
gen hoar"; "wanneer was je hier oak alweer begonnen?". 
Net "round the corner" was het inhammetje von Lindern. Met het komen en gaan van ver-
schillende mensen. Janey en Lamberto bedankt voor de Feyenoord vlag en voor het racen 
respectievelijk. 
Godfrey, Montse, Gert-Jan(us kinase), Stefan, Judith, Onno, Alex, Marijke, Claudia 
en Joanna bedankt voor het aanluisteren van mijn chaotische werkbesprekingen, de relaxte 
werksfeer, het leveren van suggesties en wetenschappelijke input. 
Voetballers: Dominik, Peter, Eric (de van den Akkers scoren altijd!) en de rest, 
hopelijk gaat het dit jaar beter dan vorig jaar!! 
Hoewel de inhoud van dit boekje binnen het lab is gefabriceerd zijn er met het tot 
stand komen van het gehele boekje oak veel mensen betrokken die geen been in het lab 
hebben. Als eerste wil ik graag mijn kersverse vrouw, Floortje, bedanken voor haar liefde, 
stimulerende woorden en beg rip. Samen hebben we de stabiliteit gecreeerd waarin we beide 
bloeien (klinkt wei erg bloemerig he, maar het is wei waar). Mijn familie en speciaal mijn 
(schoon)ouders, broer, zwager en (schoon)zussen (daar hoeft niet voor getrouwd te zijn) wil 
ik bedanken voor hun niet aflatende steun tijdens mijn studie en AIO-schap en de getoonde 
interesse in de onderwerpen die mij zoal bezighielden en -houden, oak wanneer de situatie 
wat minder rooskleurig waren voor sommigen en het hoofd soms overliep van andere 
gedachtes. 
En last but zeker niet least, de NWP-crew (of bio-borrel crew) bedankt voor "the hec-
tic" weekenden en avonden. De stelling dat er geen onderwerp is waar niet over gedis-
cussieerd kan worden is aan deze groep wei besteedt. lk amuseer me nag altijd kostelijk op 
het forum! 
Aldus gesproken: merci a taus ! 
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